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1   Introduction 
 
1.1   Infection and Immunity 
 
Host defence against pathogens is based on the non-specific or innate immune system 
and the specific or adaptive immune system. The innate immune system is also the first 
line of defence against a pathogen because it is permanent present. Components of the 
non-specific defence are skin, epithelial cells, phagocytic cells, and complement. The 
second line of defence is specific for a particular type of bacterium or virus and is thus 
called specific immune system. 
 
 
 
1.2   Innate immune system 
 
1.2.1   Pattern recognition receptors  
 
The innate immune system uses a variety of pattern recognition receptors (PRRs) that can 
be expressed on the cell surface, in intracellular compartments, or secreted into the 
bloodstream and tissue fluids (125). The principal function of PRRs is to detect a limited 
set of conserved molecular patterns (pathogen-associated molecular patterns, PAMPs) that 
are unique to microbes and to signal the host the presence of infection. The PRRs include 
the acute phase proteins mannan-binding lectins, C-reactive protein, and serum amyloid 
protein as secreted pattern recognition molecules. The macrophage mannose receptor, 
the macrophage scavenger receptor and MARCO belong to the PRRs expressed on the cell 
surface.  
The Toll-like receptor (TLR) family is the best-characterized class of PRRs in mammalian 
cells. TLRs detect multiple PAMPs (202), including lipopolysaccharide (LPS) (detected by 
TLR4), bacterial lipoproteins and lipoteichoic acids (detected by TLR2), flagellin (detected 
by TLR5), the unmethylated CpG DNA of bacteria and viruses (detected by TLR9), double 
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stranded RNA (detected by TLR3) and single-stranded viral RNA (detected by TLR7) (80). 
TLRs 1, 2, 4, 5, 6 are expressed on the cell surface and are specialised to recognize mainly 
bacterial products. In contrast TLRs 3, 7, 8 and 9 are localized in intracellular 
compartments (80,120) and detect viral nucleic acids in late endosomes and lysosomes 
(58,113).  
All PRRs sense microbial infection and trigger a multitude of antimicrobial and 
inflammatory responses like opsonization, activation of complement, phagocytosis, 
activation of proinflammatory signalling pathways, and induction of apoptosis. 
 
1.2.2   Complement 
 
The complement system is a set of plasma proteins that act together to attack 
extracellular pathogens. Complement can be activated spontaneously by certain 
pathogens or by antibody binding to the pathogen. The pathogen becomes coated with 
complement proteins that facilitate pathogen removal by phagocytes and can also kill the 
pathogen directly (92). 
 
1.2.3   Inflammatory cytokines 
 
One important function of the innate immune response is the recruitment of phagocytic 
cells and thereby effector molecules to the site of infection by the release of a number of 
cytokines and other inflammatory mediators. The cytokines secreted by phagocytes are a 
structurally diverse group of molecules including interleukin-1 (IL-1), IL-6, IL-8, IL-12, and 
tumor necrosis factor-α (TNF-α). IL-1 activates vascular endothelium and lymphocytes. IL-
6 induces fever and the production of acute-phase proteins (serum amyloid protein, C-
reactive protein, fibrinogen, mannan-binding lectin) in the liver. IL-8 is a CXC chemokine 
involved in neutrophil recruitment and activation. IL-12 activates NK cells and induces the 
differentiation of CD4 T cells into Th1 cells. TNF-α activates vascular endothelium and 
increases vascular permeability, which leads to increased entry of IgG, complement, and 
cells to tissues and increased fluid drainage to lymph nodes.  
Cells infected with viruses produce interferons. These slow down viral replication and 
enhance the presentation of viral peptides to cytotoxic T cells as well as activating NK 
cells, which can distinguish between infected and uninfected host cells. 
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1.2.4   Cells of the innate immune system 
 
Host defence against microbial pathogens relies on a concerted action of both antigen-
non-specific innate immunity and antigen-specific adaptive immunity (64,84,125). Key 
features of the innate immune system include the ability to rapidly recognize pathogens 
and/or tissue injury and the ability to signal the presence of danger to cells of the adaptive 
immune system (121). The innate immune system comprises phagocytic cells, natural 
killer (NK) cells, complement and interferons (IFN). Cells of the innate immune system use 
a variety of receptors to recognize patterns shared between pathogens, e.g. bacterial LPS, 
carbohydrates, and double-stranded viral RNA (2,32,134). Evolutionary pressure has led to 
the development of adaptive immunity, the key features of which are the ability to 
rearrange genes of the immunoglobulin family, permitting creation of a large diversity of 
antigen-specific clones and immunological memory. However, this highly sophisticated and 
potent system needs to be instructed and regulated by antigen presenting cells (APCs).  
 
1.2.4.1   Macrophages and monocytes 
 
Originally, monocytes and macrophages were classified as cells of the reticulo-endothelial 
system - RES (Aschoff, 1924). Van Furth et al. (1972) proposed the mononuclear 
phagocyte system - MPS, and monocytes and macrophages became basic cell types of this 
system. Their development takes in the bone marrow and passes through the following 
steps: stem cell - committed stem cell - monoblast - promonocyte - monocyte (bone 
marrow) - monocyte (peripheral blood) - macrophage (tissues). Monocyte differention in 
the bone marrow proceeds rapidly (1.5 to 3 days). During differentiation, granules are 
formed in monocyte cytoplasma and these can be divided as in neutrophils into at least 
two types. However, they are fewer and smaller than their neutrophil counterparts 
(azurophil and specific granules).  
The blood monocytes are young cells that already possess migratory, chemotactic, 
pinocytic and phagocytic activities, as well as receptors for IgG Fc-domains (FcγR) and 
iC3b complement. Under migration into tissues, monocytes undergo further differentiation 
to become multifunctional tissue macrophages. Monocytes are generally, therefore, 
considered to be immature macrophages. However, it can be argued that monocytes 
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represent the circulating macrophage population and should be considered fully functional 
for their location, changing phenotype in response to factors encountered in specific tissue 
after migration.  
Tissue macrophages includes macrophages in connective tissue (histiocytes), liver 
(Kupffer's cells), lung (alveolar macrophages), lymph nodes, spleen, bone marrow, serous 
fluids (pleural and peritoneal macrophages), skin (histiocytes, Langerhans's cell) and in 
other tissues. This wide tissue distribution makes these cells well suited to provide an 
immediate defence against foreign elements prior to leukocyte immigration. Because 
macrophages participate in both adaptative immunity via antigen presentation and innate 
immunity against bacterial, viral, fungal, and neoplastic pathogens, it is not surprising that 
macrophages display a range of functional and morphological phenotypes.  
 
Heterogeneity and activation of macrophages 
 
Macrophage heterogeneity is a well-documented phenomenon. It has also long been 
recognized that macrophages isolated from different anatomical sites display a diversity of 
phenotypes and capabilities. Because macrophage function is dependent in part on signals 
received from the immediate microenvironment, it is suggested that macrophage 
heterogeneity may arise from unique conditions within specific tissues.  
The production of functionally distinct macrophage populations gives the innate immune 
system added flexibility to respond to different immunological or inflammatory stimuli. 
Furthermore, it has been recognized that cells belonging to the myelomonocytic 
differentiation pathway including macrophages and dendritic cells, have a key role in 
polarized innate and adaptative responses. They act by promoting the orientation of 
adaptive responses in a type I or type II direction, as well as by expressing specialized 
and polarized effector functions.  
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Figure 1.1  Chemokines in polarized T-cell responses (from A. Mantovani, 2004 ). During type I and 
type II immune responses, master cytokines regulate chemokine production by stromal and 
inflammatory cells. Chemokines then support selective recruitment of polarized T cells and 
specific type I and type II effector cells expressing distinct panels of chemokines receptors. 
Polarized type I and type II T cells express differential chemokine receptors. Typically, the CC 
chemokine receptors CCR3, CCR4 and CCR8 have been associated with a type II phenotype, 
whereas functional CXCR3 and CCR5 are preferentially expressed on polarized type I T cells. 
CCR3 ligands also attract eosinophils andbasophils, crucial for polarized type II responses. 
Although differentially expressed, chemokine receptors are not markers for polarized T cells, in 
that there is no absolute association between chemokine receptor expression and cytokine 
repertoire of polarized T-cell populations. For instance, CCR4, expressed at much higher levels in 
polarized type II cells, is also expressed in non-polarized T-cell populations, and it is induced in 
type I cells following activation. 
 
For this evidences different authors have used a novel nomenclature M1/M2 that has the 
obvious advantage of reflecting the Th1/Th2 dichotomy. 
The M1 phenotype, acquired after the exposition to the classic activation signals like IFN-γ 
and LPS, is characterized by: high capacity to present antigen, high IL-12 and IL-23 
production, high production of toxic intermediates (nitrix oxide, reactive oxygen 
intermediates) and consequent activation of a polarized type I response. 
Instead the M2 phenotype, also indicating as "alternatively activated macrophages”, is 
acquired after the exposition to IL-10, IL-4 and IL-13 or to factors like the 
immunocomplex and LPS. M2 cells are generally characterized by low production of 
proinflammatory cytokines (IL-12, IL-1, TNF and IL-6) and high production of IL-10. 
With this general caveat, available information suggests that classically activated M1 
macrophages are potent effector cells integrated in Th1 responses, which kill 
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microorganisms and tumor cells and produce copious amounts of proinflammatory 
cytokines. By contrast, M2 macrophages tune inflammatory responses and adaptive type 
II immunity, scavenge debris and promote angiogenesis, tissue remodeling and repair. 
Integration with, and promotion of, type II responses prevail for IL-4- or IL-13-stimulated 
M2 macrophages, whereas suppression and regulation of inflammation and immunity are 
predominant in IL-10-stimulated M2 cells. 
Therefore, it is probable that the nature of an immune response is dictated in large part 
by the functional phenotype(s) of the macrophages present within the lesion.  
In addition, the orchestration and regulation of cytokine production during inflammatory 
responses constitute a key determinant of both the resolution of challenge and the 
limitation of host tissue damage. Hence, the sequential appearance within inflammatory 
lesions may allow the most appropriate response at a given stage of an immune response. 
Analysis of temporal production of cytokines during immune responses suggests that 
different macrophage populations participate at various stages, or that the changing 
conditions within the lesion differentially affect the functions of distinct macrophage 
populations.  
 
Biological functions of macrophages 
 
Macrophages are involved at all stages of the immune response. First, as already outlined, 
they act as rapid protective mechanism which can respond before T cell-mediated 
amplification has taken place. Activated macrophages play a key role in host defence 
against intracellular parasitic bacteria, pathogenic protozoa, fungi and helminths as well as 
against tumours, especially metastasing tumours. After phagocytosis, macrophages 
prevent intracellularly parasitic organisms from replication at least by three ways:  
1. Intracellular environment is unsuitable for microbial reproduction due to low pH and 
lack of nutrients in a phagolysosome.  
2. The toxic reaction may be activated to against dividing organisms. This include ROI, 
hypochlorite, NO, myeloperoxidase, neutral proteases and lysosomal hydrolases.  
3. Macrophages may also produce microbiostatic effector molecules at a steady-state 
and thus maintain intracellular microorganisms in the non-replicating state. This 
latent infection is generally observed only in such individuals whose macrophages 
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cannot be sufficiently activated. Generally, macrophages represent the second line 
of defence against different agent including pathogenic microorganisms.  
In addition, macrophages are important killer cells ; by means of antibody-dependent cell-
mediated cytotoxicity (ADCC) they are able to kill or damage extracellular targets. They 
also take part in the initiation of T cell activation by processing and presenting antigen. 
Finally they are central effector and regulatory cells of the inflammatory response. 
 
1.2.4.2   Dendritic cells (DCs) 
 
DCs are unique APCs because they are able to induce significant primary immune 
responses, thus permitting establishment of immunological memory (18,20,78,198). 
DCs represent a heterogeneous cell population, residing in most peripheral tissues, 
particularly at sites of interface with the environment (skin, mucosa) (17). They display a 
high phagocytic capacity. Following tissue damage, DCs process the captured antigens, 
load them onto MHC molecules and migrate to the secondary lymphoid organs, where 
they present the antigenic peptides in the context of MHC molecules to T cells, thereby 
initiating adaptive immune responses (73,205). DCs activate antigen-specific CD4+ T 
helper cells, which in turn regulate the immune effectors, including antigen-specific CD8+ 
cytotoxic T cells (CTL) and B cells, as well as non-antigen-specific macrophages, 
eosinophils and NK cells. Moreover, DCs induce effector cells to home to the site of 
infection (17). Four stages of DC development have been delineated: (i) bone marrow 
progenitors; (ii) precursor DCs that are patrolling through blood and lymphatics as well as 
lymphoid tissues, and that upon pathogen recognition, release large amounts of cytokines, 
e.g. IFN-γ; (iii) tissue-residing immature DCs, which possess high endocytic and 
phagocytic capacity permitting antigen capture; and (iv) mature DCs, present within 
secondary lymphoid organs, that express high levels of costimulatory molecules permitting 
antigen presentation and T cell activation (Fig.1.2).  
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Figure 1.2 The life cycle of dendritic cells (from Banchereau (17)). Circulating precursor DCs enter 
tissues as immature DCs. They may directly encounter pathogens that induce secretion of 
cytokines (e.g. IFN-γ). Immature DCs reside at strategically important sites in the periphery to 
encounter pathogens. After antigen capture, immature DCs migrate to lymphoid organs where, 
after maturation, they display peptide-MHC complexes, which allows selection of rare circulating 
antigen-specific lymphocytes. These activated T cells help DCs in terminal maturation, which 
allows lymphocyte expansion and differentiation. Activated T lymphocytes migrate and reach the 
injured tissues. Helper T cells secrete cytokines, which permit activation of macrophages (MF), 
NK cells and eosinophils. Cytotoxic T cells eventually lyse the infected cells. B cells become 
activated after contact with T cells and DCs and then mature into antibody-producing plasma 
cells. It is believed that, after interaction with lymphocytes, DCs undergo apoptosis. 
 
In addition to T cell priming, DCs appear to maintain essentially survival of naive CD4+ T 
cells (33) and immune T cell memory (159). Importantly, DCs are also involved in the 
tolerization of the T cell repertoire to self-antigen. This occurs in the thymus (central 
tolerance) by deletion of developing T cells recognising self-antigens (33), and in lymphoid 
organs (peripheral tolerance) probably by the induction of anergy or deletion of mature T 
cells. 
 
Dendritic cell activation and maturation 
 
Immature DCs reside in peripheral tissues at sentinel positions where they take up self 
and non-self antigens. However, they are not able to present the antigens. Immature DCs 
accumulate MHC molecules intracellularly and present only a small fraction at the cell 
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surface (37,155). Three types of antigen uptake are known: macropinocytosis, 
phagocytosis and clathrin-mediated endocytosis (69,172,220,221). Different types of 
antigens are internalised via these different routes. The constitutive and cytoskeleton-
dependent process of macropinocytosis allows rapid and non-specific sampling of large 
amounts of surrounding fluid and results in the formation of large intracellular vacuoles. 
Phagocytosis is a receptor-mediated process dependent on actin assembly. In general, the 
receptors mediating phagocytosis of pathogens are also engaged in clathrin-mediated 
endocytosis of soluble antigens. The latter allows uptake of macromolecules through 
specialized regions of the plasma membrane, termed coated pits (194). A large number of 
endocytic receptors are expressed on immature DCs, namely C-type lectins (93,172,210), 
receptors for the Fc portion of immunoglobulins (FcRs) (122,152), complement receptors 
(154), receptors for heat shock proteins (7,21), and scavenger receptors (148).  
A signal from pathogens, often referred to as danger signal (67), induces DCs to enter a 
developmental program, called maturation, which transforms DCs from sentinels into 
efficient APCs and T cell stimulators (17). The danger signal can be a bacterial or viral 
product as well as an inflammatory cytokine. Danger signals are recognized through 
specific pattern-recognition receptors, such as Toll-like receptors, FcR and cytokine 
receptors (125,152).  
Maturation of DCs is accompanied by fundamental morphological and functional changes. 
Antigen uptake, phagocytosis as well as macropinocytosis is down-regulated (172). In 
addition, MHC molecules are redistributed from intracellular endocytic compartments to 
the cell surface (37,155). Antigen processing, peptide loading as well as the half-life of 
MHC molecules is increased (37,155). Finally, the surface expression of T cell co-
stimulatory molecules, such as CD80, CD86 or CD40, also rises (Fig. 1.3).  
Simultaneously with the modifications of their antigen presentation abilities, maturation 
induces migration of DCs out of peripheral tissues (15) to the secondary lymphoid organs. 
Modifications in the expression of chemokine receptors (e.g. CCR7) and adhesion 
molecules (e.g. ICAM-I), as well as profound changes of the cytoskeleton organization 
contribute to the migration of DCs (173). 
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Figure 1.3 Features that change during DC maturation 
 
1.2.4.3   Neutrophils 
 
Neutrophils, which are also known as polymorphonuclear leukocytes (PMN), represent 50 
to 60% of the total circulating leukocytes and constitute the ''first line of defence'' against 
infectious agents or ''non-self'' substances that penetrate the body's physical barriers. 
Once an inflammatory response is initiated, neutrophils are the first cells to be recruited to 
sites of infection or injury. Their targets include bacteria, fungi, protozoa, viruses, virally 
infected cells and tumour cells. Their development in the bone marrow takes about two 
weeks; during this period, they undergo proliferation and differentiation. During 
maturation, they pass trough six morphological stages: myeloblast, promyeloblast, 
myelocyte, metamyelocyte, non-segmented (band) neutrophil, segmented neutrophil. The 
segmented neutrophil is a fully functionally active cell. It contains cytoplasmic granules 
(primary or azurophil and secondary or specific) and a lobulated chromatin-dense nucleus 
with no nucleolus. Upon release from the bone marrow to the circulation the cells are in a 
nonactivated state and have a half-life of only 4 to 10 h before marginating and entering 
tissue pools, where they survive for 1 to 2 days. Cells of the circulating and marginated 
pools can exchange with each other. Senescent neutrophils are thought undergo apoptosis 
(programmed cell death) prior to removal by macrophages. The viability is significantly 
shorter in individuals suffering from infectious or acute inflammatory diseases when the 
tissue requirement for newly recruited neutrophils increases considerably.  
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Neutrophil granules 
 
The neutrophil granules are of major importance for neutrophil function. The granules of 
neutrophils are generated during cell differentiation; they are produced for storage rather 
than continually. On the basis of function and enzyme content, neutrophil granules can be 
divided into three main types: azurophil, specific and small storage granules. Their 
function is not just to provide enzymes for hydrolytic substrate degradation, as in classical 
lysosomes, but also to kill ingested bacteria and, finally, to secrete their contents to 
regulate various physiological and pathological processes, including inflammation. 
 
Neutrophils in host defence 
 
The major role of neutrophils is to phagocytose and destroy infectious agents but they 
also limit the growth of some microbes, thereby buying time for adaptive (specific) 
immunological responses. With many microbes, however, neutrophil defences are 
ineffective in the absence of opsonins and various agents that amplify the cytotoxic 
response.  
Opsonization is a process, in which opsonins adsorb to the surface of bacteria or other 
particles and facilitate their adherence to the phagocyte cytoplasmic membrane through 
opsonin receptors. Specific binding between the particle and phagocyte which occurs 
during immune phagocytosis is mediated by immunoadherent receptors. There are two 
types of immunoadherent receptors: Fc-receptors mainly for IgG antibodies (FcγR) and 
complement receptors (CR1, CR3). It means that function of opsonins in the first case is 
realized by antibodies and in the second case by iC3b. Specific binding between the 
particle and phagocyte may be also performed by lectins and lectin receptors 
(lectinophagocytosis).  
To the phagocytosis itself chemotaxis of phagocytes precede into the site where 
phagocytosable material occurs. This is regulated by chemotactic factors generated by 
infectious agents themselves, as well as those release as a result of their initial contact 
with phagocytes and other components of the immune system.  
Phagocytosis is a complex process composed of several morphological and biochemical 
steps. After recognition and particle binding to the phagocyte surface, ingestion 
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(engulfment), phagosome origination, phagolysosome formation (fusion of phagosome 
with lysosomes), killing and degradation of ingested cells or other material proceed. 
Simultaneously with the recognition and particle binding a dramatic increase in oxygen 
consumption (the respiratory burst) is observed. During this, oxygen is univalently reduced 
by NADPH oxidase to superoxide anion or its protonated form, perhydroxyl radical, which 
then is catalytically converted by action of superoxide dismutase to hydrogen peroxide:  
 
O2+e-+H+ → HO2= O2-+H+ 
 
O2-+O2-+2H- → O2+H2O2 
 
 
During phagocytosis, cytosolic granules (lysosomes) fuse with the invaginating plasma 
membrane (around the engulfing microorganism) to form a phagolysosome into which 
they release their contents, thereby creating a higly toxic microenvironment. This step is 
of the first importance because during it two categories of cytotoxic substances, present in 
the preformed state in azurophil and specific granules and synthesized de novo during the 
respiratory burst, arrive at the same cell compartment. This degranulation normally 
prevents release of the toxic components into the extracellular milieu. However, some 
target may be too large to be fully phagocytosed or they avoid engulfment, resulting in 
frustrated phagocytosis in which no phagosome is formed. These may be killed 
extracellularly. However, tissue damage occurs when neutrophil microbicidal products are 
released extracellularly to such an extent that host defences (antioxidant and antiprotease 
screens) in the immediate vicinity are overwhelmed. 
The importance of neutrophils in fighting bacterial and fungal infections is well recognized. 
Recently, it has been shown that neutrophils are in abundance also in virally induced 
lesions. Neutrophils bind to opsonized viruses and virally infected cells via antibody (Fc) 
and complement (iC3b) receptors. Viruses such as influenza can be inactivated by 
neutrophils trough damage to viral proteins (e.g. hemagglutinin and neuraminidase) 
mediated by the myeloperoxidase released during degranulation. In contrast to these 
acute diseases, chronic influenza infections can diminish or exhaust the microbicidal 
potency of neutrophils.  
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Regulation of neutrophil function 
 
Under normal conditions, neutrophils roll along microvascular walls via low affinity 
interaction of selectins with specific endothelial carbohydrate ligands. During the 
inflammatory response, chemotactic factors of different origin and proinflammatory 
cytokines signal the recruitment of neutrophils to sites of infection and/or injury. This 
leads to the activation of neutrophil β2-integrins and subsequent high-affinity binding to 
intercellular adhesion molecules on the surface of activated endothelial cells in 
postcapillary venules. Under the influence of a chemotactic gradient, generated locally and 
by diffusion of chemoattractants from the infection site, neutrophils penetrate the 
endothelial layer and migrate through connective tissue to sites of infection (diapedesis), 
where they finally congregate and adhere to extracellular matrix components such as 
laminin and fibronectin.  
Cytokines are basic regulators of all neutrophil functions. Many of them including 
hematopoietic growth factors and pyrogens have shown to be potent neutrophil priming 
agents. 
Historically, PMNs have not been considered capable of responding to stimuli via gene 
expression and protein synthesis. It was thought that neutrophils reacted entirely via the 
secretion of preformed proteins contained within the cytoplasm and granules at the time 
of cell migration from bone marrow into the blood stream. While recent investigations 
demonstrated a range of gene products whose expression is modulated by signals sensed 
in the environment.  
PMNs can synthesize and secrete small amounts of some cytokines including IL-1, IL-6, 
CXCLl1, TNF-α, and GM-CSF; they may act in an autocrine or paracrine manner. A great 
number of inflammatory cytokines in synergy with IL-1, TNF-α, IL-6 and IFN-γ, can act as 
priming agents. The term “priming” refers to a stimulus that prepares PMNs for enhanced 
activity upon secondary stimulation. A variety of traditional PMN functions may be primed, 
including increase of oxidative metabolism, surface receptor expression, degranulation and 
various neutrophil cytotoxic functions like the neutrophil antibody-dependent cellular 
cytotoxicity (ADCC). In the other hand anti-inflammatory cytokines, IL-4 and IL-10 inhibit 
the production of Cxcl1 and the release of TNF-α and IL-1 which reflects in the blockade 
of neutrophil activation.  
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Furthermore, some cytokines like IFN-γ prolong neutrophil survival. PMNs, as terminally 
differentiated cells, are short-lived ad readily undergo apoptosis, or programmed death 
cell. Along to cytokines other mediators, including bioactive lipids, neuroendocrine 
hormones, histamine, and adenosine, are also involved in the regulation of neutrophil 
activation.  
Although neutrophils are essential to host defence, they have also been implicated in the 
pathology of many chronic inflammatory conditions and ischemia-reperfussion injury. 
Hydrolytic enzymes of neutrophil origin and oxidatively inactivated protease inhibitors can 
be detected in fluid isolated from inflammatory sites. Under normal conditions, neutrophils 
can migrate to sites of infection without damage host tissues. This damage may occur 
through several independent mechanisms. These include premature activation during 
migration, extracellular release of toxic products during the killing of some microbes, 
removal of infected or damage host cells and debris as a first step in tissue remodeling, or 
failure to terminate acute inflammatory responses. 
 
1.2.4.4   NK Cells 
 
Natural killer (NK) cells play an instrumental role in the innate immune responses against 
certain bacterial, parasitic and viral pathogens (156). Furthermore, NK cells have been 
shown to play an important role in suppressing tumor metastasis and growth (84). 
Activation of NK cells is primarily achieved by the viral induced interferons α/β and to a 
lesser extent by IL-12 and IL-18 (44). Once activated, NK cells produce large amounts of 
IFN-γ and a wide variety of other cytokines, combinations of which are thought to 
specifically tailor downstream adaptive immune responses against the invading pathogen 
(44). These important functions place NK cells at the interface between the innate and 
adaptive immune responses (92). 
NK cells develop from pluripotent bone marrow derived hematopoietic stem cells and at 
one stage in their development share a common progenitor with T cells. However, unlike T 
cells, NK cells do not require receptor gene rearrangement for successful maturation. The 
crucial role of IL-15 has been demonstrated in mice that lack the IL-2/15Rβ chain or the 
IL-15Rα chain. These mice are deficient in NK and NK-T cells. In addition, removal of 
interferon regulatory factor 1 (IRF-1) results in reduced numbers of NK cells that appear 
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phenotypically normal but lack cytolytic effector function. IRF-1 is a transcription factor 
essential for effective expression of IL-15 and perhaps other cytokines whose genes also 
contain IRF-1 response elements. Further development of NK cells requires the acquisition 
of inhibitory receptors, a process requiring the expression of MHC class I and as yet 
unidentified stromal derived factors (149). Terminal differentiation of NK cells into IFN-γ 
producing cells likely requires the action of IL-12 and IL-18, since loss of either results in 
significantly decreased NK cell cytotoxicity and IFN-γ production (4). The primary 
peripheral NK cell subset is present as a mature population of leukocytes, which can be 
easily identified in several compartments including peripheral blood, spleen and bone 
marrow. 
 
NK cells receptors  
 
NK cell recognition involves the initial binding to potential target cells, interactions 
between activating and inhibitory receptors with ligands available on the target, and the 
integration of signals transmitted by these receptors, which determines whether the NK 
cell detaches and moves on or stays and responds. NK cells respond by reorganizing and 
releasing cytotoxic granules and by transcribing and secreting cytokines. Recent studies 
have demonstrated reorientation of the relevant receptors into an “NK synapse” during NK 
cell encounters with potential target cells (44, 92), as observed previously in the 
interaction between T cells and antigen-presenting cells. NK cells differ from naive T cells 
in that mature NK cells are poised as effector cells for an immediate response. These 
“ready-to-go” cells express granzymes and perforin, and their lytic response can be 
triggered within minutes, without requiring transcription, translation, or cell proliferation. 
Recent studies (149) have shown that NK cells constitutively express prestored transcripts 
for IFN-γ that are immediately available to initiate cytokine synthesis upon activation. Even 
at their earliest stages of development, IFN-γ transcripts are present in the NK cell 
progenitors in the mouse bone marrow (149). 
Therefore NK cells activity is strictly regulated by a variety of opposing signals from 
receptors that can either activate or inhibit effector function (92). Target cell specificity is 
not provided by the activating receptors that may be stimulated by a variety of signals, 
but rather by an array of inhibitory receptors that recognize MHC class I. This system is 
consistent with the “missing-self hypothesis” which postulates that NK cells survey tissues 
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for normal expression of MHC class I and will become activated when in contact with cells 
that have down-regulated or do not express MHC class I. The last few years have seen a 
dramatic increase in the number of inhibitory receptors identified and a concurrent 
expansion in our understanding of their involvement in NK cell function. In contrast, many 
of the receptors involved in activation have been known for several years but only recently 
have their signalling pathways become more defined. 
 
Activating Receptors 
 
Unlike T cells and B cells, which recognize antigen using clonally restricted receptors 
generated by gene rearrangement, NK cells use a variety of different non-rearranging 
receptors to initiate cytolytic activity and cytokine production. Many of these receptors are 
not unique to NK cells, but are also expressed by T cells. Receptors implicated in mouse 
and rat NK cell activation include CD2, CD16, CD28, Ly-6, CD69, NKR-P1, 2B4 (CD244), 
NKG2D, and CD94/NKG2A. It is believed that to successfully initiate effector function, 
signaling through one receptor is not sufficient. Additive or synergistic interactions 
between multiple activating receptors, is required which perhaps signal through a set of 
shared adaptor molecules or signalling pathways (88).  
 
Inhibitory Receptors 
 
The inhibitory receptor superfamily (IRS) 9 describes an expanding group of receptors that 
block activation of a number of different cell types in the immune system. By definition, 
IRS members must act in trans, be able to recruit phosphatases (such as SHP-1) through 
an ITIM, and must associate directly with an activating receptor (92). NK cell inhibitory 
receptors fall into two main structural groups, the calcium dependent lectin-like receptors 
and the immunoglobulin-like receptors. C-type lectin family members include the Ly-49 
family identified in rodents, and CD94 and the NKG2 family identified in rodents and 
humans. These C-type lectins, predominantly expressed on NK cells, are encoded by 
genes located on distal mouse chromosome 6 and syntenic rat chromosome 4 and human 
chromosome 12 in a region called the “NK gene complex”. 
NK cells engage in several kinds of interactions with other cells of the immune system, 
including dendritic cells and macrophages. Dendritic cells can influence the proliferation 
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and the activation of NK cells both through release of cytokines including IL-12, and 
trough cell-surface interaction, including CD40/CD40 ligand, LFA-1/ICAM-1, and 
CD27/CD70. In return, NK cells provide signals that result in either activation or apoptosis 
to control the inflammatory response. 
 
 
 
1.3   Adaptative immune system 
 
Although the non-specific innate defences are effective, they do not protect against all 
invading pathogens. Microbes have developed several strategies to evade the innate 
immune system. Therefore a second defence system has evolved, the adaptive immune 
system, including antibodies and T cells. 
 
1.3.1   Antibodies 
 
Antibodies are protein complexes produced by B lymphocytes (B cells). There are several 
types of antibodies with different immunological functions. During infection IgM and IgG1-
4 are most important. IgM antibodies are synthesized in the early phase of the immune 
response and are found mainly in the blood. They are pentameric in structure and 
specialised to activate complement efficiently upon binding antigen. IgG1 and IgG3 are 
called opsonizing antibodies because these two subtypes are the most effective in 
opsonizing microbes. This opsonization facilitates the ingestion of antigens by phagocytes. 
IgG also mediates the attachment of cytotoxic cells to infected tissue, eventually leading 
to death of an infected cell (antibody-dependent cell-mediated cytotoxicity). This 
mechanism serves as a defence against intracellular pathogens. Both IgG and IgM 
neutralize microbes by binding to the surfaces of bacteria and viruses and prevent them 
from attaching to and invading host cells. Both types of antibodies are also able to activate 
complement and neutralize toxins (92). 
 
1.3.2   Cytotoxic T lymphocytes (CTLs) 
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On their surface, CTLs express a protein called CD8, which is associated with the T cell 
receptor, by which they recognize pathogen-derived peptides bound to MHC class I 
molecules (mostly from viruses). CTLs play a role in killing infected host cells similar to 
that of NK cells and produce proteolytic enzymes (granzymes) that trigger apoptosis in the 
infected cells. This type of attack kills the infected cells but commonly not the microbes. 
Microbes, released from infected cells, can be taken up by activated macrophages, which 
finally kill them. Alternatively, the CTLs might also attack the microbes by perforin and 
granulysin stored within their granules. First, perforin forms pores into the host cell 
membrane. By these pores granulysin enters the infected cell and kills the bacteria by 
creating pores in their membranes. 
 
1.3.3   T helper cells 
 
After activation naive CD4 T cells differentiate into either Th1 cells or Th2 cells. IL-12 
produced by macrophages or DCs stimulates NK cells to produce IFN-γ, which in turn 
stimulates CD4 T cells to differentiate into Th1 cells. IL-4 stimulates CD4+ T cells to 
develop into Th2 cells. Th1 cells produce IFN-γ, which activates macrophages allowing 
them to destroy intracellular microorganisms more efficiently. Th1 cells can also stimulate 
B cells to produce subclasses of antibodies and activate cytotoxic T cells. Th2 cells activate 
eosinophils and stimulate B cells to produce antibodies of the IgG1 class by secreting IL-4 
and IL-5. 
 
 
 
1.4   The genus Yersinia  
 
The genus Yersinia belongs to the family of Enterobacteriaceae. They are facultative 
anaerobe, gram-negative rods with an optimal growth at 27-30°C (45). The genus Yersinia 
includes three species that are pathogenic for rodents and humans: Y. pestis is the 
causative agent of plague, Y. pseudotuberculosis, and Y. enterocolitica cause acute or 
chronic enteric disorders such as enteritis, enterocolitis, and mesenteric lymphadenitis, 
which are normally self-limited. In some cases the infection leads to systemic 
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manifestations like septicaemia and immunopathological sequelae including reactive 
arthritis, uveitis, and erythema nodosum (48). While a fleabite generally inoculates Y. 
pestis, Y. pseudotuberculosis and Y. enterocolitica are food-borne pathogens. In spite of 
these differences in infection routes, all three have a common tropism for lymphoid tissues 
and a common capacity to resist non-specific immune response, in particular phagocytosis 
and killing by macrophages and PMNs. Electron microscopy as well as cell biology 
examinations revealed that Y. enterocolitica and Y. pseudotuberculosis are largely located 
extracellularly (14,55,77,188,191). 
 
1.4.1   Pathogenicity factors of Y. enterocolitica 
 
Yersinia possesses several virulence factors encoded either by genes of the bacterial 
chromosome (157) or by genes located on the 70-kb virulence plasmid pYV (plasmid 
Yersinia Virulence) (47,87,145,195) which enables Yersinia spp. to survive and multiply in 
the lymphoid tissues of their host. Table 1.1 gives an overview of the pathogenicity factors 
of Yersinia spp.. 
 
Table 1.1 Overview of the most important virulence factors of enteropathogenic Yersinia 
 
a) Chromosomally-encoded factors 
Factor Function Literature 
Ail Mediates adhesion to and invasion in epithelial cells as well as serum 
resistance. 
(25,129,147) 
Inv Invasin, an adhesin. Initiates by binding to β1-integrins transport of 
Yersinia across the M cells, internalisation in epithelial cells and 
secretion of IL-8. 
(6,31,60,91,95,11
4,144, 
181,184) 
Myf Fibrillae possibly acts as a colonization factor and leads together with 
Yst to diarrhea. 
(90) 
SodA Super oxide dismutate (Sod), enzyme for detoxification of exogenous 
oxygen radicals produced by phagocytes. Mediates virulence for 
colonization of liver and spleen, but not of Peyer’s patches. 
(161) 
Yst Heat-stable enterotoxin, stimulates the activity of guanylate cyclase of 
intestinal epithelial cells and leads to diarrhea. 
(52,151,160) 
HPI  
(High 
The HPI encodes the extracellular siderophore Yersiniabactin (Ybt) 
that enables the bacteria to multiply under iron-depleted conditions. 
(11,15,75) 
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Patho-
genicity 
Island) 
Genes involved in Ybt synthesis, transport and regulation are 
clustered in the HPI. Ybt possibly acts immunosuppressive on T and B 
cells, macrophages and PMNs. 
 
b) Plasmid-encoded factors 
 
 
Factor Function Literature 
YopE Cytotoxin, works as GAP (GTPase activating protein) for 
Rho-family proteins, blocks phagocytosis, disrupts actin 
filaments. 
(1,23,165,215) 
YopH Phosphotyrosine phosphatase, which dephosphorylates 
proteins of focal adhesions therefore responsible for up to 
50% of the antiphagocytic activity of yersiniae towards 
neutrophiles and macrophages. Suppression of oxidative 
burst in macrophages, inhibition of T and B lymphocyte 
activation. 
(22,24,72,170,175,223) 
YopO (YpkA) Serine-threonine kinase activated by G-actin causing 
autophosphorylation of serine residues. Disruption of actin 
filaments. Interacts with RhoA and Rac1. 
(19,68,94) 
YopM Strongly acidic protein containing leucine-rich repeats 
(LRRs). It traffics to the cell’s nucleus by means of a 
vesicle-associated pathway. 
(111,112,123,193) 
YopP Cysteine protease, interacts with members of the MAPK 
kinase (MKK) super family and IKK-β thereby disrupting 
MAPK and NF-κB signalling pathways leading to inhibited 
release of proinflammatory cytokines as well as induction of 
apoptosis in macrophages. 
(30,53,54,141,142,167) 
YopT Destruction of actin stress fibres by modification of RhoA, 
which is released from the plasma membrane and 
accumulates as monomeric protein in the cytosol. 
(89,146,224) 
YadA Mediates adherence to epithelial cells and phagocytes. 
Binds to collagen, fibronectin, and laminins. It protects Y. 
enterocolitica against killing by PMNs and lysis by 
complement due to the binding of factor H by YadA. 
(40,162,163,185) 
LcrV Suppression of TNF-α and IFN-γ. Inhibits the chemotaxis of 
neutrophils. Induces the production of IL-10 in 
macrophages. 
(135,192,219) 
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1.4.2   The type III secretion system of Y. enterocolitica 
 
By means of its type III secretion system (TTSS) some gram-negative bacteria are able to 
translocate their effector proteins directly into the cytosol of host cells (66). To date 20 
different TTSS are identified in animal and plant pathogens (46). The pYV plasmid 
encodes the Yop virulon, a system consisting of secreted proteins called Yops and their 
dedicated type III secretion apparatus called Ysc. 
Upon contact with eukaryotic target cells, Yersinia bacteria build several syringe-like 
organelles at their surface (Fig. 1.5). These organelles, called the Ysc injectisome, are 
protein pumps spanning the peptidoglycan layer and the two bacterial membranes topped 
by a stiff needle-like structure protruding outside the bacterium. The whole organelle 
comprises 27 proteins. The internal part contains 10 proteins, which have counterparts in 
the basal body of the flagellum, indicating that the two organelles have a common 
evolutionary origin. The external part of the injectisome, which spans the bacterial outer 
membrane, is a homomultimeric ring-shaped structure with a central pore of ≈50 Å (98). 
The Ysc injectisome ends with a 60–80 nm long and 6–7 nm wide needle, whereas the 
length is genetically controlled (130). Effector Yops destined for secretion through the 
injectisome have no classical signal sequence (128). Nevertheless, a minimum of 15 
residues at the NH2 terminus are necessary for Yop secretion (4,196). 
To become secreted some of the Yops need the help of small individual chaperones called 
Syc proteins. There are two categories of Yop proteins. Some are intracellular effectors, 
whereas the others are “translocators” which are needed to deliver the effectors across 
the eukaryotic plasma membrane into the cytosol of eukaryotic cells. The translocators 
(YopB, YopD, LcrV) form a pore of 16-23 Å in the eukaryotic cell membrane. 
Six effector Yops have been characterized: YopE, YopH, YopM, YopJ/P, YopO/YpkA, and 
YopT. YopH is a powerful phosphotyrosine phosphatase playing an antiphagocytic role by 
dephosphorylating several focal adhesion proteins. YopE and YopT contribute to 
antiphagocytic effects by inactivating GTPases controlling cytoskeleton dynamics. YopP 
plays an anti-inflammatory role by preventing the activation of transcription factor NF-κB. 
YopP also blocks the MKKs, inhibiting the activation of MAPK, which abrogates activation 
of CREB, a transcription factor involved in the immune response. YopP induces apoptosis 
in macrophages, either directly by acting upstream of Bid or indirectly by blocking the 
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synthesis of NF-κB–dependent antiapoptotic factors. Less is known about the role of the 
phosphoserine kinase YopO/YpkA and YopM (see also Table1.1). 
 
 
 
Figure 1.4 Secretion of Yops by the Ysc injectisome and translocation across the target cell 
membrane. (from Cornelis, 2002) When Yersinia is placed at 37°C in a rich environment, 
the Ysc injectisome is installed and a stock of Yop proteins is synthesized. During their 
intrabacterial stage, some Yops are capped with their specific Syc chaperone. Upon contact 
with a eukaryotic target cell, the adhesins YadA or Inv interact with integrins and the 
bacterium docks at the cell's surface. Then, the secretion channel opens and Yops are 
exported. YopB and YopD form a pore in the target cell plasma membrane (MP), and the 
effector Yops are translocated across this membrane into the eukaryotic cell cytosol (C). EM, 
outer membrane; P, peptidoglycan; IM, plasma membrane. 
 
1.4.3   Immune response to Yersinia 
 
Enteric Yersinia spp. are enteroinvasive pathogens, which are taken up by M cells. M cells 
are specialized epithelial cells which occur within the follicle-associated epithelium of the 
Peyer's patches (14,71). M cells expose β1-integrins at their apical (“lumenal”) surface, 
which may bind to the Yersinia invasin protein (41,182). The entry of enteric Yersinia by 
this route is an ambiguous process: on the one hand, Yersinia may use M cells as a 
structure of the mucosal immune system for invasion of host tissue, and most likely for 
subsequent dissemination. On the other hand, the mucosal immune system is stimulated 
upon entry of Yersinia at the very site where efficient immune responses are usually 
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initiated. One day after M cell invasion by Y. enterocolitica, small microabscesses 
consisting of PMNs and extracellularly located Yersinia can be detected in Peyer’s patch 
tissue (14,77).  
Yersinia has evolved efficient mechanisms mediated by the outer membrane protein YadA 
and secreted anti-host effector proteins (Yops) (for references see table 1) to evade host 
innate defence mechanisms including phagocytosis by PMNs, macrophages and the 
complement system. In accordance with these in vivo observations, Yersinia manifests 
some resistance to phagocytosis in vitro, both by macrophages (63,164) and by PMN 
(40,170,213). After replication in Peyer’s patches, enteric Yersinia disseminate via the 
lymphatics and possibly via the blood stream to the mesenteric lymph nodes, spleen, liver, 
lungs and peripheral lymph nodes (14). 
The adaptive immune response plays a crucial role in the clearance of a Yersinia infection. 
It has been clearly demonstrated that Yersinia infection leads to a strong T cell responses, 
including activation and proliferation of CD4 and CD8 T cells, and that these T cells are 
involved in control of Yersinia (15,16,26,29,61,62,137). In fact, mice deficient for T cells 
are unable to control the pathogen, and therefore develop chronic progressive and fatal 
infection (15). Adoptive transfer of Yersinia-specific CD4+ or CD8+ T cells consistently 
mediates resistance to a normally lethal challenge of Yersinia (16). As protective CD4 or 
CD8 T cells produce cytokines such as IFN-γ and IL-2, but not IL-4 or IL-10, it can be 
concluded that Th1 or IFN-γ producing cytotoxic T cells are protective in yersiniosis 
(14,16,26,28). Th1 cells produce predominantly IFN-γ, and it is established that IFN-γ can 
activate macrophages which in turn might be able to kill the pathogen. 
The role of cytokines in yersiniosis has been extensively studied in mouse strains that are 
relatively susceptible (e.g., BALB/c) or resistant (e.g., C57BL/6) to Yersinia infection. One 
reason for this differential susceptibility of mice is their different ability to mount Th1 
responses and produce IFN-γ  upon Yersinia infection (15,27). Yersinia-resistant C57BL/6 
mice can be rendered Yersinia-susceptible by neutralizing IFN-γ in vivo with monoclonal 
antibodies (15). Conversely, Yersinia-susceptible BALB/c mice can be rendered resistant by 
treatment with IFN-γ. In keeping with these results, it was found that administration of 
neutralizing anti-IL-4 antibodies also rendered BALB/c mice resistant to Yersinia infection 
(15). From these data it can be concluded that IFN-γ is a central protective cytokine in 
Yersinia infection. In addition experiments with cytokine- or cytokine receptor-deficient 
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mice clearly demonstrated that the cytokines TNF-α, IL-12, IL-18 and IFN-γ are all 
essential for control of Yersinia infection (26,28,29,81).  
In contrast to T cell responses, protective antibodies recognize the outer membrane 
protein YadA of Y. enterocolitica (214). In Y. pestis infections, antibodies against LcrV, F1 
antigen and YopD have been demonstrated to be protective. Together, these data suggest 
that different antigens are possibly involved in protective cellular and humoral immune 
responses. 
 
 
 
1.5   Microarrays technology 
 
Global transcription analysis using microarray technologies provides a new approach to the 
description of complex biological phenomena.  
The development of DNA-microarray technologies, together with the sequencing of 
genomes from different species, has provided an opportunity to monitor and investigate 
the complex interactions that regulate biological processes. The availability of such large 
amounts of information has shifted the attention of scientists towards a non-reductionist 
approach to biological phenomena. How best to interpret the enormous amount of 
information that is provided by these new technologies remains a challenging question, 
not only for bioinformaticians, mathematicians and physicists, but also for immunologists, 
who have tried to understand how the single constituents of this complex biological 
system interact. 
Understanding how the immune system is regulated and responds to pathogens will 
require whole-system approaches, because the study of single immunological parameters 
has, so far, been unable to unlock immune-system complexity. 
In the context of immunology, the best interpretation of reality is obtained by the 
description of altered patterns (perturbations induced by infections). 
In this contest microarray approaches, with their large sample capacity, can be used to 
follow globally altered patterns of gene expression over time. Moreover, microarray 
technologies allow kinetic studies of gene expression on a global scale to follow the 
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interactions of different microorganisms with cells of the immune system over the course 
of infection. 
The principle of a microarray experiment, as opposed to the classical northern-blotting 
analysis, is that mRNA from a given cell line or tissue is used to generate a labelled 
sample, which is hybridized in parallel to a large number of DNA sequences, immobilized 
on a solid surface in an ordered array. Tens of thousands of transcript species can be 
detected and quantified simultaneously.  
During recent years, DNA microarray technology has been advancing rapidly. The 
development of more powerful robots for arraying, new surface technology for glass 
slides, and new labelling protocols and dyes, together with increasing genome-sequence 
information for different organisms will enable us to extend the quality and complexity of 
microarray experiments. 
 
1.5.1   Different Array platforms  
 
Although many different microarray systems have been developed by academic groups 
and commercial suppliers, the most commonly used systems today can be divided into two 
groups, according to the arrayed material: complementary DNA (cDNA) and 
oligonucleotide microarrays.  
The arrayed material has generally been termed the probe since it is equivalent to the 
probe used in a northern blot analysis.  
Probes for cDNA arrays are usually products of the polymerase chain reaction (PCR) 
generated from cDNA libraries or clone collections, using either vector-specific or gene-
specific primers, and are printed onto glass slides or nylon membranes as spots at defined 
locations. Spots are typically 100–300 µm in size and are spaced about the same distance 
apart. Using this technique, arrays consisting of more than 30,000 cDNAs can be fitted 
onto the surface of a conventional microscope slide Fig.a.  
For oligonucleotide arrays, short 20-25mers are synthesized in situ, either by 
photolithography onto silicon wafers (high-density-oligonucleotide arrays from Affymetrix, 
http:// www.affymetrix.com) or by ink-jet technology (developed by Rosetta Inpharmatics, 
http://www.rii.com, and licensed to Agilent Technologies). Alternatively, presynthesized 
oligonucleotides can be printed onto glass slides Fig.b. 
 31
Methods based on synthetic oligonucleotides offer the advantage that because sequence 
information alone is sufficient to generate the DNA to be arrayed, no time-consuming 
handling of cDNA resources is required. Also, probes can be designed to represent the 
most unique part of a given transcript, making the detection of closely related genes or 
splice variants possible.  
 
 
 
Figure 1.5  Schematic overview of probe array and target preparation for spotted cDNA 
microarrays and high-density oligonucleotide microarrays. (From A. Schulze and J. 
Downward, 2001) Fig.A, cDNA microarrays. Array preparation: inserts from cDNA collections or 
libraries are amplified and printed at specified sites on glass slides. Target preparation: RNA 
from two different tissues or cell populations is used to synthesize single-stranded cDNA in the 
presence of nucleotides labelled with two different fluorescent dyes. Both samples are mixed in 
a small volume of hybridization buffer and hybridized to the array surface resulting in 
competitive binding of differentially labelled cDNAs to the corresponding array elements. Fig.B, 
High-density oligonucleotide microarrays. Array preparation: sequences of 16–20 short 
oligonucleotides are chosen from the mRNA reference sequence of each gene. Target 
preparation: polyA+ RNA from different tissues or cell populations is used to generate double-
stranded cDNA carrying a transcriptional start site for T7 DNA polymerase. During in vitro 
transcription, biotin-labelled nucleotides are incorporated into the synthesized cRNA molecules. 
Each target sample is hybridized to a separate probe array and target binding is detected by 
staining with a fluorescent dye coupled to streptavidin.  
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1.5.2   Target preparation 
 
Another important difference between in situ synthesized, high-density oligonucleotide 
arrays and spotted arrays lies in target preparation. In both cases, mRNA from cells or 
tissue is extracted, converted to DNA and labelled, hybridized to the DNA elements on the 
array surface of the array, and detected by phospho-imaging or fluorescence scanning. 
The high reproducibility of in situ synthesis of oligonucleotide chips allows accurate 
comparison of signals generated by samples hybridized to separate arrays. In the case of 
spotted arrays, the process of gridding is not accurate enough to allow comparison 
between different arrays. The use of different fluorescent dyes (such as Cy3 and Cy5) 
allows mRNAs from two different cell populations or tissues to be labelled in different 
colours, mixed and hybridised to the same array, which results in competitive binding of 
the target to the arrayed sequences. After hybridization and washing, the slide is scanned 
using two different wavelengths, corresponding to the dyes used, and the intensity of the 
same spot in both channels is compared. This results in a measurement of the ratio of 
transcript levels for each gene represented on the array. 
For those reasons in our experimental setting we use an oligonucleotide chips system. In 
particular for the analysis of the changing in the transcriptional response in our 
experiments we had used the GeneChip technology from Affymetrix (Affymetrix, High 
Wycombe, UK). 
The GeneChip technology platform consists of high-density microarrays and tools to help 
process and analyze those arrays, including standardized assays and reagents, 
instrumentation, and data management and analysis tools. 
GeneChip microarrays consist of small DNA fragments (referred to here as probes), 
chemically synthesized at specific locations on a coated quartz surface. The precise 
location where each probe is synthesized is called a feature, and millions of features can 
be contained on one array. By extracting, amplifying, and labeling nucleic acids from 
experimental samples, and then hybridizing those prepared samples to the array, the 
amount of label can be monitored at each feature, enabling either the precise 
identification of hundreds of thousands of target sequence (DNA Analysis) or the 
simultaneous relative quantitation of the tens of thousands of different RNA transcripts, 
representing gene activity (Expression Analysis).  
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The integration of semiconductor fabrication techniques, solid phase chemistry, random 
access combinatorial chemistry, molecular biology, and sophisticated robotics results in a 
unique photolithographic manufacturing process capable of producing GeneChip arrays 
with millions of probes on a small glass chip.  
The photolithographic process begins by coating a 5”x 5” quartz wafer with a light-
sensitive chemical compound that prevents coupling between the wafer and the first 
nucleotide of the DNA probe being created. Lithographic masks are used to either block or 
transmit light onto specific locations of the wafer surface. The surface is then flooded with 
a solution containing either adenine, thymine, cytosine, or guanine, and coupling occurs 
only in those regions on the glass that have been deprotected through illumination. The 
coupled nucleotide also bears a light-sensitive protecting group, so the cycle can be 
repeated. In this way, the microarray is built as the probes are synthesized through 
repeated cycles of random access combinatorial chemistry where combinations of probes 
are simultaneously synthesized. Commercially available arrays are typically manufactured 
at a density of over 100 million probes each 25 nucleotides in length per wafer.  
1.5.3   Probe Design 
Every probe on an Affymetrix microarray is designed to determine whether or not the 
complementary sequence of RNA is present in the sample. Because of their 25 nucleotide 
length (25mer), the probes have high specificity and are designed to reject targets that 
are not identical. This level of specificity is essential when measuring the expression of 
two very similar gene sequences. The high density of those microarrays affords the ability 
to use multiple probes for each expression measurement made. Just as the 25mer probe 
length confers high specificity, the use of multiple probes provides for high sensitivity and 
reproducibility; 22 probes are routinely used for each expression measurement. For each 
probe on the array that perfectly matches its target sequence, Affymetrix also builds a 
paired “mismatch” probe. The mismatch probe contains a single mismatch located directly 
in the middle of the 25-base probe sequence. While the perfect match probe provides 
measurable fluorescence when sample binds to it, the paired mismatch probe is used to 
detect and eliminate any false or contaminating fluorescence within that measurement. 
The mismatch probe serves as an internal control for its perfect match partner because it 
hybridizes to nonspecific sequences about as effectively as its counterpart, allowing 
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spurious signals, from cross hybridization for example, to be efficiently quantified and 
subtracted from a gene expression measurement or genotype call. 
 
Figure 8 Expression probe and array design. (from Affymetrix web site, www.affymetrix.com) 
Oligonucleotide probes are chosen based on uniqueness criteria and composition design rules. 
For eukaryotic organisms, probes are chosen typically from the 3´ end of the gene or transcript 
(nearer to the poly(A) tail) to reduce problems that may arise from the use of partially degraded 
mRNA. The use of the PM minus MM differences averaged across a set of probes greatly reduces 
the contribution of background and cross-hybridization and increases the quantitative accuracy 
and reproducibility of the measurements. 
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2   Material and methods 
 
2.1   Bacterial strains and plasmids 
 
The bacterial strains used in the present study are listed in Table 2.1  
 
Designation Description References 
pYV+  Serotype O:8, Y.enterocolitica WA-314; clinical isolate; 
contains virulence plasmid pYV; Nalr 
(79) 
 
 
pYV- Serotype O:8, virulence plasmid cured derivative of 
Y.enterocolitica WA-314; Nalr 
(79) 
 
 
pYV+ ∆yopH pYV- harbouring pYV yopH ∆17-203; Nalr, Kanar (97) 
 
pYV+ ∆yopP yopP-negative mutant, derivative of Y.enterocolitica WA-
314, insertional inactivation of yopP; Nalr, Cmr 
(167) 
 
Table 2.1 Bacterial strains used in the present study 
 
The bacteria were precultured to stationary phase in Luria Bertani medium (LB) at 27°C. 
In dependency of the used strain the medium was supplemented with specific antibiotics 
(nalidixic acid 10 µg/ml, kanamicin 25 µg/ml and chloramphenicol 20 µg/ml). For mouse 
experiments, a 1:20 dilution of the overnight Yersinia preculture was incubated for 
additional 5 h at 37°C and frozen in liquid nitrogen in LB medium with 20% glycerol. The 
stock suspensions were stored at -80 °C until further use.  
For in vitro experiments, a 1:20 dilution of the overnight Yersinia culture was incubated for 
additional 2 h at 37°C. The bacteria were washed with phosphate-buffered-saline (PBS; 
Invitrogen, Karlsruhe, Germany) and the optical density at 600 nm was determined. Heat-
killed pYV+ cells were generated by heating the bacteria at 60°C for 4 h. 
 
2.2   Mouse infections 
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 C57BL/6 mice were purchased from Harlan Winkelmann (Borchen, Germany). IFN-γR-/- 
from The Jackson Laboratory (Bar Harbor, Maine, USA). The mice were maintained under 
specific pathogen-free conditions in the breeding facility of the Medical Microbiology 
Institute of the University Clinic of Tübingen, Germany. The experiments were performed 
using 6 to 10-week-old female mice. 
The animals were housed in plastic cages with wood shavings in a high-efficiency 
particulate air-filtered barrier unit maintained at 25°C with alternating 12-h periods of light 
and dark. The mice had drinking water at all times and were fed ad libitum with an 
autoclaved rodent pellet diet.  
The mice were infected intravenously with different doses of Y. enterocolitica pYV+, Y. 
enterocolitica pYV+∆yopH and Y. enterocolitica pYV+∆yopP mutants after thawing the 
frozen stock suspensions. A volume of 200 µl of bacterial suspensions in PBS with different 
doses of bacteria was injected into the lateral tail vein of the mice. The actual injected 
dose of the bacteria (CFU/ml; colony forming units/ml) was verified by plating out serial 
dilutions on Mueller-Hinton agar after incubation at 27°C for 36 h. 
For kinetic analysis, mice were sacrificed by CO2 asphyxiation at different timepoints post 
infection. Spleen was aseptically removed and homogenized in 5 ml HBSS-buffer (Ca2+ and 
Mg2+ free Hank’s balance solution supplemented, Biochrom, Berlin, Germany; with 2% v/v 
Fetal Calve Serum, FCS, Sigma, Taufkirchen, Germany and 10mM HEPES, Biochrom, 
Berlin, Germany). Determining the concentration of the bacteria per organ (CFU/organ), 
serial dilutions of homogenated organs were plated out on Yersinia selective CIN agar and 
incubated at 27°C for 36 hours.  
For survival experiments, five to six mice from each genetic background were infected i.v. 
with different doses of each different bacterial strain. Animal survival was monitored twice 
a day over a period of 14 days. This analysis was performed in triplicate in three 
independent experiments for each mouse strain. 
 
2.3   Immunohistochemistry  
 
C57BL/6 and IFN-γR1-/- mice were intravenously infected with 5x104 CFU of a Y. 
enterocolitica wild type strain (pYV+) or with the ∆yopH or the ∆yopP mutants. After 1 or 3 
days the mice were sacrificed by CO2 asphyxiation. The spleens were removed and frozen 
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in liquid nitrogen and stored at -80°C. Sections of 6µm were prepared and fixed in 
acetone. The endogen peroxidases were blocked with 3% H2O2 in PBS for 10 min and 
subsequently to prevent unspecific antibody binding the sections were incubated with 1% 
bovine serum albumin in PBS. The tissues were stained with a polyclonal rabbit anti-Inv 
3.1 antibody. After one hour at room temperature, the sections were washed with PBS 
and covered with the secondary antibody HRP-conjugated goat anti-rabbit 
immunoglobulins (Dianova, Hamburg, Germany). Staining was completed by a five-minute 
incubation with 1% (v/v) DAB (3,3 diaminobenzidine tetrahydrochloride; Sigma, 
Taufkirchen, Germany) plus 0.1% H2O2 in PBS, which results in a brown precipitate at the 
antigen site. After washing the sections were counterstained with hematoxylin. Several 
sections for each spleen were analyzed to detect abscess formation, inflammatory 
infiltrates, necrosis, and bacterial colonization. In the picture the bacteria appear brown 
and the nuclei were colored blue. 
 
2.4   Selection of splenic CD11b positive cells 
 
A number of five to ten mice from each infection were sacrificed by CO2 asphyxiation on 
day 0, day 1 and day 3 post infection and their spleens were surgically removed and 
placed in ice-cold HBSS-buffer. The spleens were crushed and forced with a 5 ml syringe 
pestle through a 40 µm-pore nylon mesh cell strainer (Falcon; BD Biosciences). 
The cell suspensions were washed twice with ice-cold HBSS-buffer. Red blood cells were 
lysed by incubating the cell suspensions at room temperature in lysis buffer (170 mM Tris, 
160 mM NH4Cl, pH 7,4) for 5 min followed by two washes in ice-cold HBSS. Cells were 
resuspended in MACS Buffer (Ca2+ and Mg2+ free PBS supplemented with 0,5% Bovine 
Serum Albumin and 2mM EDTA) at a concentration of 1x107 cells for 90 µl. The cells 
suspensions were incubated with 10 µl of CD11b antibody conjugated beads (MACS® 
MicroBeads; Miltenyi Biotec, Bergisch Gladbach, Germany) followed by an incubation at 
+4°C for 15 min. The mixture of cells and beads was then applied to the MACS column 
(MACS Columns LS, Miltenyi Biotec, Bergisch Gladbach, Germany) for positive selection, 
the non-binding cells were allowed to flow through, and the column was washed three 
times with MACS buffer. To recover bound cells, the column was removed from the 
magnet and the cells were eluted with 5 ml of Macs buffer using the plunger supplied with 
the column. To ensure enrichment values of 96-98% purity, the magnetic separation was 
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repeated using a second column under the same conditions. Cell viability and number 
were assessed by trypan blue exclusion staining. 
 
2.5   Flow cytometry 
 
A suspension of splenic single cells was resuspended in PBS with 1% (v/v) FCS, 0,01% 
sodium azide and 2mM EDTA (FACS buffer) and labeled with fluorophore-conjugated 
antibodies (Abs) targeted against surface markers. 
In order to avoid non-specific labeling, FcγII/III receptors were blocked using rat anti-
mouse CD16/CD32 antibodies (Ab) (BD Pharmingen, Heidelberg, Germany) at 4 °C for 15 
min. The cells were resuspended in FACS buffer at a concentration of 1x107 cells/ml and 
stained with marker-specific fluorophore-conjugated antibodies (Abs) (fluorescein-5-
isothiocyanate [FITC], phycoerythrin [PE], allophycocyanin [APC] and biotin-conjugated 
Abs, or the appropriate isotype control Abs for 30 min on ice. Then cellular suspensions 
were then washed twice in FACS buffer and, if necessary, stained with fluorophore-
conjugated secondary Abs, streptavidin-PE, or streptavidin- FITC for 30 min on ice. The 
cells were washed twice as described above and fixed with 1% (v/v) paraformaldehyde in 
PBS. The subsequent flow cytometric analysis was performed on a four-laser flow 
cytometer (FACS calibur; BD Biosciences, Heidelberg, Germany). The data were analysed 
with the Cell Quest Pro software (BD Biosciences, Heidelberg, Germany). For the analysis 
100.000 cells of the propidium iodide negative population were analyzed. The following 
Abs and secondary staining reagents were used for flow cytometric studies: FITC-
conjugated rat anti-mouse Ly-6G (Gr-1: RB6-8C5), PE-conjugated rat anti-mouse CD19 
(1D3), PE-conjugated hamster anti-mouse CD11c (HL3), FITC-conjugated rat anti-mouse 
CD4 (RM4-5), FITC-conjugated rat anti-mouse CD8a (53-6.7), PE-conjugated rat anti 
mouse Pan-NK-cell (DX5), FITC-conjugated rat anti-mouse CD45R/B220 (RA3-6B2), APC-
conjugated rat anti-mouse CD11b (M1/70), PE-conjugated hamster anti-mouse CD3ε chain 
(145-2C11), PE-conjugated rat anti-mouse α-I-A/I-E (2G9) and FITC-conjugated rat anti-
mouse α-CD80 (16-10A1), rat anti-mouse α-CD86 (GL1) or α-CD40 (3/23) , and 
appropriate isotype control Abs, streptavidin-FITC, streptavidin-PE (all from BD 
Pharmingen, Heidelberg, Germany), and FITC and PE-conjugated rat anti-mouse F4/80 
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(CI:A3-1) and PE-conjugated rat anti-mouse MARCO (ED31; Serotec, Oxford, UK). The 
specificity of the staining was verified by the use of isotype control mAbs.  
 
2.6   Bone marrow-derived macrophages  
 
Bone marrow derived macrophages (BMDM) were generated from total bone marrow cells. 
Marrow cells flushed from the femurs and tibias of mice, were seeded in 100 mm Petri 
dishes (Greiner, Wemmel, Belgium) with 40 ml of Dulbecco modified Eagle medium 
(DMEM) (Invitrogen, Karlsruhe, Germany), containing 10% v/v FCS (Sigma, Taufkirchen, 
Germany), 5% horse serum (Invitrogen, Karlsruhe, Germany), and 15% L929 mouse 
myeloma strain culture supernatant as a source of M-CSF and supplemented with Na-
pyruvate at 1 mM (Biochrom, Berlin, Germany), 2 mM L-glutamine (Invitrogen, Karlsruhe, 
Germany), 100 U of penicillin per ml (Invitrogen, Karlsruhe, Germany), and 100 µg of 
streptomycin (Invitrogen, Karlsruhe, Germany), per ml. At day 8 the slightly attached cells 
were washed out with warm PBS. Subsequently the cells were harvested by incubation for 
10 min with cold PBS (4°C). BMDM resuspended in DMEM medium without horse serum, 
L929 culture supernatant and antibiotics and used for infection experiments. 
 
2.7   Phagocytosis assay  
 
Twenty hours before infection, 3x105 BMDM were seeded into 1 cm diameter tissue 
culture plates (Greiner, Wemmel, Belgium) on glass coverslips. Two hours before 
infection, the cells were washed twice and covered with Dulbecco modified Eagle medium 
lacking FBS, horse serum, L929 culture supernatant and antibiotic. 
For some experiments BMDM were primed for 24 hours with a recombinant IFN-γ 50 
ηg/ml (R&D Systems, Abingdom, UK). 
Before infection, overnight cultures of different Y. enterocolitica strains were inoculated in 
LB medium at an optical density at 600 nm of 0.2 and grown for 2 h at 37°C with shaking. 
After washing in prewarmed phosphate-buffered saline (PBS), bacteria were added to the 
cells at a multiplicity of infection (MOI) of 50:1. The bacteria were sedimented onto the 
cells at 400 x g  for 5 min. After an infection period of 30 min, bacteria associated with the 
target cells in intra- and extracellular locations were distinguished by the double-
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immunofluorescence method as described previously (1, 2). To stain extracellularly located 
bacteria, the coverslips were first washed with PBS and incubated for 30 min with 1% BSA 
in PBS to prevent unspecific antibody binding. Then the coversplips were incubated for 45 
min at RT with a polyclonal rabbit anti-Inv 3.1 antibody (diluted 1:100). Thereafter, the 
excess antiserum was removed by four washes in PBS and the coverslips were covered 
with FITC-conjugated goat anti-rabbit immunoglobulins (Dianova, Hamburg, Germany). 
After incubation for 30 min at room temperature, cells were washed four times in PBS. 
The cells were permeabilized by treatment with 2% Triton X-100 in PBS for 4 min, and 
washed again with PBS. To stain the intracellular and extracellular bacteria, the coverslips 
were incubated again with a polyclonal rabbit anti-Inv 3.1 antibody (diluted 1:100) for 
45min at room temperature. The coverslips were then washed four times in PBS, overlaid 
with carbocyanin 5-conjugated goat anti-rabbit immunoglobulins (Dianova, Hamburg, 
Germany) and with tetramethyl rhodamine isothiocyanate-conjugated phalloidin (Sigma, 
Taufkirchen, Germany) to stain F-actin and incubated for 30 min at room temperature. 
Finally, after another washing, the coverslips were mounted in Fluroprep (bioMerieux, 
Marcy l´Etoile France) containing polyvinylic alcohol and glycerin and examined by 
fluorescence microscopy. Under these conditions, the extracellular bacteria were stained 
with both FITC and Cy5 and appeared green or blue, depending on the filter used, while 
intracellular bacteria were stained only with Cy5 and appeared only blue. The fluorescence 
images were obtained with a Leica DMRE HC fluorescence microscope (Leica, Wetzlar, 
Germany). 
At least 100 cells were examined, and the number of extracellularly located bacteria and 
the total number of cell-associated bacteria was counted. For each condition, the 
experiments were done three times each in duplicate. The phagocytosis percentage 
represents the ratio of the number of intracellular bacteria to the total number of cell-
associated bacteria. 
 
2.8   Isolation of total RNA  
 
The total RNA was isolated from the selected CD11b+ cells from uninfected or infected 
mice using the Rneasy Mini-Kit following the manufacturer’s instructions (Qiagen, Hilden, 
Germany). 
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In order to reduce the biological variability, the quality and the quantity of all of the RNA 
samples were assessed to ensure the highest reproducibility in the microarray 
experiments. 
The absorbance was measured at 260/280 nm for both total RNA and biotinylated cRNA. 
Exclusively the samples with acceptable 260/280 nm ratios in the range of 1.9 to 2.1 were 
used for further microarray hybridization or for real time-PCR experiments. 
Moreover, the quality of the RNA samples prepared for the microarray hybridization was 
measured by the Agilent 2100 Bioanalyzer - Bio Sizing. Exclusively the samples with 
optimal quality given by a low baseline, sharp 18S and 28S ribosomal peaks and with a 
ratio (28S:18S) of 2:1 were used for further analysis. 
 
2.9   Reverse transcription real-time PCR 
 
For independent confirmation of gene expression results, total cellular RNA was isolated 
by using Rneasy mini kits (Qiagen) at the indicated time points from CD11b positive cells 
from the spleens of infected and uninfected mice as described above. For reverse 
transcription, 1 µg of total RNA was mixed with 0.5 µg of oligo (dT)12-18 primers (New 
England Biolabs, Frankfurt am Main, Germany), and DEPC-treated water was added to a 
final volume of 10 µl, followed by incubation at 65°C for 10 min. After adding 10 µl of a 
solution containing 5x First-Strand Buffer (Invitrogen, Karlsruhe, Germany) [250 mM Tris-
HCl, 375 mM KCL, 15 mM MgCl2], 20 mM dithiothreitol, 200 U SuperScript III (Invitrogen, 
Karlsruhe, Germany), 40 U RNaseOut (Invitrogen, Karlsruhe, Germany) and 2 mM dNTPs 
(Invitrogen, Karlsruhe, Germany), the mixture was incubated at 42°C for 60 min. Finally, 
the cDNA samples were heated at 90°C for 5 min, diluted 1:10 with DEPC-treated water 
and stored at –20°C until further use. 
RNA preparations for RT-PCR were independent from those used for array hybridisations. 
Real-time RT-PCR was carried out in duplicate in 96-well format on a GeneAmp 5700 
Sequence Detection System (Applied Biosystems, Darmstadt, Germany). Each 20-µl 
reaction contained 10 µl Platinum Quantitative PCR SupeMix-UDG (Invitrogen, Karlsruhe, 
Germany), 0.4 µl ROX Reference Dye (Invitrogen, Karlsruhe, Germany), 3.6 µl PCR grade 
water, 1 µl target gene specific Assay-on-Demand Gene Expression Assay Mix (including 
primers and dye-labeled hybridization probes; Applied Biosystems, Darmstadt, Germany), 
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and 5 µl cDNA. Thermal cycling conditions for all reactions were as follows: 2 min at 50°C, 
10 min at 95 °C, then 40 cycles of 15 s at 95°C and 1 min at 60°C. 
Gene expression levels were recorded relative to the expression of the gene Ribosomal 
protein L8 (Rpl8) as: E=2–∆∆CT (E = gene expression value, ∆∆CT = (Crossing point of 
gene of interest – Crossing point housekeeping) condition x – (Crossing point of gene of 
interest – Crossing point housekeeping) control. All PCR experiments were performed in 
duplicate, and standard deviations were calculated and displayed as error bars. 
The unpaired, two-tailed Student t test was used (to compare differences between mean 
of semiquantitative real-time RT-PCR data. 
 
2.10   Microarray experiments  
 
2.10.1   One-cycle cDNA synthesis  
 
Double-stranded cDNA was synthesized from the total RNA samples using a Superscript 
choice kit (Invitrogen, Karlsruhe, Germany) with a T7- (dT) 24 primer (Metabion, Planegg-
Martinsried, Germany) incorporating a T7RNA polymerase promoter. 
Poly-A RNA controls were used to monitor the entire target labeling process. Dap, lys, phe, 
thr, and trp are B. subtilis genes that have been modified by the addition of poly-A tails, 
and then cloned into pBluescript vectors, which contain T3 promoter sequences 
(GeneChip® PolyAControl Kit, Affymetrix, High Wycombe, UK). These poly-A controls 
spiked into the RNA sample, are carried through the sample preparation process, and 
evaluated like internal control genes. The final concentrations of these controls, relative to 
the total RNA population, were: 1:100000; 1:50000; 1:25000; 1:7500, respectively.  
After purification, cDNA was used as templates to generate biotinylated cRNAs by in vitro 
transcription reactions with a Bio-Array High-Yield RNA transcript labeling kit (Enzo 
Diagnostics Inc., Farmingdale, N.Y.). Labeled cRNAs were subsequently fragmented by 
incubation at 94°C for 35 min in the presence of 40 mM Tris-OAc (pH 8.1), 100mM KOAc, 
and 30mM MgOAc.  
At this step in order to improve the confidence of the hybridization procedure same 
biotinylated oligonucleotide were added to the hybridization cocktail (GeneChip® 
Eukaryotic Hybridization Control Kit, Affymetrix, High Wycombe, UK ). This oligonucleotide 
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represent the genes bioB, bioC, bioD, present in the biotin synthesis pathway of E. coli, 
and cre a recombinase gene from P1 bacteriophage. 
This biotin-labeled cRNA transcripts were included in staggered concentrations (1.5 pM, 5 
pM, 25 pM, and 100 pM final concentrations for bioB, bioC, bioD, and cre, respectively) to 
evaluate sample hybridization efficiency. Moreover, one other oligonucleotide called B2 
was included as a positive hybridization control to allow the analysis software to place a 
grid over the microarray image and to define the single probes position on the array.  
The labeled, fragmented cRNA (15 µg) was hybridized for 16 h at 45 °C to a murine 
genome GeneChip probe arrays MG-U74Av2 from Affymetrix (Affymetrix, High Wycombe, 
UK), comprising approximately 12600 mRNA transcripts from mouse genes and expressed 
sequence tags (ESTs). 
After hybridization, arrays were automatically washed and stained with streptavidin–
phycoerythrin using a Fluidics Station 400 (Affymetrix, High Wycombe, UK). The probe 
arrays were scanned at 3-µm resolution using a GeneChip Scanner 2500 (Affymetrix, High 
Wycombe, UK). 
The Microarray Suite software (version 5.0), MicroDB and Data Mining Tool were used to 
scan and analyze the relative abundance of each gene based on the intensity of the signal 
from each probe set. Analysis parameters used by the software were set to values 
corresponding to moderate stringency (statistical difference threshold = 30, statistical ratio 
threshold = 1.5). 
 
2.10.2   Microarray data analysis 
 
Analysis of microarray data was performed using the Affymetrix Microarray Suite 5.0, 
Affymetrix MicroDB 3.0 and Affymetrix Data Mining Tool 3.0 (Affymetrix, High Wycombe, 
UK). 
 
2.10.2.1   Assessing Data Quality 
 
All of the probe arrays were carefully inspected to allow presence of image artifacts like: 
high/low intensity spots, scratches, high regional or overall background. 
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The hybridization efficiency was measured by analyzing the level of the assay sensitivity 
for the control bioB, bioC, bioD, and cre, prior mentioned. BioB is at the level of assay 
sensitivity (1:100000 complexity ratio) and should be called “Present” at least 50% of the 
time. BioC, bioD, and cre should always be called “Present” with increasing Signal values, 
reflecting their relative concentrations. 
Furthermore the oligonucleotide B2 was used as a positive hybridization control and to 
place a grid over the images. 
Furthermore to avoid incorrect analysis the Average Background and Noise (Raw Q) had 
been estimated. Exclusively arrays with an Average Background values range from 20 to 
100 were used for further analysis. 
 
2.10.2.2   Affymetrix Statistical Algorithms  
 
The GeneChip® probe arrays analysis was performed using the Affymetrix Statistical 
Algorithms implemented in the Affymetrix® Microarray Suite Version 5.0 (Affymetrix, High 
Wycombe, UK). 
 
2.10.2.3   Single Array Analysis 
 
Signal Algorithm 
 
The signal was calculated for each probe set, which represents the relative level of 
expression of a transcript. The signal was calculated using the One-Step Tukey’s Biweight. 
Each probe pair in a probe set was considered as having a potential vote in determining 
the Signal value. The vote, in this case, was defined as an estimate of the real signal due 
to hybridization of the target. The mismatch intensity was used to estimate stray signal. 
The real signal was estimated by taking the log of the Perfect Match intensity after 
subtracting the stray signal estimate. The probe pair vote was weighted more strongly if 
this probe pair Signal value was closer to the median value for a probe set. Once the 
weight of each probe pair was determined, the mean of the weighted intensity values for 
a probe set was identified. This mean value was corrected back to linear scale and was 
output as Signal. 
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Detection algorithm 
 
This analysis generates a Detection p-value, which was evaluated against user-definable 
cut-offs to determine the Detection call. This call indicates whether a transcript was 
reliably detected (Present) or not detected (Absent). 
The Detection algorithm uses probe pair intensities to generate a Detection p-value and 
assign a Present, Marginal, or Absent call. Each probe pair in a probe set was considered 
as having a potential vote in determining whether the measured transcript was detected 
(Present) or not detected (Absent). The vote was described by a value called the 
Discrimination score [R]. The score was calculated for each probe pair and was compared 
to a predefined threshold Tau. Tau is a small positive number that can be adjusted to 
increase or decrease the sensitivity of the analysis (used value: 0.015). Probe pairs with 
scores higher than Tau vote for the presence of the transcript. Probe pairs with scores 
lower than Tau vote for the absence of the transcript. The voting result was summarized 
as a p-value. The greater the number of discrimination scores calculated for a given probe 
set that are above Tau, the smaller the p-value and the more likely the given transcript 
was truly Present in the sample. 
 
Detection p-value 
 
To calculate the statistical significance of the Detection we used the Discrimination score 
(R). This was a basic property of a probe pair that describes its ability to detect its 
intended target. It measures the target-specific intensity difference of the probe pair 
(Perfect Match-Mis Match) relative to its overall hybridization intensity (PM+MM): 
 
R = (PM - MM) / (PM + MM) 
 
For example, if the PM is much larger than the MM, the Discrimination score for that probe 
pair will be close to 1.0. If the Discrimination scores are close to 1.0 for the majority of the 
probe pairs, the calculated Detection p-value will be lower (more significant). A lower p-
value is a reliable indicator that the result is valid and that the probability of error in the 
calculation is small. Conversely, if the MM is larger than or equal to the PM, then the 
Discrimination score for that probe pair will be negative or zero. If the Discrimination 
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scores are low for the majority of the probe pairs, the calculated Detection p-value will be 
higher (less significant). The next step toward the calculation of a Detection p-value is the 
comparison of each Discrimination score to the threshold Tau. The One-Sided Wilcoxon’s 
Signed Rank test was the statistical method employed to generate the Detection p-value. 
It assigns each probe pair a rank based on how far the probe pair Discrimination score is 
from Tau. The modifiable Detection p-value cut-offs, provide boundaries for defining 
Present, Marginal, or Absent calls. In our experimental setting the detection p-value of 
≤0.04 was considered as present (P), a detection p-value of >0.04 and ≤0.06 was 
considered marginal (M) and a detection p-value >0.06 was considered absent (A). 
 
2.10.2.4   Comparison Analysis (Experiment versus Baseline arrays) 
 
In the second part of the analysis, two samples were compared against each other in 
order to detect and quantify changes in gene expression. Usually the array hybridized with 
RNA from uninfected samples was designated as the baseline and the other as an 
experiment. The analysis compares the difference values (PM-MM) of each probe pair in 
the baseline array to its matching probe pair on the experiment array. Two sets of 
algorithms were used to generate a change significance and change quantity metrics for 
every probe set. A change algorithm generates a Change p-value and an associated 
Change. A second algorithm produces a quantitative estimate of the change in gene 
expression in the form of Signal Log Ratio.  
Before comparing two arrays we had scaled to the same target intensity the arrays in 
order to correct the possible variations between two arrays (used value: 150). 
In this way the intensity of the probe sets from the experiment array were normalized to 
the intensity of the probe sets on the baseline array. When scaling is applied, the intensity 
of the probe sets (or selected probe sets) from the experimental array and that from the 
baseline array are scaled to the defined target intensity.  
 
Change Algorithm 
 
As in the Single Array Analysis, the Wilcoxon’s Signed Rank test was used in Comparison 
Analysis to derive biologically meaningful results from the raw probe cell intensities on 
expression arrays. During a Comparison Analysis, each probe set on the experiment array 
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was compared to its counterpart on the baseline array, and a Change p-value was 
calculated indicating an increase, decrease, or no change in gene expression. Cut-offs 
were subsequently applied to generate discrete Change calls (Increase, Marginal Increase, 
No Change, Marginal Decrease, or Decrease). 
 
Change p-value 
 
The Wilcoxon’s Signed Rank test uses the differences between Perfect Match and 
Mismatch intensities, as well as the differences between Perfect Match intensities and 
background to compute each Change p-value. 
From Wilcoxon’s Signed Rank test, a total of three, one-sided p-values are computed for 
each probe set. The most conservative value was chosen to determine the change call. 
That is the value that is closest to 0.5 which signifies that no change is detected. These 
are combined to give one final p-value which is provided in the data analysis output . 
The p-value ranges in scale from 0.0 to 1.0 and provides a measure of the likelihood of 
change and direction. Values close to 0.0 indicate likelihood for an increase in transcript 
expression level in the experiment array compared to the baseline, whereas values close 
to 1.0 indicate likelihood for a decrease in transcript expression level. Values near 0.5 
indicate a weak likelihood for change in either direction. Hence, the p-value scale is used 
to generate discrete change calls using thresholds. 
 
Change Call 
 
The final Change p-value described above is categorized by cutoff values. These cut-offs 
provide boundaries for the Change calls: Increase (I), Marginal Increase (MI), No Change 
(NC), Marginal Decrease (MD), or Decrease (D). 
A change call of increase (I) was assigned with a median change p-value of ≤0.0025 and a 
change call of marginal increase (MI) was assigned at a median change p-value >0.0025 
to 0.003. Change calls of marginal decrease (MD) were assigned at a median change p-
value of >0.997 to <0.998 and a change call of decrease (D) was assigned at a p-value 
>0.998. All others were assigned no change (NC). Only those probe sets that had a 
change call other than NC in comparison to uninfected and were not absent in both 
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compared groups were retained. Probe sets with an increase but a detection call of A in 
the infected cells were also discarded. 
 
Signal Log Ratio Algorithm 
 
To estimate the magnitude and direction of change of a transcript when two arrays were 
compared (experiment versus baseline) the Signal Log Ratio (SLR) was used. The SLR is 
calculated by comparing each probe pair on the experiment array to the corresponding 
probe pair on the baseline array. This strategy cancels out differences due to different 
probe binding coefficients and is, therefore, more accurate than a single array analysis. As 
with Signal, this number was computed using a one-step Tukey’s Biweight method by 
taking a mean of the log ratios of probe pair intensities across the two arrays. 
The log scale used was base 2, making it intuitive to interpret the SLR in terms of 
multiples of two. Thus, a SLR of 1.0 indicates an increase of the transcript level by 2 fold 
and -1.0 indicates a decrease by 2 fold. A SLR  of zero would indicate no change.  
In our analysis setting the filtering of the results was performed as follows: signal log2 
ratios (SLR) was calculated compared the expression of the infected experiments to the 
corresponding uninfected control for each time point. A median SLR greater than 1.5 or 
less than –1.5 was considered as significant change. 
Since we use log2, the following formulas were used for calculation of the fold change: 
     2 Signal Log Ratio    SLR ≥ 0  
Fold Change 
     (-1) ∗ 2 -(Signal Log Ratio)   SLR ≤ 0 
 
2.10.2.5   Gene cluster analysis 
 
Output from the microarray analysis was merged with the Unigene or GenBank descriptor 
and saved as an Excel data spreadsheet. 
For Cluster analysis the Genesis software was used, release 1.6.0 (Institute for Genomics 
and Bioinformatics, University of Technology, Graz, http://genome.tugraz.at). To analyze 
the relationships between the expression profiles in different conditions we performed 
hierarchical clustering by using average linkage clustering for the experiments. However, 
to analyze the eventual presence of gene groups with a similar expression profile the k-
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means algorithmic had been used with a define number of clusters 10 and a maximum of 
200 iterations. 
The functional analysis and the categorization of the genes were based on the NetAffx 
database (http://www.NetAffx.com) and on the Gene Ontology database 
(http://www.geneontology.org) (9). 
 
2.11   Statistical analyses 
 
The significance of the differences among different groups was determined by the 
unpaired two-tailed Student’s t test. P values < 0.05 were considered statistically 
significant. 
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Aim of the study 
 
The first line of defence is innate immunity, which is composed of cells that engulf 
pathogens as well as cells that release potent signalling molecules to activate an 
inflammatory response and the adaptive immune system. Pathogenic bacteria have 
evolved a set of weapons, or effectors, to ensure survival in the host. Yersinia spp. use a 
type III secretion system to translocate some effector proteins, called Yops, into the host. 
The aim of this study was to investigate how the Yersinia outer proteins influence the 
transcriptional response in cells of the innate immunity. In order to gain insight these 
complex interactions, CD11b positive cells were selected from spleen of C57BL/6 mice 
infected intravenously with a Yersinia enterocolitica wild type strain (pYV+) and from mice 
infected with two different deletion mutants ∆yopH and ∆yopP strains. 
We came to the decision to use the CD11b+ cells as a model because this population has 
an essential role in the innate immune responses and furthermore as recently shown it is 
primarily affected by Y. enterocolitica during the early stage of infection by the direct 
injection of the Yops. 
The CD11b, also called integrin alpha M, is a member of the integrin family, plays a role as 
transmembrane receptors for cell-adhesion. The CD11b molecule is part of the 
CD11b/CD18 heterodimer which is strongly expressed on myeloid cells 
(macrophages/monocytes, granulocytes and dendritic cells) and only weakly on NK cells 
and on a subset of B lymphocytes. It functions as a receptor for the complement 
component 3 (C3), the fibrinogen or for the clotting factor X. 
The CD11b+ cells can be efficiently selected via an anti-CD11b monoclonal antibody 
conjugated with magnetic particles. The cells are subsequently isolated from a 
heterogeneous cell suspension as a highly pure population via binding to a magnetic 
column. The use of this model gives us the possibility to analyze the actual influence of Y. 
enterocolitica infection on cells of the innate immune system directly in their natural 
microenvironment. 
It has been clearly demonstrated that Yersinia infection leads to strong T cell responses, 
including activation and proliferation of CD4 and CD8 T cells, and that these T cells are 
involved in control of Yersinia (Autenrieth et al., 1992a; Autenrieth et al., 1993; Bohn et 
al., 1996; 1998b; Noll and Autenrieth, 1996; Falgarone et al., 1999a; Falgarone et al., 
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1999b). These cells produced predominantly IFN-γ, and it seems that IFN-γ can activate 
macrophages which in turn might be able to kill pathogen. Moreover, it is not fully clear 
yet which of the IFN-γ-mediated antimicrobial mechanism are playing a role in cells of the 
innate immune during Yersinia enterocolitica infection. 
To address these questions we performed a transcriptional analysis in splenic CD11b+ cells 
isolated from Y. enterocolitica -infected IFN-γ receptor deficient mice. 
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Result and discussion 
 
3.1   Virulence of ∆yopP and ∆yopH mutants after intravenous 
infection 
 
To evaluate the role of YopP and YopH during the course of a Y. enterocolitica infection, 
groups of C57BL/6 female mice were intravenously infected with 5x104 CFU of the Y. 
enterocolitica wild type strain O:8 pYV+ or with a ∆yopH or ∆yopP mutants. The 
progression of the disease was pursued by counting the bacterial CFU number in the 
spleen 24 h and 72 h post infection. 
 
 
Figure 3.1 Evaluation of the role of YopP and YopH in a Y. enterocolitica systemic infection. 
C57BL/6 female mice 6-8 week-old were infected intravenously with 5x104 CFU of a Y. 
enterocolitica wild type strain (pYV+) or with a ∆yopH or ∆yopP mutants. The course of 
infection was monitored by counting the bacterial CFU number in homogenized spleens after 
24 h and 72 h post infection. Values represent the average log10 CFU per spleen for fifteen 
mice with the standard errors of the means indicated by error bars. Asterisks indicate 
significant differences when compared CFU in C57BL/6 infected with the pYV+ and ∆yopP 
strain vs ∆yopH infection (p ≤ 0.05). 
 
The wild type Y. enterocolitica pYV+ showed high colonization rate of the spleen 
(5.52±0.62 log CFU) 24 h p.i. with a significant increase of the bacterial number in the 
organs after 72 h p.i. (6.83±0.65 log CFU).  
Surprisingly, the deletion of YopP does not seem to attenuate the virulence of the 
bacteria. In contrast, the colony counts of the ∆yopH strain showed high virulence 
attenuation with more then 100-fold reduction in CFU compared to the wild type Y. 
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enterocolitica strain already after 24 h (3.67±1.38 log CFU) with a further clearance of the 
bacteria in the spleen after 72 h (3.47±0.65 log CFU).  
In order to investigate the pathology further, the effects of the different Y. enterocolitica 
strains were compared by a detailed histopathologic analysis. The mice were sacrificed on 
day one and three post infection, and the spleens were removed for histological analysis. 
Consistent with the results obtained during the kinetic analysis, the microscopic pathology 
of the spleen showed significant difference between the diverse bacteria strains. Indeed, 
the mice infected with the wild type Y. enterocolitica and with the YopP deletion mutant 
showed the presence of high percentage of bacteria aggregate that appeared to be 
delimitate by inflammatory cells. This led to the formation of disseminated abscesses in 
the spleen with a complete disorganization of the tissue morphology 72 h p.i.. In contrast, 
the infection with ∆yopH strain displayed a complete different outcome. Rarely, and if so, 
only smaller amounts of aggregated bacteria were found in the spleen 24 hours post 
infection. Furthermore, the bacteria were rapidly cleared as shown by the histological 
analysis of the spleen 72 h p.i.. 
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Figure 3.2  Abscesses formation in a Y. enterocolitica systemic infection. C57BL/6 female mice 
6-8 week-old were infected intravenously with 5x104 CFU of a Y. enterocolitica wild type 
strain (pYV+) (Fig. A and B) or with the ∆yopP (Fig. C and D) or the ∆yopH mutants (Fig. E 
and F). The spleens were removed 24 h (Fig. A, C and E) and 72 h (Fig. B, D and F) post 
infection. Tissue sections were stained with an anti-Y. enterocolitica monoclonal antibody 
and with hematoxylin. The bacteria appear brown and the nuclei blue. 
 
Surprisingly, these results suggest that the virulence factor YopP does not play a key role 
at the early stage of Y. enterocolitica infection. The high efficiency of YopP in gene 
silencing and in inducing apoptosis, demonstrated by several in vitro experiments, does 
not deliver a similar outcome in vivo.  
On the contrary, the presence of YopH seems to be essential for a successful colonization 
of the host by Y. enterocolitica and to exhibit its entire virulent strength. 
 
3.2   Composition of the splenic CD11b+ cell population upon Y. 
enterocolitica infection 
 
In order to gain insight into the complex gene expression pattern of the innate immune 
system upon Y. enterocolitica systemic infection, and to characterize the effects mediated 
by the injection of the Yersinia outer proteins YopP and YopH, microarrays representing 
12000 genes were hybridized with labeled RNA isolated from CD11b positive cells 
immuno-magnetically enriched from spleens 24 h and 72 h p.i. and compared to the 
expression level of CD11b positive cells selected from spleen of uninfected control mice of 
the same age and sex. 
For this aim, groups of six C57BL/6 female mice 6-8 week-old were infected intravenously 
with 5x104 CFU of a Y. enterocolitica pYV+ or with ∆yopH or ∆yopP mutants. The CD11b+ 
cells were selected from the spleen cell suspensions (Fig. 3.2) of uninfected and infected 
mice. The purity and the composition of the isolated cell population was characterized by 
flow cytometry analysis (Table 1). 
Figure 3.2A depict dot plots representing the CD11b positive fraction out of the total 
splenic cells population stained with an anti-CD11b antibody prior selection and after 
selection with the CD11b-conjugated magnetic beads. The purity of the isolated cells was 
analyzed by staining with APC-labelled anti-CD11b antibody and it is presented as 
histogram in the figure 3.3B. 
 55
 
Figure 3.3  CD11b+ cells purity upon selection. Fig.A Splenic single cells suspensions were prepared 
from uninfected and infected mice as reported in materials and methods. CD11b positive 
cells were positively selected by using magnetic beads conjugated with a monoclonal 
antibody against the surface marker CD11b. the CD11b+ cells fraction prior and upon 
selection. Fig.B The purity of the cells was assessed by flow cytometry analysis. Values 
represent the average of the purity per samples with the standard errors of the means 
indicated by error bars. 
 
The composition of each CD11b+ cell population was characterized by double staining with 
APC-labeled anti-CD11b antibody and PE-labeled anti-DX5, anti-B220, anti-GR1, anti-
CD11c or anti-F4/80 antibodies (Table 3.1). The main population of CD11b+ cells 
comprised CD11b+/F4/80+ cells, CD11b+/GR1+ and CD11b+/CD11c+ cells representing 
macrophages, granulocytes and a subset of dendritic cells. Low amounts of 
CD11b+/B220+, CD11b+/DX5+ and CD11b+/CD3+ cells representing mainly B cells, NK cells 
and T cells were found. One day after infection with pYV+ and with the ∆yopP strain, the 
amount of CD11b+/GR1+ as well as CD11b+/DX5+ cells increased in comparison with 
uninfected mice (approximately 1.5 fold) whereas the amount of CD11b+/F4/80+ and 
CD11b+/CD11c+ was still comparable to control CD11b+ cells. Three days after the cell 
coposition was still similar in the infection with the wild type Y. enterocolitica and ∆yopP 
mutant strain Indeed, the amount of CD11b+/GR1+ cells was slightly lower compared to 
uninfected cells, while the amount of CD11b+/F4/80+ cells was significantly increased. 
Interestingly, the CD11b+ cells isolated upon infection with the ∆yopH strain showed a 
complete different composition. In total the amount of the CD11b+/GR1+ cells was 
significantly lower compared to wild type infection with an increasing tendency though out 
the timecours of infection. By contrast, there was never found a significant increase of 
CD11b+/F4/80+ cells upon 72 h p.i.. This finding seems to be in agreement with the 
different bacterial load in the spleen of mice infected with ∆yopH. The lower virulence of 
this strain leads to a lower amount of bacteria. This correlates with a lower influx of 
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CD11b+/GR1+ cells usually considered as neutrophils, the first defense line during a 
bacteria infection. 
A total number of more than 100% cells is reached due to the existence of subsets of cell 
populations which are positive for more then two surface markers. 
 
CD11b+  DX5 CD3 B220 CD11c F4/80 GR1 
       
Uninfected 0.81±0.2 0.59±0.1 1.83±0.5 6.68±2.0 45.01±13.4 43.17±12.8 
       
pYV+       
24 h 1.26±0.1 1.62±0.2 1.50±0.1 6.89±2.6 43.46±4.0 69.33±9.0 
72 h 2.42±2.3 2.10±1.6 2.86±1.3 14.37±11.2 59.38±1.7 36.67±3.1 
       
∆yopP        
24 h 5.5±0.8 1.77±2.1 2.29±0.1 11.57±2.6 33.4±4.8 60.89±2.7 
72 h 1.56±1.5 1.1±1.1 3.94±0.9 8.55±1.4 49.61±11.4 30.78±19.1 
       
∆yopH        
24 h 1.56±0.1 1.40±1.5 2.49±0.07 16.75±2.7 51.57±28.5 44.94±13.4 
72 h 1.85±0.4 1.55±0.5 3.62±1.6 7.78±5.0 45.19±25.30 65.61±1.07 
 
Table 3.1  Composition of the splenic CD11b+ population after selection from mice prior and 
upon infection with Y. enterocolitica. CD11b+ cells selected from the spleen were 
stained with fluorophore-conjugated antibodies anti-CD11b, DX5, CD3, CD45R, CD11c, F4/80 
and Ly6G. The cell composition was analyzed by flow cytometry. The percentage of the 
CD11b+ cells positive for the indicated markers is shown in the table with the correspondent 
standard error. 
 
3.3   Reprogramming of the CD11b+ cells transcriptome in response 
to Y. enterocolitica  
 
To characterize the effect on the transcriptional response in the innate immune system 
during a Y. enterocolitica infection, the CD11b+ cells were isolated from the spleen of mice 
infected with the wild type bacteria strain pYV+ and the total mRNA was hybridized on 
oligo-microarrays. 
In order to minimize determinations of “false positive” or “false negative” results, 
exclusively, probe sets with an expression difference of at least of 3-fold (Signal Log Ratio 
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of ±1.5) between infected and uninfected mice were considered as significantly regulated 
(see materials and methods).  
The expression signal analysis revealed the presence of 822 probe sets representative of 
769 genes detected as differentially regulated, according to the applied filters, upon 
infection with Y. enterocolitica pYV+ at least at one of the two time points investigated 
(Fig. 3.4; supplementary table 1). The 85.64% (704 probe sets) of the probe sets were 
significant regulated 24 h post infection. In particular, the 47.68% of the probe sets (392 
probe sets) were significant induced in comparison with uninfected samples. Rather than 
the 37.95% (312 probe sets) was suppressed. The number of the modulated genes 
decreased significantly 72 h p.i. (410 probe sets). In detail, only the 31.02% (255 probe 
sets) of the total regulated probe sets were still significantly induced and the 18.85% (155 
probe sets) still suppressed.  
Presumably, this is the consequence of immune regulatory mechanisms, essential to 
control and to prevent an overreacting response. On other hand, the high number of 
regulated genes clearly indicates the efficient and prompt response of the innate immune 
system to Yersinia infection.  
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Figure 3.4  K-means cluster diagram of 822 differentially expressed genes in splenic CD11b+ 
cells upon systemic infection with Y. enterocolitica pYV+. Group of six C57BL/6 mice 
were intravenously infected with 5x104 CFU of Y. e. pYV+. After 24 h and 72 h p.i. the 
CD11b+ cell population was isolated from the spleen. The total RNA was hybridized on a 
murine genome GeneChip probe arrays MG-U74Av2 (Affymetrix, High Wycombe, UK), 
comprising approximately 12600 mRNA transcripts from mouse genes and expressed 
sequence tags (ESTs). A group of 822 genes was differentially regulated at least at one of 
the indicated time points in comparison with the expression profile in splenic CD11b+ cells 
selected from uninfected control mice. Fig. A The K-means algorithm was applied to the 
differentially regulated genes according to the signal log ratios to cluster co-expressed 
genes. Expression levels are colour coded, red indicates expression level above and green 
below the expression level of uninfected control mice. Group of co-expressed genes are 
indicated by letters. Fig. B Centroid view of the gene clusters (24 h p.i. and 72 h p.i.). 
 59
The K-mean algorithm was applied to the differentially regulated genes to identify genes 
with a common regulation profile (Genesis 1.6.0, Institute for Genomics and 
Bioinformatics, Graz University of Technology, Austria). This analysis revealed the 
presence of 5 major groups of commonly regulated genes (Fig.3.4). 
Group A contains the strongest induced genes after Y. enterocolitica infection with a high 
expression at both time points investigated. 
Considering the Gene Ontology categorization of all genes on the probe array used in our 
experiments, the number of genes involved in the inflammatory and immune response 
was remarkably high in this group. Indeed, several genes with cytokines activity (p<4.4x 
10-15) like IL-1α, CXCL1 and a group of genes involved in the chemotaxis process 
(p<7.8x10-14) like CXCL10, CXCL2 and CCL4 were represented by this group.  
The majority of the induced genes could be clustered in the group B. This cluster contains 
genes that were highly induced after 24 h and consequently not longer (B1) or only 
weakly regulated (B2) 72 h post infection (Fig. 3.4 B). 
This group is also significantly enriched with genes involved in the immune response 
(p<2.1x10-38) and the inflammatory process (p<2.9x10-14). Still significant is the presence 
of genes with chemokines activity (p<7.2x10-9) and with chemokines receptor activity 
(p<7.2x10-9). Notably, there are several cytokines in this cluster (TNF, IL-12, IFN-γ, IL-6) 
known to be essential for clearance a Yersinia spp. Infection (11, 13, 27, 28, 30, 50).  
In the last few years it has been recognized that cells included in the myelomonocytic 
cells, including macrophages and dendritic cells (DCs), have a key role in polarized innate 
and adaptive responses. They can act by promoting the orientation of adaptive responses 
in a type I or type II direction, as well as by expressing specialized and polarized effector 
functions. 
Intriguingly, several of the genes (CCL5, CXCL9, CXCL10, IL-12 and IFN-γ) that we found 
to be strongly induced upon Y. enterocolitica infection are known to trigger a polarization 
in a type I response. Furthermore, this evidence was supported by the observation that 
mRNAs encoding for several surface markers contributing to the formation of the 
“immunological synapse” (MHC class II, CD86, ITGAL, ICAM-1 and CD40) were 
significantly up regulated in our model. The expression of these molecules suggests that 
the CD11b+ cells are implicated in the antigen presentation process, first step for the 
development of a specific adaptive immune response. 
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We could also demonstrate for the first time that the murine homolog of the human B7-
H3, so called CD256, which is involved in the activation of T cells and in the induction of a 
potent IFN-γ production was expressed during Yersinia infection.  
Intriguingly, this is a confirmation of our hypothesis that IFN-γ seems to play a crucial role 
in the modulation of the gene expression during Y. enterocolitica systemic infection. 
Proofing the hypothesis, several genes of the most important antimicrobial pathways 
triggered by IFN-γ signaling were induced upon Yersinia infection in the splenic CD11b+ 
cell population. Factors such as the 2'-5' oligoadenylate synthetase 1G (OAS1), the 
adenosine deaminase, the RNA-specific (ADAR), protein kinase, the interferon-inducible 
double stranded RNA dependent (PRKR) and the nitric oxide synthase 2 (NOS2) were 
significantly induced upon infection. 
Furthermore, the highly expression also of the cytoplasmic transcription factor STAT-1 is a 
good example of this process. STAT-1, if it is phosphorylated in response to the activation 
of the interferon gamma receptors, forms homodimer that is translocated to the nucleus, 
and binds on the GAS (gamma activation site) elements present in the promoter of the 
IFN-γ-responsive genes. This leads to the transcription of several genes that are 
responsible for the antimicrobial activity of interferon gamma. 
Recently, a new family of IFN-γ-induced genes has been discovered that includes 
important mediators of host resistance to intracellular bacteria (39, 96, 153). This family is 
called IFN-responsive GTPase and includes the p47 and the p65 guanylate-binding protein 
(GBP), the myxovirus resistance GTPase and the very large inducible GTPase (VLIG). 
These proteins are highly expressed in a variety of hematopoietic and non-hematopoietic 
cells following infection with intracellular-bacteria and parasite in an IFN-dependent 
manner. Intriguingly, we demonstrated that all of the six characterized murine p47 family 
members [IGTP (interferon gamma induced GTPase), LRG-47 (interferon inducible protein 
1, IFI1), IRG-47 (interferon gamma inducible protein 47, IFI47), TGTP (T-cell specific 
GTPase), IIGP1 (interferon inducible GTPase 1), and GTPI (interferon inducible GTPase 2, 
IIGP2)], two of the p65 family members [GBP2 (guanylate nucleotide binding protein 2) 
and GBP3 (guanylate nucleotide binding protein 3)] and the Mx1 (myxovirus resistance 1) 
were induced in our Y. enterocolitica infection moldel. While their precise function is 
unknown, each encodes for a protein with a guanosine 5’ triphoshatase activity that has a 
potent antimicrobial activity. All these gene products can bind to subcellular membranes, 
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including the endoplasmic reticulum (ER) and the Golgi apparatus and probably they play a 
role in the host cell trafficking and in promoting the phagosome maturation.  
Furthermore, also some genes (SOCS1, SOCS3 and CISH) know to act as regulatory 
factors of the IFN-γ response were up-regulated by Yersinia infection. Recent studies had 
demonstrated that the expression of these proteins results in the inhibition of JAK/STAT-
mediated cytokine signaling. Probably the activation of this classic negative feedback loop 
is necessary to avoid an over activation of the host response. 
Interestingly, the group B is also highly enriched for genes of the apoptosis pathway 
(p<2.2x10-13); in particular a group of them show caspase activity (p<1.1x10-11) (Casp1, 
Casp7, Casp8 and Casp11). Furthermore, several of these genes are involved in the 
Caspase 8-mediated apoptosis pathway, in particular FAS (TNF receptor superfamily 
member), Daxx (Fas death domain-associated protein), TNFSF10 (tumor necrosis factor 
ligand superfamily, member 10, old name TRAIL) APAF1 (apoptotic protease activating 
factor 1) RIPK1 (Rip) receptor (TNFRSF)-interacting serine-threonine kinase and TRAF1 
(Tnf receptor-associated factor 1). This apoptosis pathway seems to be directly activated 
by Y. enterocolitica via the injection of the virulence proteins Yops to counteract the 
response of the host cells. 
On the other hand, some anti-inflammatory factors like IL-6, IL-1RA (interleukin 1 
receptor antagonist) were also highly induced. Probably the play a role in regulate the 
activation of the cell host response The exact role of IL-6 in innate immunity remains 
unclear but, as previous studies demonstrated in a Y. enterocolitica infection, the 
regulation of the inflammatory responses before serious tissue damage seems to be 
required for a correct immune response (50). Indeed, the reduction of the IL-1-mediated 
inflammatory responses at the site of infection by means of induction of IL-1RA 
(interleukin 1 receptor antagonist) in response to Y. enterocolitica infection may be a key 
role of IL-6 (50, 87, 97, 151).  
The third group of induced genes (cluster C) includes genes that are higher expressed at 
day 3 p.i. rather than at day 1 p.i.. This group includes mostly surface receptors such as 
colony stimulating factor 2 receptor beta 1, LIFR, CCR5 or FcR or the scavenger receptor 
SCARBP as well as genes encoding transcription factors or genes involved in signaling 
such as NF-IL, MEKK1, and JAK3. 
The infection with Y. enterocolitica leads also to suppression of a great number of genes 
in splenic CD11b+ cells. As shown in figure 3.4, these genes are clustered in the group D 
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and E. Genes with metabolic function and general cellular process are predominant in 
these groups. In particular lipid metabolism (p<4.7x10-3), fatty acid metabolism (p<3.4x10-
5) and sterol biosynthesis (p<1.0x10-7) are the most represented functional pathways. 
Taken together these data show a remarkable shift of expressed genes during an immune 
response in dependency of their functions. The expression of genes with general cellular 
and metabolic function was significantly reduced in favor of mediators of the immune 
response. 
Interestingly, the expression of the mRNA encoding for interleukin 4 was strongly 
suppressed in our systems. IL-4 is a potent inducer of Th2 responses. Probably, the 
suppression of IL-4 and the induction of genes such as IL-12 and IFN-γ might facilitate a 
polarization towards a Th1 response, essential in Y. enterocolitica infection. 
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3.4   Modulation of the gene expression by YopH and YopP in          
Y. enterocolitica infection 
 
The main focus of this study was to investigate if and how the lack of certain Yops can 
modulate the gene expression of cells of the innate immune system in vivo. For this aim 
C57BL/6 mice were infected intravenously with 5x104 CFU of two Y. enterocolitica strain 
pYV+∆yopP and pYV+∆yopH lacking the virulence factors YopP and YopH, respectively. 
The gene expression analysis was performed as reported in material and methods. To 
define the differentially regulated genes the expression levels obtained with the deletion 
mutant strains was compared to the expression levels upon wild type infection. 
Average linkage hierarchical clustering was applied to the regulated genes (more than 3-
fold regulated in comparison with uninfected mice) for each bacteria strain at each time 
point investigated (Figure 3.5). 
 
Figure 3.5 Modulation of gene expression by the Y. enterocolitica virulence factors YopH 
and YopP. Groups of six C57BL/6 mice were intravenously infected with 5x104 CFU of Y. e. 
pYV+ or pYV+∆yopH or pYV+∆yopP. 24 h and 72 h p.i. the CD11b+ cells population was 
selected from the spleen. The total RNA was hybridized on a murine genome GeneChip 
probe arrays MG-U74Av2 (Affymetrix, High Wycombe, UK). Fig.A Probesets which are 
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displayed fulfilled the following criteria: for at least one of the indicated groups the change in 
gene expression as shown as Signal log2 ratio (SLR) was >1.5 or < -1.5 compared to gene 
expression in uninfected control mice. The hierarchical algorithm was applied to the 
differentially regulated genes according to the signal log ratios to cluster co-expressed 
genes. Expression levels are colour coded, red indicates expression level above and green 
below the expression level of uninfected control mice.Fig. B The bars represent the numbers 
of the differentially expressed probe sets between the infected mice and uninfected control 
mice. 
 
This algorithm, applied according to the signal log ratio of all differentially expressed 
genes, revealed that the transcriptional responses after infection with pYV+ and 
pYV+∆yopP are closely related whereas the profile of the bacteria that lack YopH is clearly 
segregated suggesting that this virulence factor may play an essential role during Yersinia 
infection (Fig. 3.5 A). In line with these finding the numbers of the regulated probe sets at 
day 1 (289 probe sets) and at day 3 p.i. (211 probe sets) with pYV+∆yopH versus 
uninfected are much lower compared to the amount of probe sets regulated upon 
infection with pYV+ (day 1, 704 and day 3,501) or with ∆yopP (day 1, 558 and day 3, 433) 
as shown in figure 3.5 B. 
 
Probe sets regulated  24 h    72 h  
 pYV+ ∆yopH ∆yopP  pYV+ ∆yopH ∆yopP 
1 Induced 392 218 336  255 159 281 
Suppressed 312 71 222  155 52 142 
Tot 704 289 558  410 211 433 
 
Table 3.2  Probe sets more than 3-fold regulated in splenic CD11b+ cells compared to 
uninfected control mice. 
 
3.4.1   Modulation of gene expression by YopP 
 
A detailed analysis revealed the presence of 66 probe sets that were found to be 
differentially expressed during the infection with the ∆yopP strain compared to the 
infection with the wild type Yersinia strain (supplementary table 2). Interestingly, we did 
not find genes indicating suppression of a pro-inflammatory response and no genes 
indicating apoptotic processes known to be influenced by YopP in vitro.  
The lacking of apoptosis occurrence correlates with the finding that in the presence of 
YopP high expression of the cell cycle inhibitors p21WAF1 (CDKN1A) and p27 KIP1 
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(CDKN1B) was found in vivo, while the expression of these genes is lower in the absence 
of YopP. Like other cells of the immune system, macrophages are produced in large 
amounts during the course of an infection. To prevent an accumulation and to fine 
regulate their activity most of them die through apoptosis if not functionally activated. 
Recently, Xaus et al. had proved that IFN-γ is one of the most powerful soluble factors in 
protecting macrophages from apoptosis via induction of the cyclin-dependent kinase (cdk) 
inhibitor, p21WAF1 (167, 21). Probably the strong activation that macrophages received at 
the inflammatory loci, during Y. enterocolitica infection is sufficient to overcome the 
activation of the apoptosis process mediated by YopP. However, further studies are 
necessary to clearly understand this process and to define the real role of this virulence 
factor in vivo. 
 
3.4.2   Modulation of gene expression by YopH 
 
These findings clearly suggest that the absence of the bacterial factor YopH leads to a 
complete different transcriptional response in cells of the innate immune response. This is 
probably correlated with the diminished virulence of the bacteria strain lacking YopH that 
may facilitate the clearance of the bacteria at the site of infection. 
To follow up more specifically these differences, we compared directly the gene 
expression profile obtained upon infection with YopH deletion mutant to the expression 
level of the wild type strain infection. Thus a group of 354 probe sets representing 343 
genes were more than 2-fold differential expressed in Y.e. pYV+ versus pYV+∆yopH 
infected mice.  
Interestingly, this group was significantly enriched of genes involved in the immune 
response (p=<7.1x10-11) and in the inflammatory response (p=<2.1x10-13), with a 
significant presence of genes with chemokine activity (P=<2.1x10-9) and chemokine 
receptor activity (P=<2.7x10-14). 
The expression of the mRNA encoding for several cytokines (IL-6, IL-1α, IL-12a, IFN-γ, IL-
15, TNF, CCL5, CXCL1 and CXCL9) and for pro-inflammatory factors such as CD14, COX2, 
NOS2 was much weaker upon infection with ∆yopH compared to infection with pYV+. 
To confirm these array-based gene expression data independently, we performed Real-
Time quantitative PCR (RT-qPCR) for some representative genes (IL-1α, TNFα, IFN-γ and 
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IL-12a). RNA preparations for RT-PCR were independent from those used for array 
hybridizations. As shown in Figure 3.6, the overall expression pattern could be confirmed 
for every gene. There were, however, some negligible differences in the extent of increase 
in mRNA levels between RT-qPCR and array data. 
 
 
 
Figure 3.6  Quantification of mRNA expression by Real time-PCR. The mRNA expression of IL-
1α, TNFα, IFN-γ and IL-12a in splenic CD11b+ cells isolated from C57BL/6 mice upon 
intravenous infection with 5x104 CFU of Y. e. pYV+ or pYV+∆yopH or pYV+∆yopP. 24 h and 
72 h p.i. the CD11b+ cells population was selected from the spleen. The mRNA expression of 
the indicated genes was analyzed by semiquantitative RT-qPCR. The bars represent mean 
values of the log2 of the fold difference between infected and control mice normalized to the 
expression level of the control gene RPL8. 
 
Furthermore, several genes encoding for receptors and costimulatory molecules involved 
in the formation of the immunological synapses were significantly lower expressed upon 
∆yopH infection. In order to verify these data, the expression of some surface markers 
known to be induced on activated dendritic cells and macrophages (antigen presenting 
cells APCs) was evaluated. Single cell suspension isolated from spleen of mice infected 
with 5x104 CFU of Y. e. pYV+ or with pYV+∆yopH at 24 h p.i. were stained with 
fluorophore-conjugated antibodies anti-MHCII, CD40, CD80 and CD86, and the presence 
of these surface molecules was examined by flow cytometry. 
The expression levels of the MHC class II receptors and of the co-stimulatory molecules 
CD86, CD80 and CD40 increased on both macrophages and dendritic cells upon wild type 
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Y.e. infection (Fig. 3.7). Therefore we could conclude that the systemic infection with the 
wild type Y. enterocolitica strain induced a strong activation of the antigen presenting cells 
(APCs). The increased expression of these latter molecules suggests that the APCs might 
be competent to interact with T cells to activate an adaptative immune response.  
Conversely, the ∆yopH infection induced just a moderate increase of these surface 
molecules, revealing an incomplete activation of the innate immune response 
 
 
 
Figure 3.7 Expression of MHC class II and co-stimulatory molecules by splenic dendritic cells 
and macrophages after infection with Y. enterocolitica. Splenocytes were isolated 
upon 24 h p.i. infection with the indicated Y. enterocolitica strains. The cells were stained 
with CD11b, CD11c, F4/80 and Gr-1 to differentiate dendritic cells (Fig.A) and macrophages 
(Fig.B). Subsequently the expression of surface molecules like MHC class II, CD86, CD80 and 
CD40 (thick lines) or isotype-matched control IgG (thin lines) was assessed by flow 
cytometry gating on the propidium iodide negative population. In the histograms the 
differences between the mean fluorescence intensity (MFI) values of specific antibodies to 
isotype controls are indicated ± SD of 3 independent experiments. 
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3.4.2.1   Inflammatory cells influx in the spleen upon Y. enterocolitica  systemic 
infection 
 
Once an inflammatory response is initiated, neutrophils and macrophages are the first 
cells to be recruited to the site of infection. Chemotaxis of phagocytes proceeds into the 
site where phagocytosable material occurs. This is regulated by chemotactic factors 
generated by infectious agents themselves, as well as those released as a result of their 
initial contact with phagocytes and other components of the immune system. 
As previously mentioned, our microarray data indicate that the infection with the bacteria 
lacking the expression of YopH leads to a different modulation of the transcriptional levels 
of several chemotactic factors. For example, chemokines and interleukins such as CXCL1, 
CXCL2, CCL2, CCL3, CCL4, CCL5, IFN-γ and IL-6 were significantly lower expressed in the 
mice infected with ∆yopH in comparison to the other two strains expressing this crucial 
virulent factor. 
In order to elucidate whether this different transcriptional response was actually, 
associated with a discrepant recruitment of inflammatory cells in the spleen upon Yersinia 
infection, analysis of the different cell populations present in this organ was performed by 
flow cytometry (FACS) (Fig. 3.8 and Fig. 3.9). 
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Figure 3.8 CD11b+ cells influx in the spleen of Yersinia-infected mice. The relative number of 
the CD11b+ cells from naive mice or mice intravenously infected with 5x104 CFU of Y. 
enterocolitica pYV+ or pYV+∆yopH and or pYV+∆yopP was assessed by flow cytometry. FigA. 
The dot plots are representative of 3 independent experiments. Fig.B The bars represent 
mean values ±SD from 10 mice. Statistically significant differences compared pYV+∆yopH 
versus wild type Yersinia infection are indicated with an asterisk (p≤ 0.05). 
 
Figure 3.8 shows histograms indicating of the increased amount of CD11b positive cells in 
the spleen upon infection. In line with the lower induction of chemotactic cytokines, a 
significant low influx of inflammatory cells in the spleen of mice infected with the bacteria 
lacking the virulence factors YopH was found. Upon infection with the wild type Yersinia 
and with the bacteria that lack YopP, the CD11b+ cells augment more than three-fold at 
24 h post infection with an ongoing influx of cells, that has been constant throughout the 
progression of the disease and reached 30% of the total splenic cells after 72 hours. 
To define which cell type was mainly involved in this process, single-cell suspensions from 
spleen were stained with marker-specific fluorophore-conjugated antibodies (Abs), and the 
number of polymorphonuclear leukocytes (CD11b high, Gr-1 high and F4/80 negative) and 
macrophages (CD11b high, Gr-1 low and F4/80 high) was estimated (Fig. 3.9). 
Neutrophils have the earliest detectable change in abundance, whereas changes in 
macrophages numbers appeared a couple of days thereafter. Neutrophils, which are rare 
in the spleen of naive mice, undergo a 10-fold increase in absolute number by day one 
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post infection in both wild type Y. enterocolitica and ∆yopP infection. A similar increase in 
the number of macrophages was also observed upon infection with delay in the expansion 
of the population that increased 3-fold more than neutrophils after 72 h (Fig. 3.9).  
In agreement with the gene expression data, the mice infected with the ∆yopH strain 
showed no significant influx of macrophages one day p.i.. Only after 72 h a slightly 
increase of these cells was observed but still significantly lower in comparison with the two 
other Yersinia strains expressing the virulence factor YopH. 
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Figure 3.9 Influx of phagocytic cells in the spleen of naive and of Yersinia-infected mice. The 
absolute number of the indicated cell populations within total splenocytes from naive mice or 
mice intravenous infected with 5x104 CFU of Y. enterocolitica pYV+, pYV+∆yopH and 
pYV+∆yopP. The cell populations were defined as follows: neutrophils (CD11bhigh, Gr-1high), 
and macrophages (CD11bhigh, F4/80high, Gr-1intermediate). The bars represent mean values ±SD 
from 10 mice. Statistically significant differences compared pYV+∆yopH versus wild type 
Yersinia infection are indicated with an asterisk (p≤ 0.05). 
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3.4.2.2   Definition of a YopH specific signature 
 
As a consequence of the reduced virulence of the Yersinia enterocolitica ∆yopH strain, the 
bacterial abundance in the spleen already at 24 h p.i. was 100-fold lower compared to that 
observed in the wild type infection (Fig. 3.1). These findings lead us to the suggestion that 
the weaker immune response after infection with ∆yopH is associated with the lower 
bacterial load. To investigate whether this is the case, C57BL/6 mice were infected 
intravenously with 5x103 CFU of the Y.e. pYV+ or 5x106 CFU of the ∆yopH mutant strain 
which resulted in the same bacteria number in the spleen 24 h p.i., respectively (4.5±0.4 
and 4.8±0.6) (Fig.3.10).  
 
 
Figure 3.10 The lack of YopH leads to a significant reduction of the virulence. C57BL/6 female 
mice 6-8 week-old were infected intravenously with the indicated doses of a Y. enterocolitica 
pYV+ or with a pYV+∆yopH. The bacterial number was assessed in homogenized spleens 
after 24 h post infection. Values represent the average log10 CFU per spleen for ten mice 
with the standard errors of the means indicated by error bars. 
 
Each spleen was aseptically removed, the CD11b+ cells were selected as prior mentioned 
and the mRNA of these cells was used for additional microarray experiments. 
The expression of the 354 differentially regulated probe sets between the wild type 
infection and the ∆yopH infection was subsequently analyzed to exclude the influence of 
the different bacterial loads in the spleen (supplementary table 3).  
The k-means algorithm was applied to cluster according to the signal log ratio probe sets 
with a similar expression profile. By this approach genes with similar expression patterns 
were sorted into 5 major groups of genes (Fig. 3.11; supplementary table 3).  
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Figure 3.11 Expression profiles of the differentially regulated genes in ∆yopH vs pYV+. Fig.A 
The expression profile of the probes sets (354) differentially regulated during the infection 
with 5x104 CFU of Y. e. pYV+ versus pYV+∆yopH (more than 2-fold difference) was analyzed 
during the infection experiments with the doses that had led to the same bacterial load in 
the spleens. The K-means algorithm was applied to characterize the common expression 
profiles. Expression levels are colour coded, with red indicating expression level above and 
green below the expression level of uninfected control mice. Fig.B Expression profile of the 
different gene clusters over the time course of infection (24 h p.i. and 72 h p.i.). 
 
In details we could group the genes according their expression patterns in the following 
clusters:  
 
i. Cluster A: probe sets directly influenced by the bacterial load in the spleen  
ii. Cluster B: probe sets induced only when the bacteria produce YopH  
iii. Cluster C: probe sets induced only when the bacteria lack YopH  
iv. Cluster D: probe sets suppressed only when the bacteria produce YopH 
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v. Cluster E: probe sets directly influenced by the bacterial load in the spleen. 
 
Intriguingly, we could prove that only the expression level of a small group of genes was 
completely restored. By contrast, the most part of the genes were still weakly or not 
induced even upon infection with 5x106 CFU of the ∆yopH mutant strain. 
The probe sets that were differentially regulated by the bacterial number in the spleen are 
reunited in the cluster A (75) and in the cluster E (164) (Fig. 3.11) as induced and 
suppressed genes upon infection, respectively. 
Several of these genes are known to be transcriptional regulated via the stimulation of the 
pattern recognition receptors i.e.Toll like receptors by different bacterial products.  
The mRNA ofl genes described to be induced upon LPS stimulation such as the platelet-
activating factor receptor, the interleukin 1 receptor antagonist and the LPS receptor CD14 
were strongly induced when the infection dose of the ∆yopH mutant strain was increased. 
In line with these findings is, that the expression of many well-characterized pro-
inflammatory cytokines was restored, including TNF, IL-1α, CXCL1, CXCL2, CCL2 and 
CCL4, when the bacterial load and consequently the stimulation via the pattern recognition 
receptors on the cells was increased.  
Intriguingly, a group of 73 probe sets representing 72 genes (cluster B, Fig. 3.11) was still 
weakly or not induced upon infection with the Y. enterocolitica bacteria strain that do not 
produce the virulence factor YopH. Out of this cluster, more than 20 genes could be 
functionally classified under the biological process “immune response”.  
More strikingly, of these 72 genes, 18 are known to be IFN-γ regulated. This group 
included several chemokines involved in activation of innate and adaptive immunity (CCL5, 
IL-12a, IL-15), members of the GTPase family implicated in resistance to intracellular 
infection (IIGP1), and other proteins such as the protein kinase interferon-inducible double 
stranded RNA dependent (PRKR), the adenosine deaminase RNA-specific (ADAR) and 
NOS2 effector factors responsible for IFN-γ-microbicidal activity. 
In order to confirm this data we performed quantitative Real time-PCR for IFN-γ and for 
IL-12a (Fig. 3.13). These genes are lower expressed when the bacteria do not produce 
the virulence factor YopH, as we could show with the microarray experiments. 
Taken together this data demonstrate that there is a specific signature of YopH during 
Yersinia infection. It became evident from different in vitro studies that YopH is very 
efficient in effecting the phagocytosis process in macrophages and neutrophils . Probably 
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the lack of this virulence factor leads to a better clearance of the infection via a more 
efficient phagocytosis and to a subsequently reduced host response. Otherwise, to clear 
the wild type Yersinia strain with the full virulence machinery, the phagocytes will require 
a full activation to overcome the activity of the Yersinia outer proteins. IFN-γ seems to be 
the crucial factor for this activation. Therefore we can conclude that the presence of YopH 
triggers a much stronger immune response. 
 
 
Figure 3.13 Quantification of the mRNA expression of interferon-γ and IL-12a upon Yersinia 
∆yopH infection. The mRNA expression of IFN-γ and IL-12a was assess in splenic CD11b+ 
cells isolated from C57BL/6 mice upon intravenous infection with Y. e. pYV+ or pYV+∆yopH 
at the indicated doses. The CD11b+ cells population was selected from the spleen 24 h p.i.. 
The mRNA expression of the indicated genes was analyzed by semiquantitative RT-PCR. The 
bars represent mean values of the log2 of the fold difference between infected and control 
mice normalized to the expression level of the control gene RPL8. 
 
Unexpectedly, in our experiments there was a group of genes that was strongly induced 
only during the infection with the bacteria strain that do not produce the virulent factor 
YopH (Cluster C, Fig. 3.11; supplementary table 3).Probably, its the injection in the host 
cells cytoplasm of this bacterial protein can directly interfere at the transcriptional level 
with the expression of mRNAs. Interestingly, none of the known targets of YopH were 
found by this in vivo approach and therefore this may lead to novel effector functions of 
this virulence factor. 
This group comprised mostly genes encoding for cell adhesion molecules (a disintegrin 
and metalloprotease domain 8, ADAM8; thrombospondin 1, THBS1; selectin platelet, 
SELP) and factors involved in chemotaxis (formyl peptide receptor 1, FPR1), although 
these functional groups were not significantly enriched compared to a randomly selected 
group of genes. 
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For the first time we could prove that Y. enterocolitica infection can induce the expression 
of the scavenger receptor MARCO (macrophage receptor with collagenous structure), 
which is a new and interesting finding. 
This is a multifunctional trimeric glycoprotein, member of the class A scavenger receptor 
family. It has been implicated to varying degrees in systemic innate immunity against 
infections (8, 111, 160). Moreover, MARCO can bind LPS or LTA, as well as intact bacteria 
Escherichia coli and Staphylococcus aureus (160).  
Real time quantitative-PCR experiments were performed using RNA samples independently 
isolated from the RNA used for the microarray hybridization in order to verify previous 
results (Fig. 3.14). 
 
 
Figure 3.14 In vivo induction of MARCO expression by Yersinia infection. The mRNA expression 
of MARCO was assessed in splenic CD11b+ cells isolated from C57BL/6 mice upon 
intravenous infection with Y. e. pYV+ or pYV+∆yopH at the indicated doses. The CD11b+ cell 
population was selected from the spleen 24 h p.i.. The mRNA expression of the indicated 
genes was analyzed by Real time RT-PCR. The bars represent mean values of the log2 of the 
fold difference between infected and control mice normalized to the expression level of the 
control gene RPL8. 
 
To investigate whether the different expression of MARCO mRNA leads also a different 
receptor expression on the cell surface, we analyzed freshly isolated splenic cells by flow 
cytometry analysis. Total splenic cells were stained with different antibody (CD11b, CD11c, 
F4/80 and Gr-1) to differentiate macrophages and dendritic cell populations and to detect 
the expression of MARCO on the surface. 
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The spleen cells from uninfected mice and from intravenously infected mice with different 
doses of the wild type Y. enterocolitica strain and with the ∆yopH mutant strain were 
analyzed 24 h p.i. (Fig. 3.15). 
 
 
 
Figure 3.15 Expression of MARCO from splenic macrophages and DCs after infection with       
Y .enterocolitica. C57BL/6 mice were infected intravenous with different doses of different 
Y. enterocolitica strain as indicate in figure. 24 h post infection the splenocytes were stained 
with fluorophore conjugated antibodies anti-CD11b, F4/80, CD11c and MARCO or with the 
correspondent isotype controls. The expression of MARCO was evaluated by flow cytometry 
gating on the CD11b and F4/80 positive population or on the CD11c positive and F4/80 
negative population. The fluorescence of the antibody (thick lines) or isotype-matched 
control IgG (thin lines) is shown. In the histograms the differences between the mean 
fluorescence intensity (MFI) values of specific antibodies to isotype controls are indicated ± 
SD. The histograms are representative of 3 independent experiments.  
 
In agreement with previous studies, only a small subset of macrophages and dendritic 
cells from spleen of specific pathogens free mice express constitutively MARCO receptors 
on the surface. Upon infection with Y. enterocolitica the expression of this receptor was 
significantly induced in both macrophages and dendritic cells all over the spleen. 
Moreover, the proteins were never detected on lymphocytes and granulocytes (data not 
shown). Thus, MARCO expression seems to be dose dependent and restricted to 
macrophages and dendritic cells. Intriguingly, in confidence with the microarray data we 
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found a significant higher quantity of the receptor MARCO upon infection with Y.e. 
pYV+∆yopH. It is not clear if this difference can be correlated directly with the effect of 
YopH at the transcriptional levels in the infected cells or it is an indirect consequence of 
the different modulation of chemokines and interleukins expression in the spleen. Further 
in vitro experiments will be required to definitively address these questions. 
 
3.4.2.3   Surface molecule expression by dendritic cells and macrophages after 
Y. enterocolitica infection 
 
As previously reported, a group of genes (Cluster B; Figure 3.11) was permanently weakly 
expressed in splenic CD11b+ cells even upon infection with the highest dose of the ∆yopH 
strain (CFU 5x106) compared to wild type Y. enterocolitica. This suggests that the 
regulation of those genes is rather influenced by other factors than structural bacteria 
substances. It is very interesting that the gene expression profiles of some surface 
markers (CD86, CD40) identified to be induced upon infection on antigen presenting cells 
(APCs) belongs to this group.  
Eventually, in order to verify these data we tested splenic macrophages and dendritic cells 
upon infection by flow cytometry, if the weak expression of the mRNA leads also to a 
reduced presence of receptors on the cell membrane. 
Splenic cell suspensions from mice infected with the Y.e. pYV+ or with ∆yopH strains, were 
stained to evaluate the expression of MHC class II and of the co-stimulatory molecules 
CD86, CD80 and CD40. 
Twenty-four h after intravenous infection with the wild type Y. enterocolitica strain, the 
expression of MHC class II was remarkably increased compared to uninfected mice in both 
macrophages and dendritic cells in a dose dependent manner as shown in figure (Fig. 
3.16). Increased MHC class II expression was also observed after infection with the YopH 
deficient mutant, although the expression was significantly lower even with the highest 
infection dose (CFU 5x106) compared to the infection with the wild type bacteria. 
Furthermore, the co-stimulatory molecules CD86, CD80 and CD40 were significantly 
expressed on the cells only after the wild type infection, whereas significantly less increase 
was observed after infection with the YopH deficient mutant strain (Fig. 3.16).  
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Taken together these results indicate that the infection with YopH deficient mutant strain 
leads to a weaker activation of macrophages and dendritic cells, even when the bacteria 
load in the organs is comparable. This is probably due to the lower virulence of the 
pYV+∆yopH strain. The lack of the virulence factor YopH leads to a fast resolution of the 
infection, and a subsequently lower induction of pro-inflammatory cytokines and activation 
of the host response. 
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Figure 3.16 Expression of MHC class II and co-stimulatory molecules by splenic dendritic cells 
and macrophages after infection with Y. enterocolitica. Slenocytes were isolated 
upon 24 h p.i. infection with the indicated Y. enterocolitica strains. The cells were stained 
with CD11b, CD11c, F4/80 and Gr-1 to differentiate dendritic cells (Fig. A) and macrophages 
(Fig. B). Subsequently the expression of surface molecules like MHC class II, CD86, CD80 
and CD40 (thick lines) or isotype-matched control IgG (thin lines) was assessed by flow 
cytometry gating on the propidium iodide negative population. In the histograms the 
differences between the mean fluorescence intensities (MFI) values of specific antibodies to 
isotype controls are indicated ± SD of 3 independent experiments. 
 
3.4.2.4   IFN-γ is dispensable if Y. enterocolitica lack YopH 
 
The gene expression pattern achieved upon infection with the Y.e. ∆yopH strain revealed 
that IFN-γ and some of the most important IFN-γ-regulated genes are weakly induced by 
the bacteria lacking YopH. 
This suggests that IFN-γ might be to some extent dispensable at least in the early phase 
of infection if the bacteria do not produce this virulence factor. Therefore, we 
hypothesized that the expression of this cytokine and its mediated microbicidal activity is 
crucial to overcome the effects of YopH in inhibiting the host cells immune response. To 
address this hypothesis, IFN-γR1 deficient mice and wild type mice (C57BL/6) were 
infected with 5x104 CFU of either Y. enterocolitica pYV+ or with the ∆yopH strain. While 
IFN-γR1-/- mice were extremely susceptible to the wild type Yersinia strain pYV+ , they 
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were able to clear the infection with the YopH deficient mutant as well as the C57BL/6 
mice. The evaluation of the bacteria number in the spleen reveals a comparable amount of 
living bacteria in the spleen of the two mice strains (Fig. 3.17). Furthermore, the IFN-γR 
deficient mice were enabled to a proper clearance of the infection and fast recovery within 
some days when infected with the∆yopH  bacteria (data not shown). 
 
Figure 3.17 IFN-γ signaling is dispensable if Y. enterocolitica lack YopH. C57BL/6 and IFN-γR1-/- 
female mice 6-8 week-old were infected intravenously with 5x104 CFU of a Y. enterocolitica 
pYV+ or with a pYV+∆yopH. The bacterial number was assessed in homogenized spleens 
after 24 and 72 p.i.. Values represent the average log10 CFU per spleen for ten mice with the 
standard errors of the means indicated by error bars. 
 
3.4.2.5   IFN-γ enhances internalization of Y. enterocolitica by macrophages 
 
Taking into account that the key effect of YopH is subverting phosphotyrosine signals 
essential for the phagocytosis in macrophages and neutrophils, we decided to test 
whether IFN-γ might be able to overcome these effects by enhancing the antimicrobial 
activity of the macrophages. Bone marrow derived macrophages (BMDMs) primed or not 
primed with 50ng/ml IFN-γ for 24 h were infected with Y.e. pYV+ strain, pYV- and 
pYV+∆yopH at MOI of 50 for 30 min (Fig. 3.18). We first monitored the behaviour of Y. 
enterocolitica wild type strain in contact with BMDMs. Thirty min after infection, the 
number of cell-associated bacteria was counted and the percentage of internalized 
bacteria was calculated by using the double-immunofluorescence staining. In parallel, we 
tested wild-type Y. enterocolitica and a mutant (pYV-) deprived of the virulence plasmid 
encoding for the type III secretion machinery. Adherence of both non-opsonized bacteria 
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to BMDMs was in the same magnitude (data not shown). However, only 16% of the Y. 
enterocolitica pYV+ bacteria were ingested (Fig. 3.18 A, G), while 86% of the pYV- bacteria 
were taken up. This demonstrated that the injection of the Yops allows Y. enterocolitica to 
resist phagocytosis by macrophages. To determine the involvement of YopH effector in 
resistance to phagocytosis, a pYV+∆yopH strain was used. For each experiment, we 
measured the total number of bacteria associated with macrophages and retrieved 
consistant data for each strain tested (data not shown). In the absence of opsonization the 
YopH mutant bacteria was internalized by BMDMs at least 5-fold more than wild type 
bacteria. The percentage of phagocytosis increased from 16% (pYV+) to 70% 
(pYV+∆yopH), confirming that YopH contributes significantly to resistance to phagocytosis. 
For note, infection of pYV+ with a lower MOI than 50 lead also to internalization indicating 
that the effects mediated by YopH are dose dependent (Fig. 3.23).  
To investigate whether IFN-γ might be able to enhance Y. enterocolitica phagocytosis, 
BMDMs were primed for 24 h with IFN-γ and subsequently infected with the wild type Y. 
enterocolitica and with the YopH deletion mutant. 30 min after infection intracellular and 
extracellular located bacteria were determined. As reported previously, the wild type 
Yersinia were predominantly extracellularly located, while after priming with IFN-γ the 
internalization of pYV+ was significantly increased up to 73% (Fig. 3.18 B, G). These data 
clearly indicate that IFN-γ can overcome the inhibitory effect of YopH on phagocytosis. 
The mechanisms by which IFN-γ priming of BMDMs increased the number of internalized 
Yersinia bacteria is not clear, but our data suggest that IFN-γ increased the opportunity for 
bacterial-macrophage interaction, perhaps by an increase in the size of the cells as shown 
in the figure 3.19. Such morphological changes have previously been described following 
IFN-γ priming of human macrophages (107). 
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Figure 3.18  IFN-γ priming enhances internalization of Y. enterocolitica by macrophages. Bone 
marrow-derived macrophages from C57BL/6 mice primed (B, D and F) or not (A, C and E) 
with IFN-γ 50ηg/ml for 24 h were infected with MOI 50:1 of different Y. enterocolitica 
strains: pYV+ (A and B), pYV- (C and D) or pYV+∆yopH (E and F) cultivated at 37°C. The 
number of adherent bacteria and intracellular bacteria were determined by the double-
immunofluorescence staining. The extracellular bacteria appear green and the intracellular 
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blue in the figure. Phagocytosis results are given as percentages of phagocytosed bacteria 
normalized to the total number of cell-associated bacteria (*, p≤ 0.05 compared to the WT; 
**, p≤ 0.05 compared to the WT primed with IFN-γ). The values are the mean plus the 
standard error of three independent experiments. For each experiment, at least 100 cells 
were counted. 
 
 
Figure 3.19 IFN-γ priming increases the size of macrophages. Bone marrow-derived macrophages 
from C57BL/6 mice primed (B) or not primed (A) with IFN-γ 50ηg/ml for 24 h were stained 
with tetramethyl rhodamine isothiocyanate-conjugated phalloidin for 30 min and analyzed by 
fluorescence microscopy. The pictures were taken at the same magnification. 
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3.5   Interferon-γ-dependent immunity to Y. enterocolitica  
 
Historically, the role of IFN-γ has been only considered as necessary in infection with 
intracellular pathogens, including Mycobacterium tuberculosis, Salmonella typhimurium, 
Leishmania major and Listeria monocytogenes.  
Intriguingly, also in Y. enterocolitica infection IFN-γ seems to be crucial for protection. 
Furthermore, it has been shown that this cytokine is critical for the development of a Th1 
cell mediating resistance that is essential to successfully clear the infection. Usually IFN-γ 
is secreted by natural killer (NK) cells and T cells upon stimulation with IL-12 and IL-18 
considered the most powerful IFN-γ-inducing cytokines. These interleukins are abundantly 
secreted by antigen presenting cells following Yersinia infection. On the contrary, not 
much is known about the molecular mechanisms of the IFN-γ-induced-microbicidal 
capacity, and furthermore which cell types are the effectors of this process in a Yersinia 
infection. Several in vitro and in vivo studies with other bacteria had shown that IFN-γ-
priming of phagocytes (neutrophils and macrophages) can significantly enhance their 
antimicrobial capacity by inducing several genes. Intriguingly, our microarray data had 
shown that several IFN-γ-regulated genes were highly induced in splenic CD11b+ cells 
upon Y. enterocolitica infection (supplementary table 1). Therefore, in order to address 
what is the actual influence of this cytokines on the transcriptome of cells of the host 
innate immune response during a Y. enterocolitica infection, we decide to characterize the 
whole gene expression in splenic CD11b+ cells isolated from mice deficient for the IFN-γ 
receptor during the course of Y. enterocolitica in fection. These mice are unable to initiate 
signaling in response to IFN-γ and they may be useful to understand which pathways are 
involved in the host immune response against Y. enterocolitica. 
First of all IFN-γR1-/- mice on C57BL/6 background and correspondent C57BL/6 wild type 
mice were intravenously infected with 5x104 CFU of Y. enterocolitica pYV+ to analyze their 
response to the infection. The mice were sacrificed one and three days after infection, and 
the number of bacteria in their spleens was assessed. We could prove that the bacterial 
number increased significantly in the organs of the interferon-γ receptor deficient mice 
(Fig. 3.20 A). Moreover, 72 h p.i. the dramatic boost of the bacteria in the spleen (200-
fold increase) was associated with obvious clinical manifestations (anorexia, loss of body 
weight, lethargy) never evident in normal mice that end 4-6 days p.i. to death. 
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To further evaluate the role of IFN-γ in the progression of infection, we infected the 
interferon-γ receptor deficient mice with an infection dose of Y. enterocolitica (5x103 
CFU/mouse) that was usually well tolerated by the wild type mice. As shown in figure 3.20 
B, the IFN-γR1-/- mice revealed a significant greater mortality in comparison to wild type 
mice. Indeed they displayed 100% mortality around day 8 and day 9 as confirmed in three 
different experiments, whereas the majority of the wild type mice were able to recover. 
These data reveal a severe defect in the control of Yersinia infection. Furthermore, our 
data clearly indicate that IFN-γ is crucial already at the early stage of infection suggesting 
that its antimicrobial effects are probably achieved by cells of the innate immune system. 
 
Figure 3.20 IFN-γR1 deficiency increases the susceptibility to Y. enterocolitica infection. Fig.A 
C57BL/6 and IFN-γR-/- mice were infected intravenously with 5x104 cfu/mouse of Y. 
enterocolitica pYV+. Values represent the average log10 CFU per spleen for six mice with the 
standard errors of the means indicated by error bars. Asterisks indicate significant 
differences when compared CFU in C57BL/6 vs IFN-γR-/- mice (p ≤ 0.05). Fig.B C57BL/6 (?) 
and IFN-γR-/- (?) mice (6 per group) were infected intravenous with 5x103 cfu/mouse of Y. 
enterocolitica pYV+. The mice were monitored daily for survival. Data presented are 
representative of 3 independent experiments. 
 
3.5.1   Gene expression profile in Y. enterocolitica-infected IFN-γR1-/- mice 
 
As previously described, the splenic CD11b+ cells were selected from IFN-γR1-/- mice and 
C57BL/6 wild type mice day one and three upon intravenously infection with 5x104 CFU of 
Y. enterocolitica pYV+. The total mRNA was extracted from those cells and the gene 
expression profile was characterized by oligonucleotide microarray experiments as 
described in materials and methods. 
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3.5.1.1   Gene expression level in CD11b+ cells from spleen of uninfected IFN-
γR1-/- mice 
 
First of all, we investigated whether the lack of interferon-γ signaling leads to a different 
modulation of the gene expression already in CD11b+ cells selected from uninfected mice. 
Exclusively, probe sets whether the signal log ratio between uninfected CD11b+ cells from 
C57BL/6 and IFN-γR1-/- was >1.5 or <-1.5 (approximately 3-fold difference) were 
analyzed. Surprisingly, 211 probe sets were differentially regulated in uninfected CD11b+ 
C57BL/6 to IFN-γR1-/- spleen cells. Indeed, 88 probe sets were lower and 123 higher 
expressed suggesting that IFN-γ modulates the basal expression of a high number of 
genes. For example, several receptors (insulin-like growth factor I receptor, interleukin 1 
receptor type II, IL-8 receptor, IL-6 receptor, integrin-β7), and genes involved in 
apoptosis (Dead box polypeptide 6, Caspase 8 and FADD-like apoptosis regulator) are 
lower expressed in uninfected CD11b+ IFN-γR1-/- cells. In contrast, some genes involved in 
antigen presentation and processing e.g. IMUC class II genes, ATP binding family subtype 
b (Tap/MDR), were found to be expressed higher in CD11b+ IFN-γR deficient cells. 
In order to investigate whether these differences in basal expression can affect the 
expression levels during infection, the expression profile of those cells isolated 24 h and 
72 h p.i. from the spleen of IFN-γR deficient mice was compared to the expression profile 
in wild type mice C57BL/6. As mentioned before we considered as differentially regulated 
probe sets with a difference of more than 3-fold. Indeed, 97 probe sets after 24 and 229 
after 72 h p.i. are within this threshold. 
 
3.5.1.2   Interferon–γ regulated genes induced in Y. enterocolitica infection 
 
Comparison of the gene expression profiles between IFN-γR deficient mice to C57BL/6 wild 
type mice revealed the presence of nearly 300 probe sets representing 271 different genes 
(supplementary table 5). 
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Probe sets regulated 24 h 72 h 
 
IFN-γR1-/-  
vs  
C57BL/6 
IFN-γR1-/-  
vs  
C57BL/6 
Higher expressed 66 133 
Lower expressed  31 96 
Tot 97 229 
 
Table 3.3  Probe sets more than 3-fold regulated in Yersinia-infected IFN-γR1-/- mice 
compared to C57BL/6 infected mice. 
 
In contrast, with the severe immunological defects in response to Yersinia infection 
showed by the interferon-γ receptor deficient mice several genes involved in the immune 
and inflammatory response were higher compared to wild type mice. The higher 
expression of these genes seems to be a consequence of the great bacteria load in the 
spleen of the IFN-γR1-/- mice that led to a deregulation of the inflammatory response.  The 
high number of bacteria was responsible of an increase stimulation of the host response 
proved also by the high recruitment of inflammatory cells in the spleen. In fact, a 
significant boost of the spleen weight in these mice was detected (Fig. 3.21). Surprisingly, 
the relative number of the CD11b+ cells was apparently lower in the IFN-γR1-/- mice 72 h 
p.i., but a further analysis revealed that this was a consequence of the dramatic decline of 
live cells isolated 3 days post infection in the spleen of the Yersinia-infected IFN-γR1-/- 
mice. 
 
Figure 3.21 Influx of inflammatory cells in the spleen of Yersinia-infected IFN-γR1-/- mice. 
Fig.A The weight of the spleens was measured to evaluate the influx of inflammatory cells in 
the organs after infection. The bars represent mean values ±SD of three independent 
experiments. Fig.B The relative number of CD11b+ cells within the total spleen cells from 
IFN-γR1-/- and C57BL/6 mice (5 per group) intravenously infected with 5x104 CFU of Y. 
enterocolitica pYV+ was assessed. The splenocytes were stained with an anti-CD11b 
allophycocyanin-conjugated antibody. The percentage of cells expressing the CD11b 
molecules was analysed by flow cytometry. The bars represent mean values ±SD of three 
independent experiments. Statistically significant differences comparing IFN-γR1-/- versus 
wild type mice are indicated with an asterisk (p≤ 0.05). 
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These finding was in line with the histological analyses of the spleen in the Yersinia-
infected IFN-γR1-/- mice. The defect in the antimicrobial capacity of the interferon-γ 
receptor deficient mice leads to a significantly increase of the lesion in the spleens. As 
shown in figure 3.22, the amount and the extension of the abscesses lead to a complete 
disorganization of the spleen in these mice.  
 
 
Figure 3.22  Spleen lesions in Y. enterocolitica-infected IFN-γR1-/- mice. C57BL/6 and IFN-γR1-/- 
mice were infected intravenously with 5x104 CFU of a Y. enterocolitica wild type strain 
(pYV+) (Fig. A and B respectively). The spleens were removed 72 h post infection. Tissue 
sections were stained with an anti-Y. enterocolitica monoclonal antibody and with 
hematoxylin. The bacteria aggregates appeared brown and the nuclei blue. The pictures 
were taken at the same magnification. 
 
As consequence, of the misregulation of Yersinia infection in IFN-γR deficient mice upon, 
mRNAs encoding the IL-1R2 and the IL-1RAP were strongly induced. These proteins are 
known to be essential regulatory factors of the inflammatory responses, acting as a decoy 
receptor for IL-1 (50, 87, 97, 151). The dramatic induction of these factors might 
represent the last move of the innate response to protect tissue from damage. 
As showed in the table 3.3 more then 100 probe sets were lower expressed in the splenic 
CD11b+ cells lacking IFN-γ signaling cascade compared to wild type mice. A detailed 
analysis of this group revealed the presence of two clusters with different expression 
profiles. The first cluster represents genes that were induced in IFN-γR1-/- mice upon 
Yersinia infection but with a significantly lower extend compare to wild type mice (as 
example: SOCS1, IFIT1, IFIT2, IFIT3, GBP2 and GPB3). This suggests that IFN-γ signaling 
is not essential for the induction of these factors but act more as reinforcement of the 
expression. 
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A second group comprised factors that were absolutely not induced in the Y. 
enterocolitica-infected IFN-γR1-/- mice. Thus, we can assume that the highly susceptibly of 
the interferon-γ receptor deficient mice to Yersinia infection is a consequence of the lack 
of these factors. 
As already mentioned, for effective control of Yersinia infection, the host must mount an 
adaptative immune response that depends primarily on cytotoxic lymphocytes. These cells 
are specifically guided to infected tissue by local expression of chemokines. Intriguingly, 
several of these chemokines (CCL5, CXCL9 and CXCL10) are directly regulated via the 
interferon gamma receptor signaling. In agreement with this evidence these factors were 
not induced in CD11b+ cells from Y. enterocolitica-infected-IFN-γR1-/- mice. Therefore, 
taking into consideration that the mRNA encoding for CCL5, CXCL9 and CXCL10 was 
strongly induced in wild type mice, we can conclude that these are key modulator of the 
host immune response to Yersinia. Furthermore, recent reports provide strong evidence 
that CXCL9 and CXCL10 act as agonists for CXCR3 and, moreover, as antagonists for 
CCR3. Because CXCR3 and CCR3 are differentially expressed in Th1 and Th2 cells, our 
data suggest that these chemokines might be responsible of the Th1-type immune 
response polarization in yersiniosis. 
Surprisingly, out of the group of the not induced genes, the newly identified IFN-inducible 
GTPase family was significantly represented (IFI1, IFI47, IIGP1, IIGP2, TGTP, IGTP and 
MX1). Recently, several studies have showed that some of these genes are essential to 
control intracellular pathogens (39, 96, 153). In deed, it had been proved that IIGP1 and 
IFI1 are involved in phagosome remodelling and in the vesicular trafficking that led to the 
formation of the phago-lysosome, and consequently to inhibition of the bacteria 
replication. 
Taking into consideration that Y. enterocolitica expresses a sophisticated type III secretion 
mechanism that allow the bacteria to successfully inhibit the phagocytosis process, the up 
regulation by the host cells of factors that can only play a role when the bacteria are 
internalized seem to be an apparent contradiction. However, if one consider that almost all 
of the studies in which had been proved that the injection of the Yops can efficiently 
interfered with the phagocytosis, were performed with a high multiplicity of infection (MOI 
50) that, most likely, does not correspond with the real occurrence in vivo, this 
contradiction it is self explaining (129, 130, 135). Furthermore, we demonstrated, with a 
phagocytosis assay using bone marrow derived macrophages, that the effects of the Yops 
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are strictly dose dependent. Infection of macrophages, with an MOI of less then 50 of a 
wild type Y. enterocolitica strain, led to an incomplete inhibition of the phagocytosis. 
Moreover, if the infection experiments were performed with ten bacteria per cell, the Y. 
enterocolitica were almost completely internalized by the macrophages (Fig. 3.23). This 
could mean that at lest at the early stage of Y. enterocolitica infection, when only a small 
number of bacteria are in contact with phagocytes, some bacteria can be efficiently 
internalized. Thus, in concert with the evidence that yersiniae can proliferate in naïve 
macrophages (118, 119, ), it is likely that these cells can provide a replicative niche in 
which the bacterium can increase its numbers, while protected from neutrophils that are 
recruited to the site of infection. Further studies are required to finally address these 
finding and to clarify the role of intracellular located bacteria in the pathogenesis of the 
yersiniosis.  
These findings can explain the key role of IFN-γ and the necessity of a T-cell mediated 
immune response to successful clear Yersinia spp. infection. Moreover, this studies 
indicated that IFN-γ-activated macrophages are most likely the effector cell to ihibith Y. 
enterocolitica proliferation in murine model.  
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Figure 3.23 Y. enterocolitica inhibits macrophage phagocytosis in a dose dependent manner. 
Bone marrow-derived macrophages from C57BL/6 mice were infected with MOI 10:1 of the 
wild type Y. enterocolitica strains pYV+ (A) or with the plasmid cured strain pYV- (B) 
cultivated at 37°C. The number of adherent bacteria and intracellular bacteria were 
determined by the double-immunofluorescence technique. The extracellular bacteria appear 
green and the intracellular blue in the figure. Fig.C Phagocytosis results are given as 
percentages of phagocytosed bacteria relative to the total number of cell-associated 
bacteria. The values are the mean plus the standard error of three independent 
experiments. For each experiment, at least 100 cells were counted. 
 
In order to verify the confidence of the microarray data, quantitative Real-time PCR was 
performed. Total mRNA was extracted from CD11b+ cells isolated from IFN-γ-receptor 
deficient mice and their wild type mice controls from independent experiments. As shown 
in figure 3.24, the induction of IRF1, IIGP1, CXCL9 and IFI1 that normally occurs in Y. 
enterocolitica infected mice was significantly attenuated in the IFN-γR1-/- mice, indicating 
that IFN-γ signaling cascade is required for the increase in expression of these genes in 
the spleen. 
 
Figure 3.24  Quantification of mRNA expression of interferon-γ induced genes. The mRNA 
expression of IRF1, IIGP1, CXCL9 and IFI1 in splenic CD11b+ cells isolated from C57BL/6 
and IFN-γR1-/- mice upon intravenous infection with 5x104 CFU of Y. enterocolitica pYV+ at 
 93
the indicated time points was analyzed by semiquantitative RT-PCR. The bars represent 
mean values of fold difference between infected and control mice normalized to the 
expression level of the control gene RPL8. Asterisks indicate significant differences when 
compared mRNA expression in C57BL/6 vs IFN-γR1-/- mice (p ≤ 0.05). 
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4   Conclusions 
 
The innate immune system supplies the first line of defense against pathogens and is 
essential to activate the adaptive immune system to mount an appropriate response for 
the particular pathogen. Not surprisingly, the innate immune system is a primary target of 
several pathogens that had evolutes different mechanisms to overcome the host response. 
Some of the most efficient bacteria in silencing the innate immune response are members 
of the genera Yersinia. 
Yersinia spp. have evolved a sophisticated mechanisms called type III secretion system, 
encoded by a virulence plasmid (pYV), that lead the bacteria to inject directly in the cells 
host cytoplasm some virulence factors called Yersinia outer proteins (Yops H, P, E, M, T 
and O). By means of these mechanisms, bacteria can elude many aspects of the innate 
immune system by evading phagocytic cells, suppressing production of pro-inflammatory 
cytokines and chemokines, inducing apoptosis, and moreover inhibiting the activation of 
the adaptive immune response.  
Our data prove that YopH is the most important virulence factor during the course of Y. 
enterocolitica infection. Several recent in vitro studies have showed that YopH affects 
phagocytosis by dephosphorylation of p130Cas, focal adhesion kinase (FAk), paxillin and 
the Fyn-binding protein (FBP) which leads to the disruption of focal adhesion complexes. 
The inhibition of the phagocitosis efficiently, protects bacteria from the host cells 
response, and it allows them to successfully proliferate in the host tissue. Consequently, 
mechanisms involving helper (CD4+) and cytotoxic (CD8+) T cell responses, particularly 
interferon-γ−producing CD4 T helper 1 (Th1) cells, are essential in cooperation with 
activated macrophages, to control Yersinia infections. Notably, we demonstrate that IFN-γ 
plays a key role in reprogramming the transcriptome response in cells of the innate 
immunity in the yersiniosis. The expression of newly discovered IFN-inducible genes, the 
family of the large GTPase, never associated with Y. enterocolitica infection was described.  
The induction of these genes was strictly regulated by IFN-γ and most likely accountable 
of its antimicrobial activity in cells of innate immunity during Yersinia spp. infection. 
The present studies should prompt further research to definitely address the role of these 
newly discovered IFN-γ-inducible genes induced by and Yersinia spp. Moreover, it will be 
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of interest to study the course of Yersinia spp. infection in mice in which members of the 
GTPase family are disrupted. 
 
Genome-wide expression profiling of cells directly isolated from infected host may provide 
new insight into the key pathways involved in gene regulation, modulation and subversion 
of host responses upon bacterial infection. 
The development of DNA-microarray technologies, together with the sequencing of 
genomes from different species, has provided an opportunity to monitor and investigate 
the complex interactions that regulate biological processes. 
The development of these sophisticated methods had allowed researchers to gain insight 
some of the most important features of the immune system. 
However, one of the most challenging aspects of gene expression analysis is making sense 
of the vast quantities of data and extracting conclusions and hypotheses that are 
biologically meaningful. The collection of hundreds of analyses of immune-system gene 
expression using a wide representation of the microbial world as stimuli should allow the 
generation of expression databases that will provide immunologists with a powerful key to 
interpret the complexity of the host response and identify specific gene-expression 
programmes. These will increases our understanding of the function and regulation of 
genes and proteins, and their role in infectious diseases, in order to improve human health 
and well-being. 
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5   Summary 
 
Yersinia enterocolitica causes acute and chronic enteric infections and complications such 
as septicaemia or reactive arthritis. The survival strategy of Y. enterocolitica in hosts is to 
silence the innate immune as well as the adaptive immune response. For this purpose Y. 
enterocolitica has developed a Type III secretion system which allows to directly 
translocate six effectors proteins Yops (Yersinia outer protein H, T, O, P, M and E) into 
host cells. 
Aim of this work was the characterization of the molecular mechanisms by which the Yops 
affect gene expression in cells of the innate immune response, in vivo. For this purpose, 
CD11b+ cells, including macrophages, granulocytes, dendritic cells and NK, were selected 
from the spleen of Y. enterocolitica infected mice and gene expression profiles were 
analyzed by oligonucleotide microarray. Three groups of C57BL/6 mice were infected 
intravenous with the Y .enterocolitica pYV+, or the ∆yopP and or the ∆yopH mutants, 
respectively. It was demonstrated that while the infection with the ∆yopP showed a similar 
colonization of the spleen to the wild type pYV+ strain, the ∆yopH mutant was highly 
attenuated. Furthermore, the microarray data revealed a significant difference between 
the gene expression profiles obtained with ∆yopH strain compared to the wild type pYV+ 
or with the ∆yopP strain. Intriguingly, the majority of the differentially regulated genes 
were functionally involved in the immune response, indicating that YopH plays a crucial 
role in the yersiniosis. Analysis of the transcriptional regulation of this group of genes 
revealed the presence of a major group of IFNγ-regulated genes, suggesting that in the 
early stage of infection the activation via interferon gamma of cells of the innate immunity 
is essential to overcome the inhibitory effects of YopH. In fact, we could prove that IFN-γ 
priming of macrophages can enhance significantly their Yersinia-antimicrobial activity. In 
order to characterize the molecular mechanisms involved in this process, we performed 
gene expression analysis of CD11b+ cells isolated from Y. enterocolitica-infected-
interferon-γ receptor deficient mice. The data clearly revealed a panel newly IFN-γ-
regulated genes plausibly related to the pathogenesis of Yersinia infection. Further studies 
will be of interest to characterize the course of yersiniosis in mice in which these genes are 
disrupted. 
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Moreover, this study shows that analyses of transcriptional response in host cells directly 
isolated from in vivo infection can reveal interesting insights into host cell functions and 
immune responses. 
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 7   Supplementary data 
Supplementary table 1: Figure 3.4 
Probe sets differentially regulated in splenic CD11b+ cells isolated from C57BL/6 mice 
intravenously infected with Y. enterocolitica pYV+ compared to uninfected control mice. 
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Probe set 
ID 
Public ID 
Gene 
Symbol 
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24h 
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vs 
uninfected 
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GO 
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Cluster A 
Probe set 
       ID 
Public ID 
Gene 
Symbol 
pYV+ 
vs 
uninfected 
24h 
pYV+ 
vs 
uninfected 
72h 
GO 
Biological 
Process 
97560_at AF037437 --- 4,23 4,2 --- 
99419_g_at AF032459 Bcl2l11 4,57 4,26 apoptosis 
93214_at AF059029 Camk2d 3,7 4,71 c cell cycle 
94146_at X62502 Ccl4 5,4 4,34 chemotaxis 
102719_f_at X94151 Ccr5 3,85 4,97 chemotaxis 
97546_at AF072127 Cldn1 4,66 3,41 --- 
95348_at J04596 Cxcl1 4,38 3,84 inflammatory response 
93858_at M33266 Cxcl10 5,54 4,12 chemotaxis 
101160_at X53798 Cxcl2 5,46 5,15 chemotaxis 
97689_at M26071 F3 4,42 3,6 blood coagulation 
102341_at L46651 Gla 3,78 4,13 carbohydrate metabolism 
103963_f_at AA914345 Iigp1 6,09 4,93 cytokine and chemokine mediated signaling pathway 
96764_at AJ007971 Iigp1 5,31 4,24 cytokine and chemokine mediated signaling pathway 
94755_at M14639 Il1a 6,92 5,97 inflammatory response 
98773_s_at AI323667 Irg1 4,64 3,86 --- 
98774_at L38281 Irg1 4,56 3,64 --- 
101327_at U82610 Lcp1 4,78 3,92 response to wounding 
94688_at X83106 Mad 7,24 4,83 transcription 
160353_i_at X76850 Mapkapk2 4,75 4,38 protein amino acid phosphorylation 
104218_s_at AI507524 MGI:1923998 4,19 4,03 cell cycle 
98818_at X04435 Nr3c1 4,88 4,14 transcription 
102696_s_at AI747899 Pitpnb 4,79 4,94 transport 
160608_at AI854462 Rab20 4,55 3,48 small GTPase mediated signal transduction 
99876_at U29056 Sla 4,99 4,81 intracellular signaling cascade 
98299_s_at AF099974 Slfn4 4,92 2,95 negative regulation of cell proliferation 
99392_at U19463 Tnfaip3 5,61 4,27 apoptosis 
100030_at D44464 Upp1 5,72 5,01 nucleoside metabolism 
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98283_at X91617 --- 1,62 0 --- 
104146_at AI853551 --- 2,09 0 --- 
103517_at AA822898 --- 1,84 0,14 --- 
97162_at AI451676 --- 1,56 0,1 --- 
98049_at AI853458 1300018I05Rik  1,6 0,46 cytokinesis 
104713_at AA863717 2410002M20Rik 1,54 0,38 --- 
102741_at AW046250 Adar 1,63 0,27 RNA processing  
102965_at AW121646 AI481105 2,28 0,43 --- 
160131_at AI854404 Amotl2 1,9 0,59 --- 
93869_s_at U23781 Bcl2a1a 1,99 0,35 apoptosis 
160645_at U88908 Birc3 1,53 0,42 apoptosis  
95414_i_at AI132585 C1r 2,05 0,28 complement activation, classical pathway 
97783_at AJ242587 Ccl17 3,45 0,14 chemotaxis 
98406_at AF065947 Ccl5 2,18 -0,29 immune response 
97504_at M83749 Ccnd2 3,51 0,3 cytokinesis 
104443_at L31580 Ccr7 2,12 -0,38 chemotaxis 
104509_at AF059213 Ch25h 1,9 -0,27 cholesterol metabolism 
94255_g_at AI845237 Clic4 2,08 0,56 transportt 
160150_f_at AW125626 Cnn3 3,17 0,29 smooth muscle contraction 
101845_s_at M55219 Csprs 1,79 0,48 --- 
102638_at AB015224 Cst7 2,53 0,52 --- 
95349_g_at J04596 Cxcl1 1,69 0,33 inflammatory response  
96125_at AF110520 Daxx 2,67 0,51 apoptosis 
94271_at U70017 Dmtf1 2,26 -0,51 regulation of transcription, DNA-dependent 
94107_at AF047355 Dnase1l3 1,53 0,47 apoptosis 
161181_f_at AV234570 Dusp16 1,56 -0,14 inactivation of MAPK 
92758_at U09268 Dusp2 1,55 -0,17 protein amino acid dephosphorylation 
102737_at U35233 Edn1 1,9 -0,65 regulation of pH 
92441_at Y10007 Fap 2,34 0,11 proteolysis and peptidolysis 
102921_s_at M83649 Fas 2,19 0,52 apoptosis 
103259_at U58972 Gfi1 1,69 0,56 transcription  
102877_at M12302 Gzmb 1,52 -1,12 apoptosis 
97896_r_at AW125218 Hat1 1,67 0,46 DNA packaging  
100013_at AW121732 Ifi35 1,74 0,16 immune response 
103446_at AA959954 Ifih1 2,7 0,55 DNA restriction 
93956_at U43086 Ifit3 3,21 -0,47 immune response 
99334_at K00083 Ifng 5,19 -0,73 immune response 
161037_at U14332 Il15 1,98 0,03 immune response  
104669_at U73037 Irf7 2,39 0,45 transcription 
162202_f_at AV373853 Irf7 1,51 0,06 transcription 
103432_at AW122677 Isg20 3,13 0,43 --- 
93678_s_at AF054819 Klrk1 1,76 -0,9 --- 
103335_at U55060 Lgals9 1,81 0,39 --- 
160517_at M35153 Lmnb1 1,88 0,31 --- 
161576_f_at AV281450 MGI:1923551 1,73 0,61 --- 
103254_at AW049897 MGI:1923551 1,52 0,36 --- 
104742_at AA919832 Mgst2 1,61 -0,16 --- 
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103025_at X52574 Mov10 1,58 0,4 --- 
98417_at M21038 Mx1 2,71 0,37 immune response  
101424_at AF019249 Nmi 2,3 0,41 --- 
94505_at AW124934 Peli1 1,75 0,02 --- 
160632_at AW124627 Prkcn 1,67 0,16 --- 
99589_f_at X07625 Prm1 4,55 0,19 nuclear organization and biogenesis 
95539_at AA798971 Rab3ip 1,8 0,46 --- 
104476_at U27177 Rbl1 1,71 0,2 transcription 
104177_at AA204579 Rsad2 2,06 -0,09 --- 
98405_at U96700 Serpinb9 3,09 0,38 --- 
93898_at AB024921 Sgcb 1,86 0,12 cytoskeleton organization and biogenesis 
101847_at AF040242 Sp100 1,93 0,5 --- 
102873_at U60091 Tap2 1,55 0 immune response 
92962_at M83312 Tnfrsf5 2,01 0,04 apoptosis 
94112_at U37522 Tnfsf10 1,57 0,02 apoptosis  
96533_at AI508931 Tor3a 1,72 0,04 protein folding 
94186_at L35302 Traf1 1,5 -0,41 apoptosis 
98030_at J03776 Trim30 1,53 0,14 transcription  
103066_at L32973 Tyki 3,42 0,16 nucleotide biosynthesis 
92715_at AL078630 Ubd 2,47 -0,09 protein modification 
99964_at AW061016 Vdr 2,7 -0,2 transcription  
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99416_at AU042276 --- 2,5 1,51 --- 
161299_r_at AV049751 --- 2,87 2,08 --- 
100584_at U72941 --- 1,96 0,69 --- 
100880_at AA816121 --- 3,18 1,93 --- 
100944_at AA958903 --- 1,67 1,36 --- 
161511_f_at AV152244 --- 4,34 1,64 --- 
101820_at X70920 --- 2,79 2,65 --- 
160925_at X13664 --- 3,02 3,08 --- 
93779_at AA261092 --- 1,75 1,22 --- 
160799_at AW060549 --- 3,45 1,39 --- 
94355_at AW048394 --- 3,43 3,22 --- 
103508_at AA919750 0610009F02Rik 3,27 2,04 --- 
160228_at AI838249 1110019C08Rik 1,61 1,48 --- 
95078_at AI841400 1200015F23Rik 2,46 1,44 --- 
103562_f_at M26005 1300007C21Rik 3,21 2,32 --- 
93462_at AA168418 1810054D07Rik 2,52 1,07 --- 
102030_at AF026032 4833408C14Rik 2,92 2,42 --- 
103748_at AW125627 4933407C03Rik 2,03 1,9 --- 
98495_at AI846906 5033414D02Rik 2,03 1,28 --- 
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92993_r_at AI324972 5730497N03Rik 3,02 0,91 --- 
96196_i_at AI851708 5730589K01Rik 1,94 1,39 regulation of transcription, DNA-dependent 
94995_at AI854331 A030007L17Rik 1,81 0,69 --- 
92688_at X57199 Acp2 1,85 1,51 --- 
104168_at AA791742 Actr2 2,73 2,05 cell motility 
96188_at AF052506 Adar 3,31 2,16 RNA processing 
103615_at AA727023 AI447904 3,81 2,52 --- 
102330_at D86382 Aif1 1,5 0,93 actin filament bundle formation 
93464_at AI561567 Akap9 1,85 1,24 --- 
93500_at M63245 Alas1 2 1,76 heme biosynthesis 
99838_at AF018172 Aoah 1,87 1,08 xenobiotic metabolism 
92288_at X54424 Ap1g1 3,89 3,37 transport  
103796_at AF064071 Apaf1 1,52 1,02 apoptosis 
98473_at AF032466 Arg2 1,94 0,76 urea cycle 
98924_at Y08027 Art3 3,76 1,58 protein amino acid ADP-ribosylation 
103899_at AA690863 Atp11a 2,76 2,59 metabolism 
161166_i_at AV222721 B7h3 2,23 1,78 immune response 
102913_at AI324342 Bcl2a1a 3,45 1,13 apoptosis  
103789_at AI854614 Brd4 1,53 1,44 --- 
103759_at D31788 Bst1 1,78 1,62 defense response 
97693_at C78513 C78513 3,55 1,86 --- 
93721_at L12367 Cap1 1,52 1,06 actin cytoskeleton organization and biogenesis 
102064_at L28095 Casp1 2,11 1,11 apoptosis 
102905_at Y13089 Casp11 2,84 1,79 apoptosis 
98498_at D86353 Casp7 1,78 0,78 apoptosis 
98499_s_at U67321 Casp7 3,83 3,65 apoptosis 
102328_at AJ007749 Casp8 2,24 1,42 apoptosis  
95094_g_at AI035334 Ccar1 1,75 1,52 positive regulation of apoptosis 
93717_at U50712 Ccl12 4,17 1,76 chemotaxis 
102736_at M19681 Ccl2 4,54 2,16 chemotaxis 
102424_at J04491 Ccl3 3,84 3,32 chemotaxis 
99413_at U29678 Ccr1 2,17 1,58 chemotaxis 
93617_at AF030185 Ccrl2 3,29 0,9 G-protein coupled receptor protein signaling 
pathway 
93909_f_at X04120 Ccrn4l 1,56 0,84 rhythmic process 
98446_s_at U06834 Cct3 1,56 1,31 protein folding 
98088_at X13333 Cd14 2,77 2,47 inflammatory response 
100778_at L11332 Cd38 2,02 1,98 --- 
99434_at AF001036 Cd83 4,06 1,82 --- 
102830_at L25606 Cd86 1,88 1,1 immune response 
102831_s_at U39456 Cd86 2,49 1,37 immune response 
94881_at AW048937 Cdkn1a 3,34 2,53 regulation of cell cycle 
98067_at U09507 Cdkn1a 3,8 3,13 regulation of cell cycle 
100278_at U09968 Cdkn1b 2,72 2,67 cell cycle arrest  
94971_at AI317217 Cdkn3 3,1 2,88 cell cycle arrest 
93994_at AW212131 Chpt1 2,14 1,11 --- 
100022_at D89613 Cish 2,13 1,4 immune response 
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104392_at AI122121 Clcn7 1,76 1,17 transport 
104391_s_at AI850563 Clcn7 1,82 1,15 transport 
160415_at AI604314 Cldn1 2,83 0,93 --- 
96551_at AB024717 Clec4e 1,63 0,93 immune response 
94254_at AI845237 Clic4 1,97 0,73 transport 
94256_at AI849533 Clic4 2,54 1,1 transport 
101937_s_at AF005423 Clk4 3,39 3,31 protein amino acid phosphorylation 
100533_s_at M60285 Crem 2,43 1,72 transcription  
160526_s_at M60285 Crem 3,46 3,11 transcription 
94747_at M34397 Csf2rb1 2,88 2,94 --- 
103210_at M29855 Csf2rb2 2,55 2,6 --- 
94142_at M13926 Csf3 3,04 2,48 immune response 
101846_r_at M55219 Csprs 2,36 0,83 --- 
101436_at M34815 Cxcl9 3,94 2,83 immune response 
100300_at U43384 Cybb 3,58 2,98 transport 
104371_at AF078752 Dgat1 2,13 1,63 --- 
97740_at AI642662 Dusp16 2,15 1,52 inactivation of MAPK 
94246_at J04103 Ets2 2,4 1,15 regulation of cell cycle 
102879_s_at M31314 Fcgr1 2,15 1,39 immune response 
101793_at X70980 Fcgr1 2,85 2,01 immune response 
104419_at AI132380 Fndc3a 1,68 0,81 --- 
101800_at AF071180 Fpr-rs2 1,69 1,02 --- 
97531_at X95280 G0s2 1,84 1,45 cell cycle 
98822_at X56602 G1p2 3,55 1,91 immune response 
101294_g_at Z84471 G6pd2 2,59 2,43 metabolism 
161666_f_at AV138783 Gadd45b 1,85 0,85 regulation of cell cycle 
102779_at X54149 Gadd45b 2,35 1,13 regulation of cell cycle 
104597_at AJ007970 Gbp2 3,92 3,05 immune response 
103202_at AW047476 Gbp4 3,07 2,26 immune response 
102313_at L09737 Gch1 2,46 1,2 tetrahydrobiopterin biosynthesis 
94192_at Y17860 Gdap10 3 1,22 --- 
92217_s_at U05265 Gp49a 1,86 0,9 immune response 
162262_f_at AV357306 Gyg1 1,67 1,42 metabolism 
100597_at AW049730 Gyg1 1,93 1,69 metabolism 
97525_at U48403 Gyk 1,67 0,97 metabolism 
101658_f_at D90146 H2-Q8 2,57 2,06 immune response 
93865_s_at M35244 H2-T10, H2-T17, 
H2-T22, H2-T9 
1,63 0,9 immune response 
94746_at L22338 H2-T24 2,67 1,25 immune response 
93328_at X57437 Hdc 1,88 0,82 --- 
160101_at X56824 Hmox1 2,19 1,79 heme oxidation 
99815_at D50096 Hrh2 2,02 1,03 signal transduction 
103563_at AW125713 Ibrdc3 1,63 0,67 --- 
96752_at M90551 Icam1 2,17 1,08 immune response 
94384_at X67644 Ier3 3,44 2,13 --- 
97409_at U19119 Ifi1 2,9 1,3 immune response 
94224_s_at M74123 Ifi205 1,83 0,97 immune response 
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98465_f_at M31419 Ifi204 1,9 0,71 immune response 
104750_at M63630 Ifi47 2,94 1,76 immune response 
100981_at U43084 Ifit1 3,88 1,25 immune response 
103639_at U43085 Ifit2 5 1,93 immune response 
101641_at M86751 Igk-V21 2,08 1,45 --- 
160933_at U53219 Igtp 3,13 1,86 --- 
98410_at AJ007972 Iigp2 2,09 1,07 --- 
92301_at AB016589 Ikbke 2,96 2,39 protein amino acid phosphorylation 
100773_at M86672 Il12a 5,19 2 immune response 
98240_at U23922 Il12rb1 2,6 2 cell surface receptor linked signal transduction 
161023_at U22339 Il15ra 2,88 1,51 cell surface receptor linked signal transduction 
92689_at AB019505 Il18bp 4,01 1,95 --- 
161689_f_at AV223216 Il1r2 1,93 1,49 inflammatory response 
102658_at X59769 Il1r2 2,2 2,03 inflammatory response 
103769_at X85999 Il1rap 4,01 3,35 immune response 
93871_at L32838 Il1rn 2,33 1,35 immune response 
102218_at X54542 Il6 4,99 1,58 immune response 
100277_at X69619 Inhba 2,23 1,97 growth 
93942_at U27295 Inpp1 4,22 1,68 --- 
93850_at AI642553 Iqgap1 2,53 1,82 small GTPase mediated signal transduction 
102401_at M21065 Irf1 1,51 0,76 immune response 
94764_at M60778 Itgal 1,6 1,27 immune response 
100010_at U36340 Klf3 2,65 2,02 transcription 
160618_at AA760613 Lgals8 3,73 2,28 --- 
97173_f_at M27134 LOC436489 2,36 1,91 --- 
97173_f_at M27134 LOC436489 2,36 1,91 --- 
97420_at AW230891 Lrg1 1,67 1,53 --- 
93078_at X04653 Ly6a 2,66 2,44 --- 
101945_g_at U89352 Lypla1 3,66 3,59 metabolism 
104628_at X61172 Man2a1 1,79 1,44 metabolism 
99960_at U18310 Map2k4 1,7 1,49 MAPKKK cascade  
97106_at D13759 Map3k8 2,67 1,62 regulation of cell cycle 
99604_at AI848713 March5 1,83 0,65 --- 
93997_at AI853475 MGI:1929890 1,95 0,82 --- 
100484_at X66473 Mmp13 2,83 1,79 proteolysis and peptidolysis 
160118_at AF022432 Mmp14 3,06 2,37 proteolysis and peptidolysis 
94769_at U96696 Mmp8 2,02 1,51 proteolysis and peptidolysis 
97322_at AI835093 Ms4a6b 1,55 1,22 signal transduction 
102360_at AW214225 Mthfr 2,75 1,08 methionine metabolism 
102430_at X51397 Myd88 1,51 0,89 inflammatory response 
97763_at AB002663 Ncf1 2,19 1,79 transport 
101554_at U57524 Nfkbia 1,71 0,93 regulation of cell proliferation 
101727_at AF030896 Nfkbie 2,22 0,81 regulation of transcription, DNA-dependent 
98988_at AA614971 Nfkbiz 2,6 1,72 inflammatory response 
93831_at AI316087 Nono 2,51 1,77 mRNA processing 
104420_at U43428 Nos2 1,93 1,75 defense response to bacteria 
160189_at AI843747 Nudt4 2,51 1,99 --- 
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160189_at AI843747 Nudt4 2,51 1,99 --- 
102717_at X58077 Oas1g 3,21 1,7 immune response 
160668_at AI838195 Ogfr 1,93 0,7 regulation of cell growth 
94461_at AI852144 Pbef1 2,69 1,37 --- 
92810_at AI842259 Pdk3 2,41 1,46 protein amino acid phosphorylation 
102845_at AI836034 Pdlim7 2,27 1,96 --- 
102845_at AI836034 Pdlim7 2,27 1,96 --- 
97833_at AI853802 Pfkp 2,01 1,52 glycolysis 
92312_at U55772 Pik3c2a 2,19 1,59 intracellular signaling cascade 
99384_at M13945 Pim1 2,83 1,03 protein amino acid phosphorylation 
99513_at M72394 Pla2g4a 1,64 1,18 lipid catabolism 
102663_at X62700 Plaur 1,81 1,28 cell surface receptor linked signal transduction 
92310_at M96163 Plk2 2,17 0,93 cell cycle 
102839_at D78354 Plscr1 2,47 2,17 --- 
93290_at U35374 Pnp 2,24 1,51 --- 
98508_s_at D84376 Ppap2a 1,53 0,66 signal transduction 
93672_at U09928 Prkr 2,6 1,06 immune response 
98018_at L39017 Procr 3,58 1,71 blood coagulation  
94841_at AW048997 Psma5 1,73 0,91 ubiquitin-dependent protein catabolism 
101486_at Y10875 Psmb10 1,7 0,86 ubiquitin-dependent protein catabolism 
99433_at Y18101 Pstpip2 4,01 3,23 --- 
94159_at D50872 Ptafr 1,66 1,17 chemotaxis  
94158_f_at AF004858 Ptafr 3,75 2,37 chemotaxis  
104406_at AI060798 Ptges 1,81 1,54 prostaglandin metabolism 
104647_at M88242 Ptgs2 2,95 2,57 prostaglandin biosynthesis 
101298_g_at M23158 Ptprc 2,76 2,02 thymocyte differentiation 
94643_at U35836 Pvr 2,56 2,2 --- 
160314_at AI839803 Pyp 2,75 1,35 metabolism 
101933_at AF035646 Rab10 1,95 1,68 small GTPase mediated signal transduction  
95785_s_at Y13361 Rab7 3,92 3,02 small GTPase mediated signal transduction  
100530_at L07924 Ralgds 2,43 1,4 small GTPase mediated signal transduction  
92368_at AJ250491 Ramp3 3,42 2,36 regulation of G-protein coupled receptor protein 
signaling pathway 
94972_at AB026569 Rbms1 1,59 0,73 regulation of translation 
103231_at AA739233 Rhoh 2,57 0,67 small GTPase mediated signal transduction  
96747_at AW121294 Rhou 1,68 1,27 small GTPase mediated signal transduction  
97091_at U25995 Ripk1 2,5 1,41 apoptosis 
99127_at X61506 Sca10 1,8 1,43 --- 
160708_at AI840446 Schip1 4,06 1,98 --- 
102860_at M64085 Serpina3g 2,42 1,27 --- 
92978_s_at X16490 Serpinb2 1,93 1,88 --- 
94752_s_at U10531 Skil 3,55 1,86 cell differentiation 
93738_at M22998 Slc2a1 1,92 1,66 transport 
101877_at AI854432 Slc31a1 2,18 1,88 transport 
101713_at AB022345 Slc7a11 1,71 1,63 transport 
92736_at L03290 Slc7a2 2,33 1,85 transport 
94556_at AI746846 Snx10 1,74 1,04 transport 
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96333_g_at AW259199 Snx2 3,37 2,94 transport 
92832_at U88325 Socs1 4,38 2,39 immune response 
162206_f_at AV374868 Socs3 1,73 1,31 immune response 
92232_at U88328 Socs3 2,12 1,48 immune response 
96042_at L35528 Sod2 2,59 1,18 superoxide metabolism 
97310_at AW124318 St13 3,36 2,55 protein folding 
99847_at X73523 St3gal1 1,69 1,12 protein amino acid glycosylation 
101465_at U06924 Stat1 2,29 1,36 signal transduction 
98775_at U28726 Stk3 2,91 2,51 apoptosis 
92648_at U19521 Stxbp3 2,1 1,04 transport 
103648_at Y08830 Tacstd2 1,54 1,21 defense response 
103328_at U59864 Tank 1,68 0,66 I-kappaB kinase/NF-kappaB cascade 
103035_at U60020 Tap1 1,54 0,9 immune response 
102689_at AF110520 Tapbp 2,27 1,41 immune response 
101551_s_at X78989 Tes 2,36 1,67 --- 
101502_at X89749 Tgif 1,66 1,23 transcription 
102906_at L38444 Tgtp 3,51 2,36 --- 
102629_at D84196 Tnf 3,39 1,68 inflammatory response 
160489_at L24118 Tnfaip2 2,27 1,15 angiogenesis 
98474_r_at U83903 Tnfaip6 1,72 0,87 cell adhesion 
95543_at AI843046 Tpm4 2,23 1,55 muscle development 
103032_at AF038008 Tpst1 2,19 0,83 --- 
92942_at AA138192 Trim21 2,25 0,85 protein ubiquitination 
102678_at L27990 Trim21 2,27 1,11 protein ubiquitination 
99985_at AB027565 Txnrd1 1,79 1,25 transport 
102279_at AW046479 Ube1l 2,48 0,76 --- 
98597_at AW048912 Ube2l6 3,43 1,51 protein modification  
94197_at D89866 Ugcg 1,82 1,69 glucosylceramide biosynthesis 
95024_at AW047653 Usp18 3,6 0,98 ubiquitin-dependent protein catabolism 
98605_at AI851163 Wars 1,94 1,04 protein biosynthesis  
98606_s_at X69656 Wars 2,66 1,44 protein biosynthesis  
97950_at X75129 Xdh 1,78 1,06 transport  
102259_at AF058799 Ywhag 3,08 3,15 signal transduction 
94109_at AI850113 Zfp281 2,35 1,21 --- 
102293_at L03547 Zfpn1a1 1,68 1,54 transcription 
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92763_at U43892 Abcb7 0,28 1,58 transport 
93097_at U51805 Arg1 -0,42 2,5 urea cycle 
103697_at AW061234 AW061234 -0,92 1,61 --- 
104097_at AF002823 Bub1 -1,44 1,56 cytokinesis 
93454_at AF081789 C1qr1 -0,12 2,1 defense response 
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99535_at AW047630 Ccrn4l 0,85 2,25 rhythmic process 
101963_at X06086 Ctsl 0,12 2,57 proteolysis and peptidolysis 
98045_s_at U18869 Dab2 -0,24 1,69 cellular morphogenesis during differentiation 
102337_s_at M31312 Fcgr2b 0,64 1,51 immune response 
160873_at AV206059 Ghrl 0,06 1,67 regulation of physiological process 
100911_at AB002136 Gpaa1 0,87 1,51 GPI anchor biosynthesis 
97444_at AI844520 Ifi30 0,74 1,51 antigen processing, exogenous antigen via MHC 
class II 
104659_g_at D17444 Lifr -0,28 1,83 --- 
104658_at D17444 Lifr -0,24 1,58 --- 
97871_at AW120614 LOC434220 0,82 1,83 --- 
98440_at AA596710 Ltb4dh 0,93 2,56 --- 
103022_at U23470 Map3k1 -0,91 1,9 regulation of cell migration 
93573_at V00835 Mt1 -0,4 1,55 signal transduction 
95506_at U96723 Myo1c 0,84 1,94 transport 
160091_at AW125401 Pgam1 0,74 1,56 metabolism 
92474_at AF083497 Pld1 0,73 1,55 metabolism 
104541_at U43525 Prtn3 0,27 1,8 proteolysis and peptidolysis 
96038_at AI840339 Rnase4 -1,63 1,39 --- 
160795_at AW123662 Scamp1 0,54 2,38 transport 
100095_at U37799 Scarb1 -0,13 2,02 cell adhesion 
93918_at AA673500 Taf9 0,51 1,77 transcription 
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161317_r_at AV088715 --- 2,56 2,68 --- 
100368_at AB019601 --- 2,13 2,6 --- 
102805_at M77196 --- 1,12 2,07 --- 
104400_at AF076956 0610042I15Rik 1,75 1,84 --- 
96606_at AB025217 1500003O03Rik 3,08 3,49 --- 
96124_at AI835632 2310001H13Rik 1,44 2,08 --- 
98894_at AA867655 2610016F04Rik 1,45 1,7 regulation of transcription, DNA-dependent 
100464_at AI840585 3110043O21Rik 1,07 1,59 --- 
99343_at AA796133 4932441K18 2,24 2,5 --- 
94955_at AW125433 5530600A18Rik 2,02 2,83 --- 
99329_at AF022908 Abcc1 2,08 2,15 transport 
96054_f_at Y17345 Acp1 1,51 1,59 protein amino acid dephosphorylation 
96738_at U41765 Adam9 1,63 1,93 proteolysis and peptidolysis 
98589_at M93275 Adfp 1,28 1,62 long-chain fatty acid transport 
97733_at U05673 Adora2b 2,38 2,46 signal transduction 
96501_at AI506285 AI194738 1,39 1,72 --- 
98490_at AA822412 Arl10c 1,44 1,83 transport 
100315_at U75321 Atp8a1 1,72 1,79 metabolism 
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94423_at AW049551 BC004728 1,63 1,44 --- 
100405_at X56683 Cbx3 1,48 2,11 transcription  
161968_f_at AV370035 Ccr5 2,46 3,26 chemotaxis  
102718_at AF022990 Ccr5 2,6 3,09 chemotaxis  
97832_at AA754887 Cd97 1,9 2,07 cell adhesion 
94748_g_at M34397 Csf2rb1, Csf2rb2 2,12 1,94 --- 
100019_at D45889 Cspg2 2,21 2,97 cell adhesion 
101020_at AI842667 Ctsc 1,55 1,51 proteolysis and peptidolysis 
93860_i_at M17327 Ctse 1,5 1,43 proteolysis and peptidolysis 
93861_f_at M17327 Ctse 1,85 2,04 proteolysis and peptidolysis 
103768_at AW209561 D19Ertd678e 1,99 2,72 --- 
100037_at AW213225 Ddx18 2,81 3,2 --- 
93722_at AJ005985 Ensa 1,81 2,04 regulation of insulin secretion 
103977_at AF087644 F10 2,61 3,5 blood coagulation 
103816_at U89915 F11r 1,27 2,87 cell adhesion 
93634_at AW125157 Fbxw11 1,88 1,85 ubiquitin cycle 
160714_at AI046826 Gab1 1,62 4,46 response to oxidative stress 
96336_at AI844626 Gatm 1,24 2,03 transport 
95392_at U68182 Gcnt2 2,38 2,83 --- 
104222_f_at C79210 Ggps1 1,57 2,2 isoprenoid biosynthesis 
93231_at AJ007511 Hic1 2,67 3,02 transcription 
96696_at AI837110 Hrmt1l2 2,17 2,51 protein amino acid methylation 
103904_at X81584 Igfbp6 2 3,98 regulation of cell growth 
98828_at X07640 Itgam 1,79 2,1 cell adhesion  
99509_s_at L40172 Jak3 1,73 1,46 protein amino acid phosphorylation  
160617_at AW125783 Klf13 1,1 1,59 transcription 
93930_at U58882 Lasp1 1,89 2,25 transport 
97870_s_at AA798624 LOC434220 1,1 1,87 --- 
101944_at U89352 Lypla1 1,54 1,59 lipid metabolism 
101946_at AA840463 Lypla1 1,84 2,19 lipid metabolism 
94549_at AI315650 Mfsd1 1,19 1,5 transport 
92703_at AI325791 MGI:1923998 2,07 2,37 cell cycle 
96249_at AW122105 MGI:1927947 1,02 1,67 --- 
92464_at Y11091 Mknk1 2,79 3,02 regulation of protein biosynthesis 
102955_at U83148 Nfil3 1,84 2,02 regulation of transcription, DNA-dependent 
102780_at Z31362 Npn3 2,27 3 --- 
94351_r_at U12961 Nqo1 1,1 1,74 electron transport 
103288_at AF053062 Nrip1 2,2 2,29 negative regulation of transcription from RNA 
polymerase II promoter 
102342_at U10120 Nsf 1,22 1,67 transport 
93167_f_at AA104818 Olr1 1,74 2,09 --- 
102063_at AF079535 Pdpk1 1,46 1,79 signal transduction 
93619_at AF022992 Per1 1,06 1,56 transcription 
92390_at U86587 Pik3cd 2,6 2,75 B-cell homeostasis 
100951_at AF014010 Pkd2 1,54 2,05 JAK-STAT cascade 
160589_at AI854234 Ppig 1,62 1,56 protein folding 
100332_s_at AF093853 Prdx6, Prdx6-rs1 1,54 1,72 response to reactive oxygen species 
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103885_at AW049156 Prpf31 1,05 1,52 nuclear mRNA splicing, via spliceosome 
101966_s_at AF037206 Rnf13 1,55 1,79 proteolysis and peptidolysis 
93164_at Y12783 Rnf2 2,68 3,28 mitotic cell cycle 
99350_at C76102 Sec63 1,37 3,79 protein folding 
160539_at X66091 Sfrs1 2,1 1,97 nuclear mRNA splicing, via spliceosome 
98766_at AB016835 Sh3bp5 1,08 1,66 intracellular signaling cascade 
100618_f_at AA062013 Slc25a5 1,18 1,57 transport 
92343_at AF010138 Smarca3 1,52 1,51 transcription 
97206_at AW230369 Spint1 2,05 3,69 --- 
97519_at X13986 Spp1 1,44 4,05 cell adhesion 
104249_g_at AW227650 Ssr3 2,71 3,98 --- 
100426_s_at U36776 Syk 3,4 4 activation of MAPK 
92427_at D25540 Tgfbr1 3,27 3,47 protein amino acid phosphorylation 
160469_at M62470 Thbs1 1,21 1,64 cell adhesion 
93985_at AW120868 Tiparp 1,93 2,15 protein amino acid ADP-ribosylation 
99501_at AA882416 Tloc1 2,62 3,36 protein transport 
101514_at AF041433 Trappc3 1,74 2,01 transport 
94209_g_at AW045202 Txndc7 1,6 1,97 electron transport 
94208_at AW045202 Txndc7 1,89 2,08 electron transport 
99799_at X64361 Vav1 1,35 1,56 immune response 
103520_at M95200 Vegfa 2,71 3,87 angiogenesis 
95800_s_at X53250 Zfa, Zfx 2,15 2,38 transcription 
95801_s_at L36316 Zfp260 1,4 2,17 --- 
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98524_f_at AI848479 --- -1,86 -1,36 --- 
161268_f_at AV318100 --- -1,7 -1,46 --- 
101863_at C78246 --- -1,82 -1,75 --- 
160272_at AI849356 --- -1,8 -0,74 --- 
94916_at AW122260 --- -1,96 -1,73 --- 
161132_at AA727482 --- -1,92 -0,01 --- 
97102_at AA276948 --- -2,32 -1,47 --- 
160642_at AI853079 --- -2,15 -0,9 --- 
98767_at AI842603 --- -1,6 -0,6 --- 
92202_g_at AI553024 Zbtb16 -2,49 -2,18 apoptosis 
95285_at AI153315 --- -1,56 -1,37 --- 
95636_at AW123628 0610010K14Rik -1,72 -0,28 transcription 
102969_at AI847369 0610025P10Rik -1,55 -0,71 --- 
94907_f_at AW045632 1110001J03Rik -1,66 -1,33 --- 
96862_at AI848584 1110002B05Rik -1,87 -0,85 --- 
160240_at AI852051 1110003E01Rik -1,55 -1,03 --- 
160378_at AI853127 1110006I15Rik -1,61 -0,37 --- 
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103881_at AA691185 1110013G13Rik -1,59 -0,56 metabolism 
104573_at AA921069 1110025L05Rik -1,61 -0,36 --- 
160245_at AW045564 1110034O07Rik -1,94 -1,36 --- 
95596_at AW122957 1110054H05Rik -1,67 -0,57 --- 
160787_at AW124900 1500010J02Rik -2,79 -0,5 --- 
97885_at AB031386 1810009M01Rik -1,57 -1,35 --- 
160955_at AW124904 2010309E21Rik -4,55 -1,23 --- 
99187_f_at AI835662 2010315L10Rik -1,62 -1,03 transport 
92338_f_at AI957030 2310001H12Rik -1,6 -0,5 --- 
96122_at AW049373 2310016A09Rik -3,57 -0,87 --- 
101404_at AI853654 2310061I09Rik -1,62 -0,43 --- 
104513_at AA688938 2410004N09Rik -3,21 -1,25 --- 
96885_at AW122271 2510015F01Rik -3,9 0,76 --- 
103545_at AA240695 2610019E17Rik -1,55 -0,82 --- 
95514_at AI846302 2610510H01Rik -1,77 -0,25 --- 
100955_at AA989957 2700084L22Rik -2,39 -0,88 ubiquitin cycle 
95150_at AI852196 2810052M02Rik -1,53 -0,83 --- 
160166_r_at AI843495 2810409H07Rik -2,02 -0,12 --- 
160235_at AI843521 5033425B17Rik -1,56 -0,24 --- 
161005_at AI835776 5730420B22Rik -1,92 -1,27 electron transport 
95890_r_at AA185884 5730488B01Rik -1,65 -1,16 --- 
95021_at AW124028 9430010O03Rik -1,5 -1,02 --- 
103667_at AA866655 A130034M23Rik -2,08 -0,69 --- 
103689_at AA833514 Abcc3 -2,02 -0,73 transport 
92913_at Z48670 Abcd2 -1,73 -0,31 fatty acid metabolism  
103401_at L11163 Acads -1,83 -0,36 lipid metabolism 
160921_at AW125884 Acas2l -3 -1,96 metabolism 
161224_f_at AV258262 Ace -1,89 -1,37 proteolysis and peptidolysis 
98976_at AJ242912 Adamdec1 -1,73 -1,08 proteolysis and peptidolysis 
160255_at AA657044 Ahnak -2,28 -1,29 --- 
160495_at M94623 Ahr -1,5 0,05 transcription 
94459_at AA681764 AI462493 -1,66 -0,67 --- 
95902_at AW229127 AI465270 -1,56 -0,77 --- 
100970_at X65687 Akt1 -1,81 -1,34 apoptosis 
94290_at AW124346 Akt1s1 -2,36 -0,71 Notch signaling pathway 
104407_at L25274 Alcam -1,75 -1,29 cell adhesion 
100948_at AW049351 Ank -1,72 -1,23 transport 
93354_at Z22661 Apoc1 -1,74 -1,09 transport 
97887_at Z22216 Apoc2 -2,31 0,18 lipid metabolism  
95356_at D00466 Apoe -1,99 -1,17 transport  
102704_at U88623 Aqp4 -3,65 -0,7 transport 
100575_at AI841645 Ard1 -1,64 0,34 DNA packaging  
98001_at U58203 Arhgef1 -1,5 -0,94 intracellular signaling cascade 
100473_at AI851750 Arrb1 -2 -0,65 signal transduction 
92375_at AW211207 Ascc1 -1,59 -0,78 transcription 
93798_at AI839988 Atp1a1 -2,11 -1,46 transport 
93797_g_at AW123952 Atp1a1 -1,82 -1,19 transport 
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103935_at AI504474 Atp2a3 -1,58 -1,02 transport 
161331_r_at AV114328 Atp5d -2,67 -1,75 ATP biosynthesis 
103497_at AA592351 BC025546 -1,51 -1,13 --- 
103449_at AA795923 BC040823 -2,37 -1,23 --- 
96035_at L47335 Bckdha -1,64 0,16 metabolism 
99514_at AI835443 Bmyc -1,99 -1,42 regulation of cell cycle 
96255_at AF067395 Bnip3l -1,51 -0,04 apoptosis 
94815_at X13586 Bpgm -3,69 -1,14 metabolism 
101078_at Y16258 Bsg -1,61 -0,34 --- 
95984_at AI586160 C79468 -4,68 -0,78 --- 
104589_at AF091096 C80913 -2,08 -1,49 protein folding 
160479_at M29394 Cat -1,76 -0,64 response to oxidative stress 
102397_at AF038029 Cbfa2t3h -1,9 -1,12 granulocyte differentiation 
92849_at M58004 Ccl6 -1,59 -1,45 chemotaxis 
104388_at U49513 Ccl9 -2,4 -0,25 chemotaxis 
162384_f_at AV252118 Ccrn4l -1,61 0,12 rhythmic process 
97828_at AF033115 Cd27b -1,53 -0,37 apoptosis 
104023_at AW060457 Cd300c, Cd300a -1,75 -0,58 --- 
161012_at J03857 Cd79b -2,46 -2,25 cell surface receptor linked signal transduction 
95063_at AI606257 Cdca7 -1,95 -1,02 cytokinesis  
98447_at M62362 Cebpa -1,68 -0,6  transcription 
103900_at AW124150 Centg3 -1,54 -0,72 transcription 
101426_at AW125333 Cerk -2,79 -0,69 ceramide metabolism  
102622_r_at AJ011106 Clcn1 -3,61 -1,77 transport  
97928_at AW045278 Cln6 -1,59 -0,04 lysosome organization and biogenesis 
93048_at AJ005253 Clpp -1,73 -0,67 proteolysis and peptidolysis 
102966_at AA934166 Cnot6l -2,01 -1,37 --- 
98535_at AF076156 Comt -2,19 -0,52 catecholamine metabolism 
160590_r_at AI853323 Comtd1 -2,46 -1,45 catecholamine metabolism 
160813_r_at AI893329 Cox6b2 -2,29 -1,8 --- 
160383_at X80899 Cox7a2l -1,62 -0,17 electron transport 
93550_at D88792 Csrp2 -3,87 -0,87 development 
161522_i_at AV218205 Cst3 -1,63 -1,43 --- 
104045_at AW122372 D10Bwg0791e -3,48 -0,99 nucleosome assembly 
95657_f_at AW125164 D13Wsu177e -1,68 -0,58 --- 
99828_at AA673252 D3Ertd789e -2,69 -1,05 --- 
97770_s_at AA733372 D6Wsu176e -1,71 -1,33 --- 
93821_at AW046101 D8Ertd594e -2,33 -1,14 --- 
161060_i_at AV338120 Ddx51 -4,24 -1,16 --- 
98989_at AF057368 Dhcr7 -4,47 -1,77 steroid biosynthesis 
102797_at X95281 Dhrs3 -1,82 0,05 metabolism 
95620_at AW120882 Dhrs7 -1,52 -1,08 metabolism 
103225_at AW018420 Dnase1l1 -1,83 0,17 DNA catabolism 
97220_at AW122732 Dscr2 -1,56 -0,49 --- 
93285_at AI845584 Dusp6 -1,56 -1,08 protein amino acid dephosphorylation 
100311_f_at U72032 Ear1 -1,93 -1,25 --- 
95426_at AW048512 Echs1 -2,03 0,25 fatty acid metabolism 
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103537_at AF076681 Eif2ak3 -2,18 -1,07 electron transport 
160554_at AI839363 Eif3s6 -1,54 -0,51 protein biosynthesis 
96344_at X61600 Eno3 -1,62 -0,91 glycolysis 
94332_at AI882555 Ets1 -3,48 -1,21 --- 
100567_at M20497 Fabp4 -2,53 -1,28 transport 
94917_at AI844932 Fbxo8 -1,86 -0,64 ubiquitin-dependent protein catabolism 
97518_at D29016 Fdft1 -1,54 -0,87 lipid biosynthesis 
103699_i_at AI646638 Frat2 -2,92 -1,93 Wnt receptor signaling pathway 
102260_at AF017275 Gfi1b -1,52 -0,9 --- 
93268_at AI852001 Glo1 -1,61 -0,49 carbohydrate metabolism 
94897_at D87896 Gpx4 -2,08 -1,1 response to oxidative stress 
93750_at J04953 Gsn -1,92 -0,71 vesicle-mediated transport 
97819_at AI843119 Gsto1 -1,54 0,13 metabolism 
96710_at AI854262 H2afv -2,09 -0,87 nucleosome assembly 
95485_at D29639 Hadhsc -1,57 -0,36 lipid metabolism 
92580_at U39473 Hars -1,95 -0,62 protein biosynthesis 
104376_at AF006602 Hdac5 -1,56 -0,29 transcription 
104014_at Y12650 Hfe -1,83 -0,34 antigen presentation 
94288_at J03482 Hist1h1c -2,05 -1,85 nucleosome assembly  
94325_at AW124932 Hmgcs1 -1,67 -1,38 metabolism 
96048_at U50631 Hrsp12 -3,31 0,23 --- 
100451_at AF059275 Hsf1 -1,55 -0,06 transcription 
99053_at X65493 Icam2 -1,57 -0,56 cell adhesion 
160571_at AF020039 Idh1 -1,51 0,05 metabolism  
100552_at M28233 Ifngr1 -1,99 -0,48 intracellular signaling cascade 
95546_g_at X04480 Igf1 -1,84 -0,88 apoptosis 
102824_g_at X67210 Ighg -1,56 -1,16 --- 
102823_at X67210 Ighg -2,19 -1,64 --- 
98500_at D13695 Il1rl1 -1,61 -1,29 defense response 
100601_at AF022110 Itgb5 -3,69 0,45 cell adhesion 
97302_at AI854285 Ivns1abp -1,89 -1,27 --- 
103310_at AA220427 Jarid1b -3,2 -0,87 transcription 
102892_at U65592 Kcnab2 -1,51 0,03 transport  
95490_at AW120891 Kdelr1 -1,51 -0,63 transport 
96168_at AI591702 Kif23 -2 -1,63 --- 
99622_at U20344 Klf4 -1,95 -1,08 transcription 
94477_at AW123796 LOC434498 -2,39 -1,46 --- 
101083_s_at AF109905 Lsm2 -2,6 -0,05 --- 
160553_at X63782 Ly6d -5,02 -4,24 defense response 
100468_g_at X57687 Lyl1 -2,15 -1,55 transcription  
100467_at X57687 Lyl1 -1,92 -0,91 transcription  
104677_at AI852008 Man1b1 -1,79 -0,86 ER-associated protein catabolism 
103020_s_at AI317205 Map3k1 -1,83 -1,16  protein amino acid phosphorylation  
98036_at AA870525 Marveld1 -2,19 -1,82 --- 
96012_f_at AI835367 Matr3 -2,02 -1,34 --- 
96013_r_at AI835367 Matr3 -2,01 -1,07 --- 
97451_at AI837599 Mcfd2 -1,64 -0,42 transport  
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103599_at M20824 Mdm1 -2,21 -1,31 --- 
97357_at AI426400 Mef2c -2,88 -2,05 regulation of transcription, DNA-dependent  
93039_at AF009513 MGI:1889205 -3,62 -1,71 --- 
102340_at AA833077 Mina -1,64 -0,77 regulation of cell proliferation 
101007_at AI845732 Mknk2 -1,71 -0,15 regulation of protein biosynthesis 
95338_s_at M82831 Mmp12 -2,17 -1,19 proteolysis and peptidolysis 
95339_r_at M82831 Mmp12 -2,26 -1,68 proteolysis and peptidolysis 
103226_at Z11974 Mrc1 -3,54 -1,7 endocytosis 
160431_at AW124432 Mrpl12 -1,91 -0,7 protein biosynthesis 
96864_at AI848770 Mrps26 -1,65 -0,86 ribosome biogenesis 
162009_f_at AV246753 Msh2 -2,52 -1,1 DNA metabolism  
99024_at U32395 Mxd4 -1,81 -0,41 transcription 
98586_at AW107230 Nap1l1 -2,01 -1,46 nucleosome assembly 
95961_at AW122131 Nbeal2 -1,74 -1,39 --- 
95129_at AW121057 Ncor2 -1,53 -0,65 transcription  
94982_f_at AI852470 Nme3 -2,44 -1,12 nucleotide metabolism 
94981_i_at AI852470 Nme3 -2,39 -1,02 nucleotide metabolism 
98604_at U79774 Nnp1 -1,6 -0,98 rRNA processing 
160732_at AA726383 Npepl1 -3,94 -1,8 --- 
103922_f_at AI839690 Nqo3a2 -1,54 -0,86 lipid biosynthesis 
100125_at U43918 Pa2g4 -1,62 -0,64 transcription 
92775_at AA656757 Pabpc4 -1,55 -1,01 --- 
95470_at AI846025 Pak1ip1 -1,58 -1,18 --- 
101957_f_at X14206 Parp1 -2,76 -0,98 DNA metabolism 
93615_at AF020200 Pbx3 -1,72 -0,49 transcription  
103029_at D86344 Pdcd4 -2,9 -1,61 --- 
101042_f_at U51014 Pep4 -1,61 -0,68 proteolysis and peptidolysis  
93421_at AF033655 Pftk1 -2,29 -0,99  transport 
160419_r_at AA866869 Phgdhl1 -1,52 -1,12 --- 
160615_at AI835963 Pias3 -1,77 -1,59 transcription  
100607_at AF026124 Pld3 -1,87 -0,77 metabolism 
100927_at U28960 Pltp -2,86 -1,12 transport  
160439_at U53584 Polg -2,38 -0,26 DNA replication 
97926_s_at U10374 Pparg -2,09 -0,34 transcription 
93116_at J02626 Prkacb -2,03 -1,29 protein amino acid phosphorylation 
160204_at AI838470 Prr6 -2,54 -1,14 --- 
160328_at AI838015 Prss15 -3,77 -1,2 --- 
104030_at AI848841 Ptch1 -1,65 -0,78 organogenesis 
161694_f_at AV230409 Ptgs1 -1,87 -0,57  lipid biosynthesis 
99600_at AI838337 Ptov1 -1,84 -0,8 --- 
92356_at M90388 Ptpn22 -1,5 -0,47 protein amino acid dephosphorylation 
94998_at AI838452 Rala -1,68 -0,63 small GTPase mediated signal transduction 
104680_at AJ250489 Ramp1 -2,06 -1,01 transport 
161757_f_at AV298789 Ranbp5 -3,07 -1,35 transport 
93070_at AI847564 Ranbp5 -1,57 -0,42 transport 
102419_at M34476 Rarg -2,86 -1,14 transcription 
93319_at U20238 Rasa3 -1,77 -0,81 intracellular signaling cascade 
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103457_at AF083464 Rev3l -1,64 -0,93 DNA replication 
97844_at U67187 Rgs2 -1,79 -1,51 cell cycle 
98057_at AW121162 Rnf166 -2 -1,09 --- 
161327_f_at AV104703 Rpl10a -2,29 -1,46 protein biosynthesis 
92834_at X51528 Rpl13a -1,87 -0,61 protein biosynthesis 
92857_at AI853960 Rpl22 -2,02 -0,36 protein biosynthesis 
101680_at X05021 Rpl27a  -1,83 -0,96 protein biosynthesis 
161480_i_at AV055186 Rplp1 -1,62 -1,03 protein biosynthesis 
99093_at AI852864 Rps10 -1,66 -1,01 transcription 
100003_at D38216 Ryr1 -2,21 -0,75 transport 
95453_f_at AF087687 S100a1 -1,9 -0,08 --- 
160388_at AI848668 Sc4mol -1,83 -1,2 lipid biosynthesis 
94057_g_at M21285 Scd1 -3,6 -1,95 lipid biosynthesis 
95758_at M26270 Scd2 -1,73 -0,55 lipid biosynthesis 
96060_at U25844 Serpinb6a -2,09 -1,2 --- 
160869_at AI849490 Sirt3 -1,66 -0,46 transcription 
99500_at U13174 Slc12a2 -3,38 -2,18 transport 
95060_at AF058054 Slc16a7 -1,57 -1,04 transport 
95733_at AI838274 Slc29a1 -1,58 -0,43 transport 
104380_at Z71268 Slc35a1 -1,58 -0,49 transport 
103877_at AW060485 Slc35c2 -1,94 -0,8 transport 
103527_at AW124360 Slc35e4 -1,96 -1,09 --- 
102384_at AI842968 Smarca2 -1,73 -1,09 transcription 
104408_s_at L35032 Sox18 -2,46 -1,65 transcription 
96192_at AF062567 Sp3 -1,76 -1,34 transcription 
94432_at AI117157 St6gal1 -2,25 -1,39 protein amino acid glycosylation 
102318_at X86000 St8sia4 -2,06 -1,61 protein amino acid glycosylation 
95513_at AW124310 Statip1 -1,94 -1,04 ubiquitin cycle 
103330_at AI838709 Strbp -2,58 -1,95 transcription 
160428_at AF058956 Suclg2 -1,65 -1,09  metabolism 
93728_at X62940 Tgfb1i4 -1,81 -0,66 transcription  
104601_at X14432 Thbd -2,94 -0,13 blood coagulation 
162023_f_at AV364086 Thbd -2,23 -1,02 blood coagulation 
93780_at AW060827 Them2 -1,86 -0,57 --- 
99603_g_at AF064088 Tieg1 -1,66 -0,73 transcription 
96708_at AW120643 Tmed3 -1,68 -0,6 intracellular protein transport 
99462_at D38046 Top2b -1,85 -1,05 DNA metabolism 
94554_at AW120965 Trappc5 -2,22 -1,56 --- 
103092_at AW124316 Trim37 -4,14 -0,53 --- 
95939_i_at AW047237 Trio -1,73 -0,76 --- 
95940_f_at AW047237 Trio -1,63 -0,61 --- 
97473_at AW124470 Tspan4 -2,61 -0,96 --- 
102423_at AI649125 Uxs1 -2,19 -1,13 carbohydrate metabolism 
92558_at M84487 Vcam1 -1,97 -1,69 cell adhesion 
95709_at AW012491 Vkorc1 -1,56 -0,29 vitamin K biosynthesis 
100523_r_at U92454 Wbp5 -1,51 -0,92 --- 
96836_r_at AI447619 Zfp161 -1,59 -0,98 transcription  
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104604_at U62908 Zfp96 -2,21 -0,56 transcription  
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162412_r_at AV317927 --- -2,08 -2,09 --- 
162198_f_at AV373027 --- -1,78 -1,7 --- 
101179_at D50494 --- -1,64 -1,99 --- 
95184_f_at AA419684 --- -1,39 -1,79 --- 
101363_at AI644801 --- -0,95 -1,89 --- 
161356_at AV207158 --- -1,46 -1,74 --- 
104429_at AF027865 --- -0,68 -1,54 --- 
96791_at AW047875 1500005K14Rik -1,09 -1,93 --- 
92316_f_at J00592 2010309G21Rik  -2,33 -2,65 --- 
97425_at AI840191 2210409B22Rik -1,43 -1,56 --- 
161018_at AI661590 2310010J17Rik -1,28 -2,05 --- 
93568_i_at AI853444 2610042L04Rik -0,67 -1,53 --- 
160934_s_at X05546 3110007P09Rik -1,47 -2,01 --- 
161735_r_at AV281129 5730469M10Rik -1,6 -1,85 --- 
93465_at AA711915 9130211I03Rik -1,13 -1,56 transcription 
98346_at AI593759 9530051K01Rik -1,64 -1,81 --- 
160236_at AI835624 9630044O09Rik -0,56 -3,88 --- 
93193_at X15643 Adrb2 -1,49 -1,69 signal transduction 
98758_at L34570 Alox15 -1,18 -1,77 metabolism 
97524_f_at X02578 Amy2 -1,36 -1,92 metabolism 
161467_f_at AV348528 Atp1b1 -0,96 -1,75 transport  
95284_at AI662509 BB219290 -1,3 -1,99 --- 
95893_at AA204265 Blk -1,68 -1,74 intracellular signaling cascade 
100772_g_at AF068182 Blnk -1,49 -1,67 intracellular signaling cascade 
94689_at C79248 C79248 -1,44 -1,97 --- 
92322_at X94353 Camp -2,17 -2,62 defense response 
99856_r_at AI852919 Catnd2 -1,88 -1,87 cell adhesion 
94232_at AI849928 Ccnd1 -0,94 -1,97 regulation of cell cycle 
99945_at M28240 Cd19 -1,14 -1,6 --- 
92683_at X02339 Cd3d -1,57 -2,99 cell surface receptor linked signal transduction 
102778_at X13450 Cd79a -1,59 -2,5 cell surface receptor linked signal transduction  
103040_at AI837100 Cd83 -0,33 -2,29 --- 
99820_f_at AA204255 Cecr5 -1,61 -1,55 metabolism 
93284_at D78135 Cirbp -1,11 -1,52 --- 
102794_at Z80112 Cxcr4 -1,36 -1,83 chemotaxis  
95701_at AW124069 Cxxc5 -0,06 -3,04 --- 
98072_r_at X77731 Dck -0,32 -1,52 nucleobase, nucleoside, nucleotide and nucleic acid 
metabolism 
100155_at L57509 Ddr1 -1,82 -2,3 cell adhesion 
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161788_f_at AV347228 Edg1 -1,44 -3,46 signal transduction 
161802_i_at AV369921 Egr1 -0,41 -3,06 transcription 
98575_at X13135 Fasn -2,02 -2,37 lipid biosynthesis 
94141_at X64224 Fcer2a -0,87 -3,13 defense response 
102065_at AB007813 Fcna -1,83 -1,57 transport  
95295_s_at X59398 Flt3 -1,98 -2,6 protein amino acid phosphorylation  
96172_at AA795946 Gimap4 -0,45 -1,54 --- 
102995_s_at M13226 Gzma 0,22 -2,25 apoptosis 
102274_at M95514 H2-Oa -1,57 -2,41 antigen processing  
92833_at L07645 Hal -1,08 -2,5 metabolism 
97318_at AI846197 Hars2 -0,74 -2,06 D-amino acid catabolism 
162457_f_at AV003378 Hba-a1 -1,15 -1,6 transport  
101869_s_at J00413 Hbb, Hbb-b1, 
Hbb-b2 
-1,5 -2,37 transport  
103534_at V00722 Hbb-b2 -1,95 -2,89 transport  
93067_f_at U62674 Hist2h2aa1, 
Hist2h2aa2 
-1,17 -1,93 --- 
96269_at AA716963 Idi1 -1,84 -2,4 lipid biosynthesis  
98974_at AI183084 Igh-5 -1,39 -1,9 humoral defense mechanism  
93584_at V00821 Igh-6  -1,99 -2,41 humoral immune response 
99420_at X94418 Igh-V7183 -1,76 -2,33 --- 
102372_at M90766 Igj -1,43 -2,18 humoral immune response 
102156_f_at M80423 Igk-C -1,75 -2,6 --- 
93086_at M18237 Igk-C  -1,2 -1,93 --- 
101656_f_at U60442 IgM -0,63 -1,55 --- 
93605_r_at AF061260 Igsf4a -1,06 -1,83 cell adhesion  
92286_g_at AA967539 Il4 -1,81 -3,27 immune response 
95511_at X69902 Itga6 -1,47 -1,63 cell adhesion  
93894_f_at U49866 Klra3 -1,06 -2,93 defense response 
93893_f_at U56404 Klra3 -0,74 -1,59 defense response 
101331_f_at U55641 LOC243467, 
LOC384419, 
LOC434044 
-1,86 -2,42 --- 
98776_at AF035203 LOC380800 -0,91 -1,91 --- 
100299_f_at U55576 LOC381783 -0,8 -2,41 --- 
160083_at M63335 Lpl -1,15 -2,67 lipid metabolism 
95611_at AA726364 Lpl -0,62 -1,59 lipid metabolism 
102940_at U16985 Ltb -0,93 -2,46 immune response 
99855_at AB006787 Map3k5 -1,14 -1,51 apoptosis 
104591_g_at L13171 Mef2c -1,08 -2,92 transcription 
93195_at AI957146 Mfhas1 -1,45 -2,19 --- 
94259_at AB024935 MGI:1929282 -1,63 -1,83 --- 
161107_r_at AA529901 Mogat2 -0,26 -1,57 lipid metabolism  
104173_at AA797989 Ms4a1 -1,76 -2,17 defense response 
99446_at M62541 Ms4a1 -1,13 -1,71 defense response 
103491_at AA968123 Nav1 -1,99 -1,99 microtubule bundle formation 
98118_at Y07708 Ndufa1 -1,95 -3,06 --- 
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162172_f_at AV365271 Nedd4 -1,58 -3 protein modification 
93101_s_at U96635 Nedd4 -1,41 -2,03 protein modification 
92271_at X63963 Pax6 -0,5 -1,56 transcription 
93694_at AF036893 Per2 -0,69 -3,4 transcription 
95073_at Y09046 Pex19 -0,82 -1,54 peroxisome organization and biogenesis 
160105_r_at AI847033 Pigk -0,91 -1,62 proteolysis and peptidolysis 
162252_f_at AV335799 Plekha1 -0,91 -1,59 --- 
161590_r_at AV290437 Plf, Mrpplf4 -1,08 -3,89 --- 
93915_at Z54283 Pou2af1 -1,22 -1,59 transcription 
162129_f_at AV378129 Ppfibp2 -1,72 -1,81 DNA integration 
160862_at AF035645 Ptp4a3 -1,52 -1,55 protein amino acid dephosphorylation 
98511_at L17076 Raly -1,67 -1,94 --- 
94545_at AW123115 Rtn1 -1,72 -1,8 nucleosome assembly 
97126_at D38218 Ryr3 -0,46 -1,92 transport 
99665_at U05252 Satb1 -1,65 -1,72 transcription 
94056_at M21285 Scd1 -1,32 -1,82 lipid biosynthesis 
93557_at U43285 Sephs2 -1,85 -1,72 --- 
98550_at AI854006 Set -1,65 -1,46 DNA replication 
103918_at AI846682 Slc15a2 -0,8 -1,72 transport  
100009_r_at X94127 Sox2 -0,57 -1,58 transcription  
93657_at U87620 Spib -0,62 -1,6 transcription 
97994_at AI019193 Tcf7 -0,1 -2,23 transcription 
104526_at U36393 Tcfeb -1,59 -1,63 transcription 
161516_r_at AV157222 Vapa -0,68 -1,64 --- 
97484_at AI852704 Zmynd11 -1,56 -1,71 transcription 
 
 
Cluster E2 
Probe set 
ID 
Public ID 
Gene 
Symbol 
pYV+ 
vs 
uninfected 
24h 
pYV+ 
vs 
uninfected 
72h 
GO 
Biological 
Process 
93372_at U73478 Anp32a -2,83 -3,4 --- 
92406_at D31956 Cd7 -2,68 -2,78 immune response 
160906_i_at AA184423 E430003D02Rik -3,58 -3,95 --- 
160857_at U30244 Efnb2 -3,04 -3,27 organogenesis 
97509_f_at U22324 Fgfr1 -4,51 -4,96 organogenesis 
94781_at V00714 Hba-a1 -2,46 -3,24 transport 
93351_at U44389 Hpgd -3,48 -2,77 prostaglandin metabolism 
161486_f_at AV080003 Igh-VJ558 -2,21 -3,25 --- 
100583_at J00475 Igh-VJ558 -2,69 -3,71 --- 
96964_at L14554 Igk-C , Igk-V28  -1,67 -5,05 --- 
93638_s_at J00579 Igl-V1 -4,19 -4,52 humoral immune response 
92737_at U20949 Irf4 -3,67 -4,56 transcription 
93677_at AF030311 Klrd1 -2,71 -2,75 --- 
102235_at X13945 Lmyc1 -3,55 -4,33 transcription 
93106_i_at M20878 LOC381765 -3,86 -4,38 --- 
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104592_i_at AI595996 Mef2c -4,8 -4,72 transcription 
96588_at D10204 Ptger3 -4,81 -6,46 signal transduction 
93855_at U91601 Rem1 -2,98 -3,06 small GTPase mediated signal transduction 
95387_f_at AA266467 Sema4b -3,2 -2,6 cell differentiation 
 
 
Supplementary table 2 
 
Probe sets differentially regulated in splenic CD11b+ cells isolated from C57BL/6 mice 
intravenously infected with Y. enterocolitica pYV+ ∆yopP strain compared to mice infected 
with the Y. enterocolitica pYV+ strain. 
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101826_at X58216 --- 2,54 -0,63 transcription 
162149_i_at AV325777 --- 1,8 0,37 transcription 
161060_i_at AV338120 2310061O04Rik 2 0,14 --- 
96748_i_at AA619554 9130011B11Rik -0,13 1,68 regulation of cell cycle 
92432_at AI844359 A630056B21Rik 2,14 0,41 ubiquitin-dependent protein catabolism 
95705_s_at J04181 Actb 1,37 2,79 transcription 
96260_at AB021491 AL033314 1,75 1,58 actin cytoskeleton organization and biogenesis 
93372_at U73478 Anp32a 2,16 2,83 cell communication 
93798_at AI839988 Atp1a1 1,81 1,25 proteolysis and peptidolysis 
93797_g_at AW123952 Atp1a1 2,3 1,74 proteolysis and peptidolysis 
95466_at AI837006 Cotl1 2,59 1,83 electron transport 
93285_at AI845584 Dusp6 1,9 1,24 immune response 
94941_at AJ243533 Eif2ak4 2,15 0,48 transport 
94332_at AI882555 Ets1 2,63 1,28 --- 
94781_at V00714 Hba-a1 1,79 0,07 cell adhesion 
101869_s_at J00413 Hbb-b1 1,66 -0,31 cell adhesion 
103534_at V00722 Hbb-b1 1,83 -0,28 cell adhesion 
160601_at AF015768 Lfng 1,86 0,78 glycogen metabolism 
160732_at AA726383 Npepl1 3,29 0,15 kidney development 
95357_at AI325802 Nvl 2,78 1,89 intracellular signaling cascade 
93694_at AF036893 Per2 -0,18 2,35 transcription 
93039_at AF009513 Pgcp 3,3 0,47 defense response 
160439_at U53584 Polg 1,56 -0,23 --- 
99916_at D90242 Prkch 1,79 0,93 --- 
97548_at AI155120 Prpf39 2,94 0,68 --- 
96554_r_at AW107462 Taf15 0,58 2,61 --- 
162430_at AV294852 Tor1b 2,33 0,09 activation of MAPK 
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94964_at L18880 Vcl 1,24 1,52 cell adhesion 
102277_at M36514 Zfp26 1,61 0,86 --- 
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95858_at C76988 --- -1,68 -0,9 --- 
161411_i_at AV315398 --- -1,85 0,47 development 
94113_at AA163908 --- -0,95 -3,89 exocytosis 
160934_s_at X05546 --- -3,79 -3,38 DNA repair 
92703_at AI325791 2310032M22Rik -1,19 -1,98 --- 
97749_at AI836270 9130415E20Rik -2,23 -1,76 ubiquitin-dependent protein catabolism 
160993_at AI854813 A630053O10 -2 -0,54 transforming growth factor beta receptor 
signaling pathway 
96188_at AF052506 Adar -1,73 -0,79 apoptosis 
93464_at AI561567 Akap9 -3,02 -4 protein amino acid phosphorylation 
103789_at AI854614 Brd4 -2,03 -2,54 regulation of cell cycle 
162366_r_at AV233144 C2 -1,82 -0,5 --- 
93721_at L12367 Cap1 -2,06 -1,93 transport 
100405_at X56683 Cbx3 -1,21 -2,01 electron transport 
98067_at U09507 Cdkn1a -1,66 -0,83 regulation of cell cycle 
100278_at U09968 Cdkn1b -2,32 -3,41 regulation of cell cycle 
161825_f_at AV381191 Ceacam10 -1,88 -0,05 --- 
160511_at L12029 Cxcl12 -0,96 -1,95 immune response 
93965_r_at AF038995 Ddx6 -1,58 -1,54 transcription 
93964_s_at AF038995 Ddx6 -1,56 -1,57 transcription 
103926_at AV380793 Eif4g1 -2,1 -1,31 G-protein coupled receptor protein signaling 
pathway 
102341_at L46651 Gla -3,67 -1,01 chemotaxis 
102995_s_at M13226 Gzma -2,05 0,73 fatty acid biosynthesis 
160101_at X56824 Hmox1 -2,46 -0,35 --- 
96696_at AI837110 Hrmt1l2 -1,88 -0,93 cytokine and chemokine mediated signaling 
pathway 
99334_at K00083 Ifng -2,43 -0,13 --- 
97574_f_at AF036736 Igh-VJ558 -2 0,29 --- 
93927_f_at L33954 Igh-VJ558 -1,9 0,56 --- 
104268_at X51975 Il6ra -1,63 -1,75 --- 
103022_at U23470 Map3k1 -0,46 -1,55 --- 
100484_at X66473 Mmp13 -1,97 0,64 receptor mediated endocytosis 
95351_at AA414339 Ncoa6 -0,6 -2,52 regulation of cell cycle 
160949_at AI848924 Parg -0,96 -2,66 transport 
97808_at AI844532 Sf3b1 -1,28 -1,55 cellular morphogenesis 
104158_at AW046671 Skiip -1,14 -2,1 regulation of transcription, DNA-dependent 
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99607_at Z47088 Skp1a -1,21 -1,83 transcription 
100947_at AI847906 Tcf20 -3,57 -0,69 --- 
99126_at L04961 Xist -1,83 -1,98 --- 
 
 
Supplementary table 3: Figure 3.11 
 
Probe sets differentially regulated in splenic CD11b+ cells isolated from C57BL/6 mice 
intravenously infected with Y. enterocolitica pYV+ ∆yopH strain compared to mice infected 
with the Y. enterocolitica pYV+ strain. 
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161299_r_at AV049751 --- --- 
161511_f_at AV152244 --- --- 
104400_at AF076956 0610042I15Rik --- 
97733_at U05673 Adora2b signal transduction 
96501_at AI506285 AI194738 --- 
93500_at M63245 Alas1 heme biosynthesishesis 
103899_at AA690863 Atp11a  metabolism 
102064_at L28095 Casp1 apoptosis 
102905_at Y13089 Casp11 apoptosis 
102736_at M19681 Ccl2 chemotaxis 
102424_at J04491 Ccl3 chemotaxis 
94146_at X62502 Ccl4 chemotaxis 
99413_at U29678 Ccr1 inflammatory response 
161968_f_at AV370035 Ccr5 chemotaxis 
102718_at AF022990 Ccr5 chemotaxis 
104443_at L31580 Ccr7 chemotaxis 
98088_at X13333 Cd14 inflammatory response 
94881_at AW048937 Cdkn1a regulation of cell cycle 
100022_at D89613 Cish immune response 
160415_at AI604314 Cldn1 --- 
97546_at AF072127 Cldn1 --- 
160526_s_at M60285 Crem transcription 
100533_s_at M60285 Crem transcription 
102638_at AB015224 Cst7 --- 
95348_at J04596 Cxcl1 inflammatory response 
101160_at X53798 Cxcl2 chemotaxis 
104371_at AF078752 Dgat1 --- 
94246_at J04103 Ets2 regulation of cell cycle 
103977_at AF087644 F10 blood coagulation 
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102921_s_at M83649 Fas apoptosis  
102779_at X54149 Gadd45b activation of MAPKK activity 
161666_f_at AV138783 Gadd45b activation of MAPKK activity 
92217_s_at U05265 Gp49a, Lilrb4 immune response 
93328_at X57437 Hdc --- 
96696_at AI837110 Hrmt1l2 protein amino acid methylation 
94384_at X67644 Ier3 --- 
100981_at U43084 Ifit1 immune response 
103639_at U43085 Ifit2 immune response 
92301_at AB016589 Ikbke protein amino acid phosphorylation 
161023_at U22339 Il15ra cell surface receptor linked signal transduction 
92689_at AB019505 Il18bp --- 
94755_at M14639 Il1a inflammatory response 
93871_at L32838 Il1rn inflammatory response 
98774_at L38281 Irg1 --- 
103432_at AW122677 Isg20 --- 
101820_at X70920 LOC546644 --- 
94688_at X83106 Mad transcription 
160118_at AF022432 Mmp14 proteolysis and peptidolysis 
102955_at U83148 Nfil3 regulation of transcription, DNA-dependent 
101554_at U57524 Nfkbia regulation of cell proliferation 
98988_at AA614971 Nfkbiz inflammatory response 
94461_at AI852144 Pbef1 pyridine nucleotide biosynthesis 
103508_at AA919750 Pcgf5 --- 
102696_s_at AI747899 Pitpnb transport 
102839_at D78354 Plscr1 --- 
98018_at L39017 Procr blood coagulation 
94158_f_at AF004858 Ptafr inflammatory response 
94159_at D50872 Ptafr inflammatory response 
104406_at AI060798 Ptges prostaglandin metabolism 
160608_at AI854462 Rab20 transport  
95785_s_at Y13361 Rab7 transport 
160708_at AI840446 Schip1 --- 
92978_s_at X16490 Serpinb2 --- 
98405_at U96700 Serpinb9 --- 
101877_at AI854432 Slc31a1 transport 
94556_at AI746846 Snx10 transport 
96042_at L35528 Sod2 superoxide metabolism 
101551_s_at X78989 Tes --- 
102629_at D84196 Tnf inflammatory response 
99392_at U19463 Tnfaip3 apoptosis 
103066_at L32973 Tyki dTDP biosynthesis 
98597_at AW048912 Ube2l6 protein modification 
100030_at D44464 Upp1 nucleoside metabolism 
95024_at AW047653 Usp18 ubiquitin-dependent protein catabolism 
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104419_at AI132380 --- --- 
102969_at AI847369 0610025P10Rik --- 
103748_at AW125627 4933407C03Rik --- 
104168_at AA791742 Actr2 cell motility 
96188_at AF052506 Adar RNA processing 
100584_at U72941 Anxa4 kidney development 
98473_at AF032466 Arg2 urea cycle 
98924_at Y08027 Art3 protein amino acid ADP-ribosylation 
97693_at C78513 C78513 --- 
98406_at AF065947 Ccl5 immune response 
102719_f_at X94151 Ccr5 immune response 
93617_at AF030185 Ccrl2 G-protein coupled receptor protein signaling pathway 
93908_f_at X16670 Ccrn4l rhythmic process 
93909_f_at X04120 Ccrn4l  rhythmic process 
102831_s_at U39456 Cd86 defense response 
98067_at U09507 Cdkn1a regulation of cell cycle 
104509_at AF059213 Ch25h metabolism 
93994_at AW212131 Chpt1 --- 
96551_at AB024717 Clec4e immune response 
94256_at AI849533 Clic4 transport 
100019_at D45889 Cspg2 cell adhesion 
101845_s_at M55219 Csprs, Sp100-rs --- 
95349_g_at J04596 Cxcl1 inflammatory response 
92758_at U09268 Dusp2 protein amino acid dephosphorylation 
102737_at U35233 Edn1 regulation of pH 
97689_at M26071 F3 blood coagulation 
92441_at Y10007 Fap proteolysis and peptidolysis 
101793_at X70980 Fcgr1 immune response 
102313_at L09737 Gch1 tetrahydrobiopterin biosynthesis 
102341_at L46651 Gla carbohydrate metabolism 
97525_at U48403 Gyk carbohydrate metabolism 
100013_at AW121732 Ifi35 immune response 
99334_at K00083 Ifng immune response 
103963_f_at AA914345 Iigp1 cytokine and chemokine mediated signaling pathway 
100773_at M86672 Il12a immune response 
161037_at U14332 Il15 immune response 
102218_at X54542 Il6 immune response 
100277_at X69619 Inhba growth 
101327_at U82610 Lcp1 response to wounding  
160618_at AA760613 Lgals8 --- 
160517_at M35153 Lmnb1 --- 
93997_at AI853475 MGI:1929890 --- 
104742_at AA919832 Mgst2 --- 
102360_at AW214225 Mthfr methionine metabolism 
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101727_at AF030896 Nfkbie regulation of transcription, DNA-dependent 
104420_at U43428 Nos2 defense response to bacteria 
94505_at AW124934 Peli1 --- 
102663_at X62700 Plaur cell surface receptor linked signal transduction 
93672_at U09928 Prkr immune response 
99589_f_at X07625 Prm1 nuclear organization and biogenesis 
104647_at M88242 Ptgs2 prostaglandin biosynthesis 
95803_at D85785 Ptpns1 phagocytosis 
160314_at AI839803 Pyp metabolism 
92901_at M60909 Rara  transcription 
104146_at AI853551 Rasip1 positive regulation of cell proliferation 
94972_at AB026569 Rbms1 DNA replication 
103231_at AA739233 Rhoh small GTPase mediated signal transduction 
93738_at M22998 Slc2a1 transport 
162206_f_at AV374868 Socs3 immune response 
97206_at AW230369 Spint1 --- 
99847_at X73523 St3gal1 protein amino acid glycosylation 
103328_at U59864 Tank I-kappaB kinase/NF-kappaB cascade 
101502_at X89749 Tgif transcription 
99144_s_at D50031 Tgoln1 --- 
93985_at AW120868 Tiparp protein amino acid ADP-ribosylation 
102959_at U61363 Tle4 transcription 
160489_at L24118 Tnfaip2 angiogenesis 
98474_r_at U83903 Tnfaip6 cell adhesion 
92962_at M83312 Tnfrsf5 apoptosis 
94112_at U37522 Tnfsf10 apoptosis 
95543_at AI843046 Tpm4 muscle development 
104582_g_at AI845438 Zdhhc6 --- 
94109_at AI850113 Zfp281 --- 
 
Cluster C 
Probe set 
ID 
Public ID 
Gene 
 Symbol 
GO 
Biological 
Process 
101912_at AI019679 1100001G20Rik --- 
95740_at AA727291 2300003P22Rik proteolysis and peptidolysis 
103024_at X13335 Adam8 cell-cell adhesion 
103759_at D31788 Bst1 defense response 
161825_f_at AV381191 Ceacam10 --- 
99952_at X93035 Chi3l1 carbohydrate metabolism  
99387_at L22181 Fpr1 chemotaxis 
101800_at AF071180 Fpr-rs2 --- 
97531_at X95280 G0s2 cell cycle 
98111_at L40406 Hsp105 protein folding 
102658_at X59769 Il1r2 inflammatory response 
161689_f_at AV223216 Il1r2 inflammatory response 
94171_at AF051367 Itgb2l cell-matrix adhesion 
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160564_at X81627 Lcn2 transport 
97420_at AW230891 Lrg1 --- 
102974_at U18424 Marco defense response 
94769_at U96696 Mmp8 proteolysis and peptidolysis 
96603_at AW123556 Qscn6 --- 
96747_at AW121294 Rhou small GTPase mediated signal transduction 
102712_at X03505 Saa3 acute-phase response 
104692_at M72332 Selp cell adhesion 
94752_s_at U10531 Skil cell differentiation 
101713_at AB022345 Slc7a11 transport 
97519_at X13986 Spp1 cell adhesion 
160469_at M62470 Thbs1 cell adhesion 
 
Cluster D 
Probe set 
ID 
Public ID 
Gene  
Symbol 
GO 
Biological 
Process 
97102_at AA276948 --- --- 
160272_at AI849356 --- --- 
102969_at AI847369 0610025P10Rik --- 
160378_at AI853127 1110006I15Rik --- 
160245_at AW045564 1110034O07Rik --- 
160787_at AW124900 1500010J02Rik --- 
92338_f_at AI957030 2310001H12Rik --- 
101404_at AI853654 2310061I09Rik --- 
160166_r_at AI843495 2810409H07Rik --- 
103667_at AA866655 A130034M23Rik --- 
103689_at AA833514 Abcc3 canalicular bile acid transport 
93193_at X15643 Adrb2 signal transduction 
100970_at X65687 Akt1 apoptosis 
100473_at AI851750 Arrb1 signal transduction 
93797_g_at AW123952 Atp1a1 cation transport 
103449_at AA795923 BC040823 --- 
96255_at AF067395 Bnip3l apoptosis 
104023_at AW060457 Cd300c,Cd300a --- 
98447_at M62362 Cebpa transcription 
101426_at AW125333 Cerk  protein kinase C activation 
102966_at AA934166 Cnot6l --- 
95466_at AI837006 Cotl1 --- 
94916_at AW122260 Cyp51 electron transport  
93821_at AW046101 D8Ertd594e --- 
102797_at X95281 Dhrs3 metabolism 
93285_at AI845584 Dusp6 protein amino acid dephosphorylation 
94332_at AI882555 Ets1 --- 
100567_at M20497 Fabp4 transport 
98575_at X13135 Fasn lipid biosynthesis 
95596_at AW122957 Foxk2 --- 
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93268_at AI852001 Glo1 carbohydrate metabolism 
93750_at J04953 Gsn vesicle-mediated transport  
92580_at U39473 Hars protein biosynthesis 
94781_at V00714 Hba-a1 transport 
103534_at V00722 Hbb-b2 transport 
104376_at AF006602 Hdac5 transcription 
160571_at AF020039 Idh1 metabolism 
102892_at U65592 Kcnab2 transport 
99603_g_at AF064088 Klf10 transcription 
102123_at Z31689 Lip1 lipid metabolism  
100467_at X57687 Lyl1 transcription 
101007_at AI845732 Mknk2 regulation of protein biosynthesis 
98524_f_at AI848479 Mtm1 protein amino acid dephosphorylation 
99024_at U32395 Mxd4 transcription 
98586_at AW107230 Nap1l1 nucleosome assembly 
95961_at AW122131 Nbeal2 --- 
103922_f_at AI839690 Nqo3a2 electron transport 
100125_at U43918 Pa2g4 proteolysis and peptidolysis 
160615_at AI835963 Pias3 transcription 
100607_at AF026124 Pld3 metabolism 
100927_at U28960 Pltp transport 
97926_s_at U10374 Pparg transcription 
101836_at D45859 Ppm1b protein amino acid dephosphorylation 
93116_at J02626 Prkacb protein amino acid phosphorylation 
95597_at M34141 Ptgs1 prostaglandin biosynthesis 
92356_at M90388 Ptpn22 protein amino acid dephosphorylation 
94998_at AI838452 Rala small GTPase mediated signal transduction 
104680_at AJ250489 Ramp1 transport 
93070_at AI847564 Ranbp5 protein-nucleus import, docking 
93319_at U20238 Rasa3 intracellular signaling cascade 
96038_at AI840339 Rnase4 --- 
160388_at AI848668 Sc4mol lipid biosynthesis 
93557_at U43285 Sephs2 --- 
96060_at U25844 Serpinb6a --- 
95733_at AI838274 Slc29a1 transport  
103877_at AW060485 Slc35c2 transport 
102384_at AI842968 Smarca2 nucleosome assembly 
95513_at AW124310 Statip1 --- 
160428_at AF058956 Suclg2 metabolism 
104526_at U36393 Tcfeb transcription 
104601_at X14432 Thbd blood coagulation 
160642_at AI853079 Tmem5 --- 
99462_at D38046 Top2b neuron migration 
94554_at AW120965 Trappc5 transport 
97473_at AW124470 Tspan4 --- 
100955_at AA989957 Ube2t ubiquitin cycle 
92558_at M84487 Vcam1 cell adhesion 
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Cluster E 
Probe set 
ID 
Public ID 
Gene 
Symbol 
GO 
Biological 
Process 
160955_at AW124904 2010309E21Rik --- 
96122_at AW049373 2310016A09Rik --- 
104513_at AA688938 2410004N09Rik --- 
104640_f_at AI464596 4930553M18Rik --- 
160921_at AW125884 Acas2l acetyl-CoA biosynthesis 
160927_at J04946 Ace proteolysis and peptidolysis 
161224_f_at AV258262 Ace proteolysis and peptidolysis 
98976_at AJ242912 Adamdec1 proteolysis and peptidolysis 
160255_at AA657044 Ahnak intracellular signaling cascade 
160495_at M94623 Ahr transcription 
96260_at AB021491 AL033314 transcription 
93372_at U73478 Anp32a --- 
104215_at AA592069 Atf6 regulation of cell cycle 
93798_at AI839988 Atp1a1 cation transport 
161331_r_at AV114328 Atp5d ATP biosynthesis 
96035_at L47335 Bckdha metabolism 
99514_at AI835443 Bmyc regulation of cell cycle 
103789_at AI854614 Brd4 --- 
95984_at AI586160 C79468 --- 
104589_at AF091096 C80913 protein folding 
103682_at AA122571 C80913 protein folding 
160479_at M29394 Cat response to oxidative stress 
102397_at AF038029 Cbfa2t3h granulocyte differentiation 
162384_f_at AV252118 Ccrn4l rhythmic process 
92406_at D31956 Cd7 immune response 
101908_s_at AF101164 Ceacam1, 
Ceacam2 
--- 
94465_g_at AF029347 Clcn3 transport  
97928_at AW045278 Cln6 lysosome organization and biogenesis 
93550_at D88792 Csrp2 cell differentiation 
102794_at Z80112 Cxcr4 chemotaxis 
104045_at AW122372 D10Bwg0791e nucleosome assembly 
99828_at AA673252 D3Ertd789e --- 
103460_at AI849939 Ddit4 --- 
161060_i_at AV338120 Ddx51 --- 
93964_s_at AF038995 Ddx6 --- 
93965_r_at AF038995 Ddx6 --- 
98989_at AF057368 Dhcr7 steroid biosynthesis 
100311_f_at U72032 Ear1 --- 
103537_at AF076681 Eif2ak3 protein biosynthesis 
96344_at X61600 Eno3 glycolysis 
102065_at AB007813 Fcna phosphate transport 
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97509_f_at U22324 Fgfr1 organogenesis 
103699_i_at AI646638 Frat2 Wnt receptor signaling pathway 
97819_at AI843119 Gsto1 metabolism 
104014_at Y12650 Hfe immune response 
94288_at J03482 Hist1h1c nucleosome assembly 
94325_at AW124932 Hmgcs1 acetyl-CoA metabolism  
93351_at U44389 Hpgd prostaglandin metabolism 
96048_at U50631 Hrsp12 --- 
96269_at AA716963 Idi1 lipid biosynthesis 
100552_at M28233 Ifngr1 --- 
95546_g_at X04480 Igf1 apoptosis 
102823_at X67210 Ighg --- 
93605_r_at AF061260 Igsf4a cell adhesion 
98500_at D13695 Il1rl1 defense response 
104268_at X51975 Il6ra cell surface receptor linked signal transduction 
92737_at U20949 Irf4 transcription 
100601_at AF022110 Itgb5 cell adhesion 
97302_at AI854285 Ivns1abp --- 
96168_at AI591702 Kif23 --- 
102235_at X13945 Lmyc1 regulation of cell cycle 
160934_s_at X05546 LOC435551 --- 
93568_i_at AI853444 LOC544991  --- 
160553_at X63782 Ly6d defense response 
99855_at AB006787 Map3k5 apoptosis 
103599_at M20824 Mdm1 --- 
93852_at AW045443 Mef2a transcription 
97357_at AI426400 Mef2c transcription 
93039_at AF009513 MGI:1889205 --- 
103226_at Z11974 Mrc1 endocytosis 
162009_f_at AV246753 Msh2 DNA metabolism 
93246_at AW260482 Narg1 angiogenesis 
103491_at AA968123 Nav1 microtubule bundle formation 
95129_at AW121057 Ncor2 transcription 
96153_at L37297 Ngp defense response 
100120_at L17324 Nid1 cell adhesion 
160732_at AA726383 Npepl1 proteolysis and peptidolysis  
103508_at AA919750 Pcgf5 --- 
160412_at U10903 Pdcd2 apoptosis 
103029_at D86344 Pdcd4 --- 
93421_at AF033655 Pftk1 electron transport  
160105_r_at AI847033 Pigk proteolysis and peptidolysis 
160204_at AI838470 Prr6 --- 
161757_f_at AV298789 Ranbp5 transport 
102419_at M34476 Rarg transcription 
98057_at AW121162 Rnf166 --- 
100732_at X73829 Rps8 ribosome biogenesis 
94394_at M21019 Rras regulation of cell cycle 
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94545_at AW123115 Rtn1 nucleosome assembly 
100003_at D38216 Ryr1 transport  
94057_g_at M21285 Scd1 lipid biosynthesis 
95387_f_at AA266467 Sema4b cell differentiation 
160869_at AI849490 Sirt3 transcription 
104158_at AW046671 Skiip transcription 
99500_at U13174 Slc12a2 transport  
95060_at AF058054 Slc16a7 transport  
162333_r_at AV093322 Slpi --- 
94432_at AI117157 St6gal1 protein amino acid glycosylation 
93106_i_at M20878 Tcrb-J cellular defense response 
102425_at U61362 Tle1 transcription 
103092_at AW124316 Trim37 protein ubiquitination 
102423_at AI649125 Uxs1 --- 
92202_g_at AI553024 Zbtb16 apoptosis 
104418_at AA796868 Znrf2 --- 
 
 
Supplementary table 4 
 
Probe sets differentially regulated in splenic CD11b+ cells isolated from uninfected IFN-
γR1-/- mice compared to uninfected C57BL/6 mice. 
 
Cluster A 
Probe set 
ID 
Public ID Gene  
Symbol 
IFN-γR1-/- 
vs 
C57BL/6 
GO 
Biological 
Process 
101617_s_at U59758 --- 1,63 --- 
98974_at AI183084 --- 1,79 --- 
104429_at AF027865 --- 1,97 --- 
102805_at M77196 --- 2,32 --- 
160799_at AW060549 --- 2,78 --- 
92740_at J00475 --- 4,23 --- 
94355_at AW048394 --- 4,34 --- 
92741_g_at J00475 --- 4,57 --- 
104314_r_at AI851206 1110032A03Rik 2,23 --- 
95031_at AW060212 1110059H15Rik 1,85 --- 
98894_at AA867655 2610016F04Rik 1,59 transcription 
93441_at AI595322 2700099C18Rik 2,27 --- 
101998_at AW125086 4833420G17Rik 1,74 --- 
160191_at AW122058 4931433E08Rik 2,15 --- 
96196_i_at AI851708 5730589K01Rik 1,83 transcription 
102870_at AW125272 5930418K15Rik 1,99 --- 
161114_i_at AV330064 6330509M23Rik 1,52 --- 
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160905_s_at AI840713 A030009H04Rik 1,94 --- 
102910_at M24417 Abcb1a 1,75 transport 
103615_at AA727023 AI447904 2,25 --- 
96069_at AI840094 Akr7a5 1,55 metabolism 
92288_at X54424 Ap1g1 3,86 protein complex assembly 
94512_f_at AI843210 Arcn1 2,41 --- 
93235_at AI020029 BB128963 1,79 --- 
102913_at AI324342 Bcl2a1a 3,16 apoptosis 
99405_at U30241 bd2, bj2 1,8 --- 
94363_at AI840815 Bms1l 1,55 --- 
95094_g_at AI035334 Ccar1 2,1 positive regulation of apoptosis 
98446_s_at U06834 Cct3 2,44 protein folding 
99434_at AF001036 Cd83 4,05 --- 
102831_s_at U39456 Cd86 1,56 defense response 
102806_g_at M77196 Ceacam1 1,55 --- 
160330_at AW122453 Chordc1 1,52 --- 
101937_s_at AF005423 Clk4 3,94 protein amino acid dephosphorylation 
93861_f_at M17327 Ctse 1,72 proteolysis and peptidolysis 
100300_at U43384 Cybb 3,04 transport 
98952_at AW120971 D8Ertd325e 3,31 --- 
92198_s_at L41365 Daf1, Daf2 2,75 immune response 
160935_at AI036466 Ddhd1 1,5 lipid catabolism 
93309_at U42386 Ddx3x 2 --- 
160286_at AA733594 Dek 1,51 transcription 
160153_at AI835917 Dnajc7 1,58 protein folding 
94941_at AJ243533 Eif2ak4 1,54 protein amino acid phosphorylation 
94253_at AW061243 Eif2s1 1,59 protein biosynthesis 
93722_at AJ005985 Ensa 1,94 regulation of insulin secretion 
101587_at U89491 Ephx1 2,71 proteolysis and peptidolysis 
102427_at AI849991 Fyttd1 1,93 --- 
99011_at U70538 Galnt3 1,93 --- 
95974_at M55544 Gbp1 2,2 immune response 
95392_at U68182 Gcnt2 2,78 --- 
92449_at AF002701 Gfra2 2,05 neurogenesis 
104402_at AA030469 Gtf3c4 1,77 transcription 
101868_i_at X90807 H2-DMb2 2,37 antigen processing 
160101_at X56824 Hmox1 2,38 response to stimulus 
96696_at AI837110 Hrmt1l2 3,71 protein amino acid methylation 
93226_i_at Z70661 Igh-1a 4,16 antibody-dependent cellular cytotoxicity  
96973_f_at X02468 Igh-V 1,91 --- 
97008_f_at L33943 Igh-V  1,99 antibody-dependent cellular cytotoxicity  
100721_f_at U10410 Igh-VJ558 1,66 --- 
101641_at M86751 Igk-V21 1,7 --- 
93638_s_at J00579 Igl-V1 1,91 humoral immune response 
98828_at X07640 Itgam 1,6 cell adhesion 
101327_at U82610 Lcp1 2,61 response to wounding 
97563_f_at AF042798 LOC211331 1,54 --- 
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93904_f_at AF059706 LOC238418 1,59 --- 
94389_at AA915720 Lsm5 2,2 transcription 
101946_at AA840463 Lypla1 2,11 lipid metabolism 
101945_g_at U89352 Lypla1 3,58 lipid metabolism 
160353_i_at X76850 Mapkapk2 2,08 protein amino acid dephosphorylation 
96011_at AB009275 Matr3 2,04 --- 
95338_s_at M82831 Mmp12 2,02 proteolysis and peptidolysis 
92644_s_at M12848 Myb 2,39 regulation of cell cycle 
103791_at AW048763 Narg1 2,24 angiogenesis  
93101_s_at U96635 Nedd4 1,79 protein modification 
93563_s_at AB017202 Nid2 1,58 cell adhesion 
93831_at AI316087 Nono 2,06 transcription 
99076_at U09504 Nr1d2 3,33 transcription 
160925_at X13664 Nras 2,49 regulation of cell cycle 
160189_at AI843747 Nudt4 2,06 --- 
95075_at AW229141 Nup35 1,77 --- 
160970_at AI848335 Odf2 1,63 --- 
103508_at AA919750 Pcgf5 1,51 --- 
101732_at M12039 Phxr5 1,58 --- 
101865_at AB009615 Pip5k2a 2 --- 
102696_s_at AI747899 Pitpnb 4,44 transport 
99916_at D90242 Prkch 1,75 protein amino acid dephosphorylation 
97919_at AI837467 Prpf38b 1,65 --- 
97560_at AF037437 Psap 3,66 lipid metabolism 
99433_at Y18101 Pstpip2 2,83 --- 
97363_at M95408 Ptk2 1,54 cell motility 
95803_at D85785 Ptpns1 1,59 phagocytosis 
101298_g_at M23158 Ptprc 3,03 protein amino acid dephosphorylation 
95785_s_at Y13361 Rab7 1,94 transport 
99032_at AF009246 Rasd1 3,44 small GTPase mediated signal transduction 
160192_at AF031568 Rbmxrt 1,71 RNA processing 
101902_at X17459 Rbpsuh 1,63 angiogenesis  
101966_s_at AF037206 Rnf13 2,21 proteolysis and peptidolysis 
93164_at Y12783 Rnf2 4,69 transcription 
100980_at U58512 Rock1 1,7 apoptosis 
100612_at K02927 Rrm1 2,72 DNA replication 
160795_at AW123662 Scamp1 1,84 transport 
94057_g_at M21285 Scd1 1,92  lipid biosynthesis 
160373_i_at AI839175 Sdpr 2,06 --- 
99621_s_at AA690583 Sfpq 1,79 transcription 
160539_at X66091 Sfrs1 2,49 transcription 
98299_s_at AF099974 Slfn3, Slfn4 1,64 negative regulation of cell proliferation 
92343_at AF010138 Smarca3 2,19 transcription 
96333_g_at AW259199 Snx2 2,19 transport 
97160_at X04017 Sparc 1,61 --- 
101684_r_at X67863 Srst 1,58 transcription 
104249_g_at AW227650 Ssr3 4,78 cotranslational protein-membrane targeting 
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97310_at AW124318 St13 4,4 protein folding 
98775_at U28726 Stk3 3,95 apoptosis 
100426_s_at U36776 Syk 3,35 activation of MAPK activity 
93918_at AA673500 Taf9 2,29 transcription 
94262_at AI172920 Thrap3 2,17 transcription 
95543_at AI843046 Tpm4 1,61 muscle development 
99149_at AI851230 Trim59 1,56 --- 
97486_at AA693246 U2af1 1,82 transcription 
92560_g_at U12884 Vcam1 2,02 cell adhesion 
160583_at AA880988 Xlkd1 2,98 cell adhesion 
101883_s_at L22977 Xlr3a 2,48 --- 
104582_g_at AI845438 Zdhhc6 2,08 --- 
 
 
Cluster B 
Probe set 
ID 
Public ID Gene  
Symbol 
INF-γR1-/- 
vs 
C57BL/6 
GO 
Biological 
Process 
161476_at AV011715 --- -1,72 --- 
162496_r_at AV153195 --- -1,69 --- 
162379_r_at AV245272 --- -1,52 --- 
96791_at AW047875 1500005K14Rik -1,81 --- 
95740_at AA727291 2300003P22Rik -1,89 proteolysis and peptidolysis 
161462_r_at AV346841 2610005L07Rik -3,56 --- 
161387_i_at AV253622 5730555F13Rik -2,88 --- 
104206_at AA815845 5730557B15Rik -2,31 --- 
104035_at AW123795 9130404D08Rik -2,29 --- 
92913_at Z48670 Abcd2 -1,69  transport 
93100_at X13297 Acta2 -2,32 cytoskeleton organization and biogenesis 
161629_i_at AV037200 Afp -2,41  transport 
161088_r_at AV171460 Akap8 -1,99 mitotic chromosome condensation  
162034_r_at AV369210 Antxr2 -1,73 --- 
102815_at U65986 Anxa11 -1,78 --- 
98473_at AF032466 Arg2 -1,51 arginine metabolism 
102854_s_at U03434 Atp7a -1,54 transport 
93142_at D86603 Bach1 -2,57 transcription 
101217_at D18865 BC023892 -1,82 --- 
161214_r_at AV265258 BC037034 -2,01 --- 
162221_i_at AV112892 Blmh -2,17 proteolysis and peptidolysis 
103789_at AI854614 Brd4 -2,48 --- 
96037_at X61454 Bri3 -1,58 --- 
103759_at D31788 Bst1 -1,79 defense response 
100932_at AF084459 Capn1 -2,03 proteolysis and peptidolysis 
161825_f_at AV381191 Ceacam10 -2,47 --- 
103217_at Y14041 Cflar -2,05 proteolysis and peptidolysis 
99952_at X93035 Chi3l1 -1,93 metabolism 
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160655_at D85391 Cpd -2,33 proteolysis and peptidolysis 
97925_at AB028241 Csnk1e -1,88 protein amino acid dephosphorylation 
101436_at M34815 Cxcl9 -1,96 immune response 
99463_at X63023 Cyp3a13 -2,47 transport 
102224_at AF056187 D930020L01 -1,87 --- 
93965_r_at AF038995 Ddx6 -2,77 --- 
93964_s_at AF038995 Ddx6 -2,58 --- 
95944_at AV299153 Dhx36 -1,65 --- 
103994_at AI152867 Eif2c2 -2,16 protein biosynthesis 
92231_at D28818 Epb4.1l4a -3,02 --- 
160901_at V00727 Fos -2,78 regulation of cell cycle 
160850_at U32197 Fpgs -1,68 folic acid and derivative biosynthesis 
160873_at AV206059 Ghrl -1,86 regulation of physiological process 
100514_at M63660 Gna13 -1,92 angiogenesis 
103215_g_at AW048883 Hspb2 -2,18 protein folding 
100552_at M28233 Ifngr1 -1,7 --- 
98776_at AF035203 Igh-6 -2,4 humoral defense mechanism 
96764_at AJ007971 Iigp1 -2,82 cytokine and chemokine mediated 
signaling pathway 
102658_at X59769 Il1r2 -1,58 inflammatory response 
104268_at X51975 Il6ra -2,22 cell surface receptor linked signal 
transduction 
94137_at L13239 Il8rb -2,45 chemotaxis 
161407_i_at AV312395 Inpp1 -1,55 --- 
162193_f_at AV371872 Itgb7 -2,05 cell adhesion 
102362_i_at U20735 Junb -2,56 regulation of cell cycle 
102364_at J04509 Jund1 -1,86 regulation of cell cycle 
161796_r_at AV367240 Kcnq1 -1,54 transport 
96109_at U25096 Klf2 -1,55 transcription 
161301_f_at AV049898 Lgals9 -2,81 --- 
97420_at AW230891 Lrg1 -1,61 --- 
104592_i_at AI595996 Mef2c -4,55 transcription 
97510_at AJ001118 Mgll-rs1 -2,85 --- 
94769_at U96696 Mmp8 -1,5 proteolysis and peptidolysis 
162369_f_at AV239570 Mmp9 -1,57 proteolysis and peptidolysis 
98010_at L09600 Nfe2 -1,59 transcription 
161912_r_at AV377244 Numb -1,6 development 
102583_at AJ132195 Olfr138 -2,02 G-protein coupled receptor protein 
signaling pathway 
104648_at AI844597 Pacs1 -1,77 protein-Golgi targeting 
162475_f_at AV092014 Pglyrp1 -1,81 apoptosis 
104099_at AF076482 Pglyrp1 -1,78 apoptosis 
103387_at AB011550 Phf1 -1,57 transcription 
160829_at U44088 Phlda1 -2,66 FasL biosynthesis 
161270_i_at AV319920 Prkwnk1 -1,97 protein amino acid dephosphorylation 
160739_at AI835081 Prkwnk1 -1,72 protein amino acid dephosphorylation 
104647_at M88242 Ptgs2 -2,23 prostaglandin biosynthesis 
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94929_at M97590 Ptpn1 -1,94 protein amino acid dephosphorylation 
92303_at D31898 Ptprr -2,37 protein amino acid dephosphorylation 
103067_at Z48587 Rala -1,55 small GTPase mediated signal 
transduction 
102131_f_at AU014874 Rnf20 -1,93 --- 
161480_i_at AV055186 Rplp1 -1,76 protein biosynthesis 
104177_at AA204579 Rsad2 -1,53 --- 
104106_at AI837830 Sbno1 -2,02 --- 
94181_at AJ223206 Scrg1 -1,76 --- 
161935_r_at AV329249 Sh3bgr -2,44 --- 
162007_i_at AV337065 Sipa1 -1,7 regulation of cell cycle 
161650_at AV090497 Slpi -1,87 --- 
103680_at AA683850 Srpr -1,76 protein targeting 
94104_at AF051911 Tert -1,97 telomere maintenance 
161385_r_at AV250738 Tph1 -2,86 metabolism 
100348_at AW214136 X83313 -1,98 --- 
100897_f_at AF100956 Zfp297 -3,17 --- 
 
Supplementary table 5 
Probe sets differentially regulated in splenic CD11b+ cells isolated from IFN-γR1-/- mice 
intravenously infected with Y. enterocolitica pYV+ strain compared to C57BL/6 infected 
mice. 
 
 
 Public ID Gene Symbol 
INF-γR1-/- 
vs 
C57BL/6 
24 h 
INF-γR1-/- 
vs 
C57BL/6 
72 h 
GO 
Biological 
Process 
100880_at AA816121 --- -0,42 -1,79 --- 
100944_at AA958903 --- -2,14 -1,67 --- 
101223_r_at C77112 --- 2,96 -0,57 --- 
102254_f_at AA289585 --- -0,94 -2,49 --- 
160799_at AW060549 --- 0,15 2,72 --- 
160906_i_at AA184423 --- -0,66 1,73 --- 
161317_r_at AV088715 --- 1,71 0 --- 
161369_r_at AV239611 --- 2,13 -0,47 --- 
161448_f_at AV355612 --- -0,91 -1,54 --- 
161511_f_at AV152244 --- -0,01 -1,99 --- 
162393_at AV266447 --- 3,07 -0,12 --- 
92320_f_at AA415783 --- 0,97 2,86 --- 
95184_f_at AA419684 --- -0,28 2,05 --- 
96215_f_at AI153421 --- -1,18 -2,11 --- 
104314_r_at AI851206 1110032A03Rik 0,06 1,64 --- 
160359_at AI854358 1190002H23Rik 0,46 1,69 cell cycle 
160184_at AA815795 1200007D18Rik 0,7 1,52 transport 
96791_at AW047875 1500005K14Rik 0,07 1,87 --- 
104000_at AI181346 2210023G05Rik -0,19 4,74 --- 
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95740_at AA727291 2300003P22Rik -0,04 2,55 proteolysis and peptidolysis 
92338_f_at AI957030 2310001H12Rik 0,53 -1,59 --- 
93138_at AI853219 2410012H22Rik 1,73 -0,05 --- 
97247_at AW124778 2610034N03Rik -0,41 -1,55 metabolism 
93568_i_at AI853444 2610042L04Rik -0,61 2,08 --- 
93569_f_at AI853444 2610042L04Rik  -1,08 1,83 --- 
99080_at AI853930 2810012H18Rik -0,01 -1,79 --- 
102910_at M24417 Abcb1a 0,75 -2,55 transport 
101578_f_at M12481 Actb -0,91 2,02 --- 
104578_f_at AI195392 Actn1 0,39 1,63 --- 
104579_r_at AI195392 Actn1 0,86 1,57 --- 
92280_at AA867778 Actn1 0,72 3,4 --- 
100450_r_at L48015 Acvrl1 0,33 1,61 protein amino acid phosphorylation 
98632_at M10319 Ada 0,33 2,01 immune response  
100751_at AF011379 Adam10 2 -0,11 proteolysis and peptidolysis 
104326_at AI838951 Adpgk 0,61 3,01 carbohydrate metabolism 
103615_at AA727023 LOC545384 0,49 -1,71 --- 
102330_at D86382 Aif1 -0,54 -2,09 actin filament bundle formation 
93464_at AI561567 Akap9 -0,48 -2,73 --- 
97111_at AA290180 Als2cr3 1,1 2,08 --- 
93037_i_at M69260 Anxa1 0,76 1,78 cell cycle 
102815_at U65986 Anxa11 0,14 1,92 --- 
101393_at AJ001633 Anxa3 0,75 1,5 --- 
92288_at X54424 Ap1g1 1,64 -0,76 transport 
99915_at L41352 Areg 2,63 3,7 --- 
93097_at U51805 Arg1 2,54 1,24 arginine metabolism 
98084_at AI849834 Arl2bp 0,58 2,07 --- 
104155_f_at U19118 Atf3 -1,47 -1,63  transcription 
93142_at D86603 Bach1 -1,58 -1,54 transcription 
95247_at AA517754 BB001228 2,66 0,11 --- 
100949_at AI461767 BC004044 0,45 1,88 --- 
102913_at AI324342 Bcl2a1a 1,1 -1,79 apoptosis  
99018_at AA874446 Bclaf1 1,8 0,04 transcription 
103707_at U77461 C3ar1 1,56 -0,29 chemotaxis  
97710_f_at AI425990 C530046L02Rik 1,01 1,56 --- 
101728_at S46665 C5r1 1,61 0,84 chemotaxis 
92322_at X94353 Camp -0,13 2,4 defense response  
102424_at J04491 Ccl3 1,73 -1,29 chemotaxis 
98406_at AF065947 Ccl5 -1,09 -2,82 immune response  
102719_f_at X94151 Ccr5 1,55 -1,16 chemotaxis 
93617_at AF030185 Ccrl2 -0,52 -1,64 G-protein coupled receptor protein 
signaling pathway 
103281_at AF077003 Cd2ap -0,4 -2,16 --- 
98980_at U18372 Cd37 0,11 1,5 --- 
160493_at D16432 Cd63 0,5 2,15 --- 
100278_at U09968 Cdkn1b -0,92 -1,94 cell cycle 
101637_at L38422 Ceacam10 1,39 2,84 --- 
161825_f_at AV381191 Ceacam10 1,15 3,32 --- 
99952_at X93035 Chi3l1 0,57 1,86  metabolism 
101956_at AI834849 Ckap4 0,62 2,31 --- 
94255_g_at AI845237 Clic4 -0,54 -1,5 transport 
93688_at D21826 Cmah 2,96 1,64 transport 
160150_f_at AW125626 Cnn3 -3,13 -1,27 smooth muscle contraction 
94305_at U03419 Col1a1 0,26 4,33 cell adhesion 
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101080_at AB009993 Col5a1 0,38 4,34 cell adhesion 
92851_at U49430 Cp 0,06 2,48 transport 
103581_at Y14004 Cte1 0,14 1,66 lipid metabolism 
96912_s_at X15591 Ctla2a, Ctla2b 0,2 1,87 --- 
103518_at X15592 Ctla2b -0,32 3,18 --- 
95348_at J04596 Cxcl1 1,9 0,61 inflammatory response 
93858_at M33266 Cxcl10 -0,09 -3,23 immune response 
160511_at L12029 Cxcl12 0,91 2,99 chemotaxis  
102025_at AF030636 Cxcl13 0,82 4,8 chemotaxis 
101160_at X53798 Cxcl2 1,78 0,56 chemotaxis 
101436_at M34815 Cxcl9 -5 -8,13 immune response 
98045_s_at U18869 Dab2 2,6 0,72 cellular morphogenesis during 
differentiation 
103617_at D63679 Daf1 1,15 1,57 immune response 
92198_s_at L41365 Daf1, Daf2 0,86 4,2 immune response 
103460_at AI849939 Ddit4 1,36 1,7 --- 
93964_s_at AF038995 Ddx6 0,26 -1,56 --- 
160711_at AI844846 Decr1 0,08 -2,63 metabolism 
96679_at AW120711 Dnajb9 1,77 1,53 protein folding 
94492_at AB025406 Dstn 0,68 1,55 --- 
104687_at AJ006074 Edg6 0,1 1,86 signal transduction 
97426_at X98471 Emp1 2 1,01 cell growth 
100472_at D10727 Enah 2,03 4,8 development 
97317_at AW122933 Enpp2 0,79 2,57 nucleotide metabolism 
97689_at M26071 F3 -0,64 -1,99 blood coagulation 
160231_at AI851129 Farsla -0,04 -1,7 protein biosynthesis 
101793_at X70980 Fcgr1 -0,36 -2,36 immune response 
102879_s_at M31314 Fcgr1 -0,27 -1,99 immune response 
160424_f_at AI846851 Fdps -0,19 2,2 lipid biosynthesis 
99098_at AW045533 Fdps -0,13 2,02 lipid biosynthesis 
97509_f_at U22324 Fgfr1 -1,51 1,89  protein amino acid 
phosphorylation 
94297_at U16959 Fkbp5 0,8 2,67 protein folding 
92483_g_at AF006466 Fmnl1 0,21 1,97 actin cytoskeleton organization and 
biogenesis 
160088_at U90535 Fmo5 -0,51 5,55 electron transport 
99835_at AF017128 Fosl1 2,75 1,78 regulation of transcription, DNA-
dependent 
95756_at AI839681 Ftsj3 0,14 -1,61 --- 
97531_at X95280 G0s2 1,74 0,91 cell cycle 
98822_at X56602 G1p2 -0,34 -1,72 immune response  
160714_at AI046826 Gab1 3,66 0,38 activation of MAPK activity 
95974_at M55544 Gbp1 2,85 1,79 immune response 
104597_at AJ007970 Gbp2 -1,73 -3,77 immune response 
103202_at AW047476 Gbp4 -1,33 -2,71 immune response 
160335_at U95053 Gclm 0,95 1,63 glutathione biosynthesis 
94192_at Y17860 Gdap10 -0,68 -1,78 --- 
92449_at AF002701 Gfra2 3,73 -0,27 neurogenesis 
100085_at U30509 Ggt1 1,43 2,1 glutathione metabolism 
160873_at AV206059 Ghrl 0,77 2 regulation of physiological process 
100064_f_at M63801 Gja1 1,17 1,7 cell communication 
100065_r_at M63801 Gja1 2,35 0,12 cell communication 
160893_at AI882325 Gngt2 -0,64 -1,56 signal transduction 
96337_at AF033350 Gp1bb, Sept5 0,81 2,14 cell adhesion 
99441_at AW123852 Gphn -0,02 -2,16 protein targeting 
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104227_at AI504074 Gpr97 1,15 2,17 signal transduction 
102995_s_at M13226 Gzma -1,93 -2,19 apoptosis 
102877_at M12302 Gzmb -1,78 0,26 apoptosis 
92866_at X52643 H2-Aa -0,5 -1,58 immune response 
100998_at M21932 H2-Ab1, Rmcs1 -0,52 -1,74  immune response 
162346_f_at AV153894 H2-DMa -0,94 -2,6 immune response 
93092_at U35323 H2-DMa -1,12 -1,89  immune response 
98034_at U35330 H2-DMb1 -0,56 -2,73 immune response  
98035_g_at U35330 H2-DMb2 -0,47 -1,86 immune response  
94285_at X00958 H2-Eb1 -0,57 -1,51 immune response 
93865_s_at M35244 H2-T10, H2-T17, 
H2-T22,  H2-T9 
-0,99 -1,88 defense response 
101876_s_at M35247 H2-T10, H2-T17, 
H2-T22, H2-T9 
-0,71 -1,74 defense response 
97551_at AI846182 Hip1r -0,94 1,69 receptor mediated endocytosis 
93024_at M32460 Hist1h3g 0,25 2,28 nucleosome assembly 
96696_at AI837110 Hrmt1l2 1,73 0,31 embryonic development 
97867_at X83202 Hsd11b1 0,42 1,9 lipid metabolism 
101891_at Y09517 Hsd17b2 0,32 1,76 lipid biosynthesis 
98002_at M32489 Icsbp1 -1,73 -1,85 transcription 
100050_at M31885 Id1 1,7 2,86 regulation of angiogenesis 
97409_at U19119 Ifi1 -0,8 -2,32 defense response 
93321_at AF022371 Ifi203 -0,25 -2,17 immune response 
98465_f_at M31419 Ifi204 -0,23 -1,52 transcription 
94224_s_at M74123 Ifi205 -0,22 -2,32 transcription  
104750_at M63630 Ifi47 -0,97 -3,21 defense response 
100981_at U43084 Ifit1 -0,07 -1,91 immune response 
103639_at U43085 Ifit2 -1,02 -3,8 immune response 
93956_at U43086 Ifit3 -0,23 -3,29 immune response 
98776_at AF035203 Igh-6 0,42 -2,15 immune response  
102823_at X67210 Ighg -3,67 -2,63 --- 
102824_g_at X67210 Ighg -1,5 -0,28 --- 
160933_at U53219 Igtp -1,56 -2,53 --- 
103963_f_at AA914345 Iigp1 -3,5 -4,38 cytokine and chemokine mediated 
signaling pathway 
96764_at AJ007971 Iigp1 -5,41 -7,25 cytokine and chemokine mediated 
signaling pathway 
98410_at AJ007972 Iigp2 -1,05 -1,88 --- 
102658_at X59769 Il1r2 1,13 2,62 transport  
161689_f_at AV223216 Il1r2 1 2,61 transport 
103769_at X85999 Il1rap 2,08 2,41 cytokine and chemokine mediated 
signaling pathway 
98349_at X62646 Il6st 1,55 -0,22 signal transduction 
102401_at M21065 Irf1 -1,65 -1,41  immune response 
94171_at AF051367 Itgb2l 1,36 3,51 cell-matrix adhesion  
162193_f_at AV371872 Itgb7 -1,84 -2,41 cell adhesion 
94977_at X15373 Itpr1 -0,14 -1,51 transport 
104121_at M90365 Jup 0,77 2,71 cell adhesion 
101624_at AF008573 Kcns1 0,14 2,04 transport 
97937_at AA611766 Klf5 0,7 2,21 angiogenesis 
93527_at Y14296 Klf9 1,16 1,95 transcription 
93679_at AF030313 Klrk1 -2,25 0,54 --- 
101327_at U82610 Lcp1 2,26 -0,24 response to wounding 
160517_at M35153 Lmnb1 0,69 1,81 --- 
94389_at AA915720 Lsm5 -2,13 0,04 mRNA processing 
101115_at J03298 Ltf 1,15 3,8 transport 
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93078_at X04653 Ly6a -1,77 -1,87 --- 
103258_at U19271 Ly75 -0,32 1,63 immune response 
94425_at AB007599 Ly86 -0,86 -2,13 immune response 
97447_at AI836718 Map1lc3a 0,12 1,76 ubiquitin cycle 
99367_at AA434661 Mapre1 1,55 0,02 cell cycle 
102974_at U18424 Marco 1,8 4,01 phosphate transport 
104591_g_at L13171 Mef2c 0,07 -2,02 transcription 
104592_i_at AI595996 Mef2c -2,18 -3,03 muscle development 
98312_at AB016768 MGI:2183426 -3,87 -3,7 --- 
101159_at Z23066 Mitf 0,04 -1,65  transcription  
94769_at U96696 Mmp8 1,4 1,83 proteolysis and peptidolysis 
98373_at AI462516 Ms4a4c 0 -1,59 --- 
93573_at V00835 Mt1 0,91 1,96 nitric oxide mediated signal 
transduction 
98417_at M21038 Mx1 -0,24 -2,19 immune response  
92644_s_at M12848 Myb 0,03 4 regulation of cell cycle 
93427_at AW122310 Myo1d 0,67 1,57 cytoskeleton organization and 
biogenesis 
93590_at AI844370 Ndst1 0,54 1,58 polysaccharide biosynthesis  
93101_s_at U96635 Nedd4 0,58 2,89 protein modification 
103234_at M35131 Nefh 1,38 2,83 intermediate filament cytoskeleton 
organization and biogenesis 
160846_at AI846534 Nek6 0,82 2,12 protein amino acid phosphorylation 
96153_at L37297 Ngp 1,06 2,48 defense response 
93563_s_at AB017202 Nid2 2,53 0,29 cell adhesion 
96259_at U35646 Npepps 0,4 1,8 proteolysis and peptidolysis 
94351_r_at U12961 Nqo1 1,23 2,22 electron transport 
98818_at X04435 Nr3c1 1,62 0,19 transcription 
92773_at AF079528 Nrp1 -0,99 -1,87 angiogenesis 
95016_at D50086 Nrp1 -1,55 -2,17 angiogenesis 
95075_at AW229141 Nup35 0,08 1,75 --- 
100436_at M27008 Orm1 0,04 3,79 transport 
100437_g_at M27008 Orm1, Orm2 0,19 4,64 transport 
103278_at AB013850 Padi4 -0,01 1,52 protein modification 
160412_at U10903 Pdcd2 -0,1 -1,88 apoptosis 
95423_at Y00884 Pdia4 1,8 0,6 electron transport 
93619_at AF022992 Per1 0,73 1,91 transcription 
93694_at AF036893 Per2 0,44 2,56 transcription 
104099_at AF076482 Pglyrp1 -0,13 2,56 apoptosis 
162475_f_at AV092014 Pglyrp1 0,08 2,86 apoptosis 
160829_at U44088 Phlda1 2,06 1,61 FasL biosynthesis 
103299_at AW123773 Pld4 -0,29 -1,66 --- 
102839_at D78354 Plscr1 0,82 2,25 --- 
103943_at AI838513 Ppfia4 -0,22 -3,71 --- 
100606_at M18070 Prnp 0,36 3,05 response to oxidative stress 
98018_at L39017 Procr -1,76 -1,6 blood coagulation 
93389_at AF039663 Prom1 0,91 2,27 phototransduction 
93390_g_at AF039663 Prom1 0,06 1,9 phototransduction 
97560_at AF037437 Psap 2,36 -0,16 lipid metabolism 
101486_at Y10875 Psmb10 -1,42 -1,62 ubiquitin-dependent protein 
catabolism 
93085_at D44456 Psmb9 -1,44 -1,53  immune response 
95597_at M34141 Ptgs1 0,51 1,93 lipid biosynthesis 
104647_at M88242 Ptgs2 0,94 -1,91 prostaglandin biosynthesis 
97363_at M95408 Ptk2 0,43 1,29 blood vessel development 
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100427_at U37465 Ptpro -0,85 -1,95 protein amino acid 
dephosphorylation 
96602_g_at AW045751 Qscn6 1,36 2,29 --- 
96603_at AW123556 Qscn6 1,52 3,43 --- 
160965_at AA163960 Rasa4 -1,22 -2,09 intracellular signaling cascade 
99032_at AF009246 Rasd1 0,1 5,16 small GTPase mediated signal 
transduction 
103804_at AB006960 Reck 0,91 2,64 cell cycle 
99028_at AI788534 Rnf8 0,11 2,18 protein ubiquitination 
104177_at AA204579 Rsad2 0,02 -1,97 --- 
95544_at AI843150 Rusc1 0,27 1,6 --- 
160795_at AW123662 Scamp1 1,96 1,67 transport 
94057_g_at M21285 Scd1 0,67 1,7 lipid biosynthesis 
161132_at AA727482 Scel 2,29 1,56 --- 
94181_at AJ223206 Scrg1 0,16 3 --- 
160373_i_at AI839175 Sdpr 1,37 3,05 --- 
104692_at M72332 Selp 0,19 1,52 inflammatory response 
102860_at M64085 Serpina3g -2,05 -1,74 apoptosis 
92978_s_at X16490 Serpinb2 2,68 0,71 --- 
94147_at M33960 Serpine1 -1,65 4,12 regulation of angiogenesis 
97487_at X70296 Serpine2 1,55 4,37 development 
161935_r_at AV329249 Sh3bgr 0,75 1,77 --- 
99876_at U29056 Sla 1,97 0,67 intracellular signaling cascade 
102947_at AJ006036 Slc22a2 1,84 -0,1 ion transport  
97957_at AF072759 Slc27a4 0,52 1,84 metabolism 
92292_at M75135 Slc2a3 2,23 0,83 transport  
93471_at AI594427 Slc4a7 -0,25 -1,5 anion transport 
101713_at AB022345 Slc7a11 2,15 0,15 transport 
103830_at M95604 Snai1 1,87 3,71 development  
92832_at U88325 Socs1 -2,06 -0,78 immune response 
97160_at X04017 Sparc 0,66 3,65 --- 
97519_at X13986 Spp1 2,6 0,21 cell adhesion 
103680_at AA683850 Srpr -0,35 -1,63 protein targeting 
104249_g_at AW227650 Ssr3 2,07 -0,49 cotranslational protein-membrane 
targeting 
98596_s_at Y15003 St3gal5 -2,79 2,87 protein amino acid glycosylation 
101465_at U06924 Stat1 -0,71 -1,92 transcription 
100426_s_at U36776 Syk 3,75 -0,33 activation of MAPK activity  
103035_at U60020 Tap1 -1,37 -1,84 immune response 
102873_at U60091 Tap2 -1,69 -0,91 immune response 
93367_at U86137 Tep1 -0,48 -1,56 telomere maintenance 
101551_s_at X78989 Tes 1,79 1,22 --- 
92427_at D25540 Tgfbr1 1,79 -0,53 embryonic development  
93882_f_at D50032 Tgoln1, Tgoln2 1,57 -0,62 --- 
102906_at L38444 Tgtp -2,91 -5,96 --- 
160469_at M62470 Thbs1 3,43 1,49 cell adhesion 
160613_at AW049768 Tinagl 0,58 1,81 proteolysis and peptidolysis 
96748_i_at AA619554 Tmem30b 2,23 -0,01 --- 
160817_at AA727424 Tmem40 -0,09 1,82 --- 
99392_at U19463 Tnfaip3 1,63 -0,73 apoptosis 
92962_at M83312 Tnfrsf5 -1,28 -1,68 apoptosis 
161361_s_at AV213431 Tnnt1 0,38 4,59 muscle development 
161385_r_at AV250738 Tph1 3,29 0,99 serotonin biosynthesis 
160376_at AW125508 Trp53inp2 0,34 2,42 --- 
160085_at U35741 Tst 1,19 1,57 sulfate transport 
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92715_at AL078630 Ubd -2,96 -0,97 protein modification 
94367_at AI850362 Uck2 2,29 0,38 carbohydrate metabolism 
95024_at AW047653 Usp18 -0,3 -2 ubiquitin-dependent protein 
catabolism 
93463_at AW122517 Usp19 2,27 -0,37 ubiquitin-dependent protein 
catabolism 
97960_at AW125800 Usp22 1,57 0,58 --- 
94964_at L18880 Vcl 1,63 0,13 cell adhesion 
104181_at AJ132103 Vnn3 -0,52 -1,6 nitrogen compound metabolism 
161337_f_at AV121930 Wars -1,47 -1,51 protein biosynthesis 
98605_at AI851163 Wars -1,83 -1,36 protein biosynthesis 
98606_s_at X69656 Wars -1,48 -1,77 protein biosynthesis 
160583_at AA880988 Xlkd1 2,16 2,82  cell adhesion 
101883_s_at L22977 Xlr3a, Xlr3b 0,1 -1,5 --- 
102259_at AF058799 Ywhag 2,52 -0,11 signal transduction 
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